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Abstract 
Chronic exposure to arsenic causes negative health outcomes, particularly malignant neoplasms 
of the skin, lung and bladder. Although epidemiological data has associated arsenic exposure to 
cancer, a clear molecular mechanism has remained elusive. This thesis studied the impact of 
As2O3 exposure on histone acetylation and microRNA expression at both tolerated and toxic 
levels in vitro to determine an epigenetic-based mechanism of carcinogenesis. 
This thesis outlines a framework for identifying tolerated and toxic As2O3 exposures, as a 
prerequisite to epigenetic characterisation. Tolerated As2O3 exposure increased cellular survival, 
anchorage-independent colony formation, cell-cycle progression and proliferation in HEK293T 
cells. HEK293T and UROtsa cells treated with tolerated As2O3 exhibited global H3K9 
hyperacetylation at 3 hours and global H3K9 hypoacetylation at 72 hours. This was mediated by 
an imbalance in the intracellular HDAC2 to PCAF mRNA expression ratio. Global H3K9 
hypoacetylation occurred for both tolerated and toxic exposures, giving poor mechanistic 
differentiation between these separated cellular outcomes. Chromatin immunoprecipitation 
identified PCAF recruitment, E2F1 binding and H3K9 acetylation at the FOS proto-oncogenic 
promoter leading to an elevation in FOS mRNA levels at the tolerated concentration only. This 
thesis also reports As2O3 induced chromatin relaxation in HEK293T cells followed by a return to 
nominal levels for the tolerated concentration. This is in contrast to the toxic exposure, which 
leads to clear chromatin condensation and apoptosis. This thesis postulates that arsenic-induced 
global H3K9 hypoacetylation is caused by a miR-372 -mediated attenuation mechanism targeting 
PCAF mRNA, as predicted through bioinformatic analysis.  
In summary, tolerated As2O3 exposure resulted in measurable perturbations in both global and 
promoter-specific histone acetylation in addition to the aberrant expression of microRNAs, 
which led to cellular transformation over toxicity.   
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G9a euchromatic histone-lysine N-methyltransferase 2 
GAD1 glutamate decarboxylase 1 
GNAT Gcn5 N-acetyltransferase 
GSH glutathione 
GSSG glutathione disulphide 
GTP guanosine triphosphate 
HaCaT normal immortalised human keratinocyte 
HASPIN germ cell associated 2  
HAT histone acetyltransferase 
HAT1 histone acetylatransferase 1 
HBEC normal human bronchial epithelial cells 
HDAC histone deacetylase 
HDACi histone deacetylase inhibitor 
HEK293T  human embyonic kidney cells 
HELF human embryo lung fibroblast 
HIF-1α hypoxia inducible factor 
HL60  acute myeologenous luekaemia  
HMT histone methyltransferase 
HOX Homeobox 
HSP heat shock protein  
IARC Internation Agency for Research on Cancer 
iAs inorganic arsenic 
IGH immunoglobulin heavy locus 
INS insulin 
JHDM1A K(lysine)-specific demethylase 2A 
JMJC jumonji domain containing proteins 
JMJD2A K(lysine)-specific demethylase 4A 
JMJD2C K(lysine)-specific demethylase 4C 
JMJD3 K(lysine)-specific demethylase 6B 
JUN jun proto-oncogene  
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K562 chronic myeologenous luekaemia  
KLF4 kruppel-like factor 4 
KRAS kirsten rat sarcoma viral oncogene homolog 
LCN2 lipocalin 2  
LET-7C microRNA let-7c 
lincRNA large intergenic non-coding RNA 
LINE long interspersed elements 
lncRNA long non-coding RNA 
LSD1 K(lysine)-specific demethylase 1A 
MBD DNA methyl-binding protein 
MBT malignant brain tumour domain 
MDM2 MDM2- proto-oncogene, E3 ubiquitin protein ligase 
miR microRNA 
miR microRNA 
MLH1 mutL homolog 1 
MLL K(lysine)-specific methyltransferase 
MMA monomethylarsonic acid 
MNase micrococcal nuclease  
mRNA messenger RNA 
MSK1 ribosomal protein S6 kinase 
MSK2 ribosomal protein S6 kinase polypeptide 4 
MST1 macrophage stimulating 1 
MT-3 metallothionein 3 
MTT 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide 
MYC v-myc avian myelocytomatosis viral oncogene homolog 
MYST K(lysine) acetyltransferase 8 
NAD+ nicotinamide adenine dinucleotide  
NADPH nicotinamide adenine dinucleotide phosphate 
ncRNA non-coding RNA 
NFΚB nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 
NRF2 nuclear factor, erythroid 2-like 2  
NSD1 nuclear receptor binding SET domain protein 1 
P16 cyclin-dependent kinase inhibitor 2A 
P300 E1A binding protein p300 
P53 tumour protein p53 
PARP poly (ADP-ribose) polymerase-1 
PBMC peripheral blood mononuclear cell 
PBS phosphate buffered saline 
PCAF K(lysine) acetyltransferase 2B 
PCDH protocadherin 
PCNA proliferating cell nuclear antigen 
PCR polymerase chain reaction 
PDX1 pancreatic and duodenal homeobox 1 
PHD plant homeodomain 
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piRNA PIWI-interacting RNA 
PKB protein kinase B 
PKC protein kinase C 
PKCα protein kinase C, alpha 
PLA2G2C phospholipase A2, group IIC 
PMRT1 protein arginine methyltrasnferase 1 
PRMT5 protein arginine methyltrasnferase 5 
PTM post-translational modification 
PUMA BCL2 binding component 3 
QOF quality of life 
qRT-PCR quantitative real-time polymerase chain reaction  
RING1A ring finger protein 1 
RISC RNA-induced silencing complex 
RNA ribonucleic acid 
RNF168 ring finger protein 168, E3 ubiquitin protein ligase 
RNF20 ring finger protein 20, E3 ubiquitin protein ligase 
RNF40 ring finger protein 40, E3 ubiquitin protein ligase 
RNF8 ring finger protein 8, E3 ubiquitin protein ligase 
ROS reactive oxygen species 
RWPE human prostate epithelial cells 
SAH s-adenosylhomocysteine 
SAHA suberanilohydroxyamic acid  
SAM s-adenosylmethionine 
SDS-PAGE polyacrylamide gel electrophoresis  
SET Drosophilia Su(var)3-9 and enhancer of zeste proteins 
SET1A SET domain containing 1A 
SETDB1 SET domain, bifurcated 1 
SIRT sirtuin 
SLC4A4 solute carrier family 4 (sodium bicarbonate cotransporter), member 4 
SOC  super optimal broth  
SOCS6 supressor of cytokine signalling 6 
SP1 SP1 transcription factor  
SQSTM1 sequestome 1 
SSB single stranded DNA breaks 
SUV39H1 suppressor of variegation 3-9 homolog 1 
SUV420H1 suppressor of variegation 4-20 homolog 1 
SUV420H2 suppressor of variegation 4-20 homolog 2 
SUZ12 polycomb repressive complex 2 subunit 
T-UCR transcribed ultraconserved region 
T24 human bladder carcinoma cells 
TA tubastatin 
TIF2 transcriptional intermediary factor 2 
TIP60 K(lysine) acetyltransferase 8 
TK6 human immortalised lymphoblast  
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TMS1 target of methylation-associated silencing-1  
TR thioredoxin reductase 
Trx thioredoxin 
TSA trichostatin A 
U-tAs maternal urinary arsenic measurement  
UHRF1 ubiquitin-like with phd and ringer finger domains 1 
UROtsa normal human urothelial cells 
USP21 ubiquitin specific peptidase 21 
USP22 ubiquitin specific peptidase 22 
USP3 ubiquitin specific peptidase 3 
UTR untranslated region 
WHO World Health Organisation 
WNT5A wingless-type MMTV integration site family, member 5A 
XTT 2,3-Bis-(2-Methoxy-4-Nitro-5-Sulphophenyl)-2H-Tetrazolium-5-Carboxanilide 
ZNF zinc finger  
ZSCAN zinc finger and scan domain containing 1  
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- 1 - 
Introduction 
1.1 – Chemistry and Behaviour of Arsenic in Brief. 	  
Arsenic (As) is a grey metalloid element found at an abundance of 2-10 x 10-4 % in the Earth’s 
crust (Grund et al. 2008). It is in group 15 and period 4 with an atomic number of 33 and an 
atomic mass of 74.92 (http://www.rsc.org/periodic-table/element/33/arsenic, accessed: 02.14). 
The electronic configuration of arsenic is [Ar]3d104s24p3, it remains solid at 25ºC and sublimes at 
616ºC. Arsenic can form over 200 different minerals in the environment, the most prevalent of 
which is arsenopyrite (FeAsS) – an arsenic sulphide. This mineral form is usually oxidised by O2, 
Fe3+ and NO3- (Bhattacharya 2004). Arsenic can also occupy a number of oxidation states 
including -3, 0, +3 and +5. This variety in oxidative states allows for the formation of many 
different arsenic compounds in the environment (Table. 1). 
 
+ Table 1: Inorganic and organic arsenic species found in the environment.   
Adapted from: (Ng et al. 2001).  
 
Name Chemical Formula 
- Trivalent inorganic arsenicals - 
arsenic (III) oxide As2O3 
arsenenous acid HAsO2 
arsenic (III) chloride AsCl3 
arsenic (III) sulphide As2S3 
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Table 1 cont. 
Name Chemical Formula 
- Pentavalent inorganic arsenicals - 
arsenic (V) oxide AsO5 
arsenic acid H3AsO4 
arsenenic acid HAsO3 
- Organic arsenicals - 
methylarsine CH3AsH2 
dimethylarsine (CH3)2AsH 
trimethylarsine (CH3)3As 
 
 
Arsenic demonstrates great chemical persistence especially in groundwater, which has a pH range 
of 6.5 – 8.5. Compared to other metal contaminants such as Ni2+, Zn2+ and Pb2+, arsenicals are 
able to remain soluble across the whole groundwater pH range leading to the accumulation of 
arsenic species up to concentrations of many micrograms per litre (Smedley & Kinniburgh 2001). 
The combined redox potential (Eh) and pH properties of groundwater make it a favourable 
chemical environment for arsenic persistence.  
 
This is partly due to arsenic speciation, which is dependent on Eh and pH of the environmental 
solvent (Fig. 1.1). In a study systematically measuring groundwater properties in Bangladesh, 
Anawar et al. showed that Eh and arsenic concentration are inversely correlated (Anawar et al. 
2011). When dissolved in water, arsenic can form a number of different compounds including 
arsenate, arsenite, monomethylarsonic acid (MMA) and dimethylarsinic acid (DMA) (Ng et al. 
2001).  
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The real world solvent environment is rarely homogenous; instead it is decorated with 
sedimentary material, clays, metallic compounds and organic matter. Arsenic can adsorb onto 
these materials at differing affinities and it does so with some dependency on phosphate 
concentration, the redox state of metal oxides, the speciation of arsenic itself, such as As(V) or 
As(III), the microbial biota and pH (Kent & Fox 2004; Z. Lin & Puls 2000). Due to these 
variable-dependent adsorption effects, these materials not only behave as natural attenuators of 
environmental arsenic but also simultaneously act as fragile arsenic sinks susceptible to 
mobilisation by chemical changes induced by human behaviours. In the Ganges delta for 
EHC 224: Arsenic and Arsenic Compounds 
 
 
 
 
 
 
 
Fig. 2. The Eh-pH diagram for As at 25 C and one atmosphere with total 
arsenic 10-5 mol/litre and total sulfur 10-3 mol/litre. Solid species are enclosed 
in parentheses in cross-hatched area, which indicates solubility less than 
10 5.3 mol/litre (From: Ferguson & Gavis, 1972). 
 
 
 
 
offers very high sensitivity for the determination of arsenic, and 
coupled with HPLC enables equally sensitive estimation of a wide 
variety of arsenic species. 
 
 
 
 16
+ Figure 1.1: Arsenic speciation with respect to redox potential (Eh) and pH at 25ºC and 
1 atmosphere.  
 The blue boxes represent the measured range of Eh and pH usually found in groundwater in 
Bangladesh. Adapted from Ferguson & Gavis. 1972. combined with data from Anawar et al. 
2011.  
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example, the use of fertilisers in addition to the withdrawal of groundwater led to a localised 
adjustment in phosphate levels leading to the desorption of arsenic (Chowdhury et al. 1999).  
 
1.2 – Sources of Human Exposure to Arsenic.  
 
Naturally occurring arsenic is predominantly in the form of arsenopyrite (FeAsS). It is also often 
found mixed with other mineral deposits, especially those that have a high sulphide content, as 
arsenic can co-ordinate with sulphur ligands (Ng et al. 2001). Due to this, arsenic can make its 
way into groundwater especially in areas with high levels of sulphide mineralisation. Of the 
naturally occurring arsenic minerals, 60% exist as arsenates, 20% as sulphides and the remaining 
20% are composed of arsenites, oxides, silicates and elemental arsenic (Mandal & Suzuki 2002).  
 
Industrial and polluting sources of arsenic have been on the decline due to policy changes driven 
by environmental concerns. Very few countries actually produce arsenic compounds, with a 
limited number allowing the use of arsenic as a plant and wood preservative. Historically arsenic 
compounds were used in large quantities as pesticides (Ng et al. 2001). Arsenic trioxide is still 
produced by China and exported to the US in metallic form for industrial processes (Grund et al. 
2008). The U.S Environmental Protection Agency (EPA) has allowed the use of organic arsenic 
compounds at strict thresholds – specifically a dosage that does not cause bladder cell 
cytotoxicity, as herbicides and pesticides, whilst banning its use in rights-of-way and recreational 
parks, with the promise of regular re-evaluations on their usage (Hughes et al. 2011).   
 
The largest recorded human exposure to arsenic is in Bangladesh, where a 10-year survey 
between 2000 – 2010 estimated that 35 to 77 million people have been chronically exposed via 
contaminated drinking water (Flanagan et al. 2012). Of this population, 57 million people have 
been exposed to concentrations exceeding World Health Organisation (WHO) guidelines at 10 
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µg/L, with the remaining individuals being exposed to concentrations greater than Bangladesh’s 
own internal guidelines of 50 µg/L (Anawar et al. 2011). Arsenic exposure is a global issue, as 
elevated groundwater arsenic concentrations have also been identified across the world in 
Argentina, Canada, Chile, China, Hungary, Japan, Mexico, New Zealand, Taiwan, Thailand and 
the United States (Moore et al. 2002; Kurttio et al. 1999; Hopenhayn-Rich et al. 1998; C. J. Chen 
et al. 1985; Bhattacharya 2004). Furthermore, arsenic can enter the food chain through normal 
agricultural activities such as the growth of rice and vegetables (Mandal & Suzuki 2002). This is 
of particular concern as these products are often exported to locations without environmental 
arsenic contamination. 	  
 
The mechanism through which arsenic makes its way into groundwater is still under debate. The 
oxidation of arsenopyrite is believed to be the most significant contributor of arsenic release into 
the environment. However, iron compounds with adsorbed arsenic susceptible to microbial 
metabolism, have also been implicated as these breakdown liberating arsenic into sedimentary 
material and groundwater (Nickson et al. 1999; McArthur et al. 2001). The heavy use of fertilisers 
is also believed to exacerbate the problem, as this encourages microbial growth and alters the 
local phosphate levels. The resulting change microbial and phosphate levels provisions the 
release of arsenic into the environment (Hartley et al. 2013).  
 
1.3 – Epidemiological Evidence of Arsenic-Induced Negative Health Outcomes 
 
Arsenic poisoning can occur over acute and chronic time scales with differing health outcomes. 
Historically arsenic has been used for a variety of purposes including medicinally in the late 
1700s, pigments in toys and wallpapers, and as a intentional homicidal poison (Hughes et al. 
2011). Whilst acute arsenic exposure is relatively rare today, cases of accidental consumption in 
the form of pesticides or through intentional ingestion for suicide have been reported (Ratnaike 
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2003). Small doses of arsenic trioxide can induce severe acute toxicological responses including 
vomiting, diarrhoea, abnormal cardiac function, muscular spasms and damage of the 
gastrointestinal tract (Grund et al. 2008). A lethal dose of arsenic in acute poisoning is 200 mg to 
300 mg, although one case has been reported where a 43-year-old male survived following the 
consumption 54 g of arsenic trioxide due to intense medical intervention and surgery (Dueñas-
Laita et al. 2005).  
 
Chronic arsenic exposure leads to a broad range of deleterious health outcomes including 
cardiovascular disease, neuropathy, cognitive impairments, reproductive issues, in addition to 
cancers of the skin, bladder and lungs (Kapaj et al. 2006). An early report of cardiovascular 
impairment as a result of chronic arsenic exposure was the identification of a blackfoot disease 
endemic in Taiwan localised to regions with access to arsenic contaminated drinking water 
(Tseng 1977; Engel et al. 1994). The study by Tseng et al. used blackfoot disease as a proxy for 
skin cancer, and demonstrated that these two health outcomes were correlated. This also 
presented early evidence of the association between chronic arsenic exposure and carcinogenesis. 
Chronic arsenic exposure can have damaging effects in conjunction with lifestyle choices such as 
smoking. A 6-year study that examined smokers exposed to arsenic contaminated drinking water 
demonstrated an increased mortality rate from heart disease compared to a geographically local 
control group (Y. Chen et al. 2011). Arsenic exposure is also believed to exacerbate existing 
health issues, such as diabetes mellitus, where those suffering from this illness also exhibit 
elevated impairment of kidney function (J. P. Wang et al. 2009). This study also verified the effect 
in rats with diabetes.  
 
There is growing evidence of neurological disorders that arise as result of long-term arsenic 
exposure, particularly negative effects on motor function, cognitive ability and psychiatric state. 
Chronic arsenic exposure has been associated with reduced juvenile intellectual function and 
poorer school performance in a dose-dependent manner (Wasserman et al. 2004; Ehrenstein et 
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al. 2007). Psychiatric issues have also been reported in adults diagnosed with arsenicosis including 
an elevation of depression, anxiety and suicidal attempts in comparison with a control group (Sen 
& Biswas 2011). Given that these neurological issues affect both children and adults, there was a 
standing hypothesis that chronic exposure over a lifetime has a severe impact on quality of life 
(QOF). One study examined QOF through the utility of a self-reporting questionnaire, covering 
multiple life metrics including mental health to demonstrate a lower QOF score and socio-
economic status in arsenic exposed patients (Syed et al. 2012).  
 
The International Agency for Research on Cancer (IARC) has classified arsenic as a human 
carcinogen, i.e. Group 1 (IARC Working Group on the Evaluation of Carcinogenic Risks to 
Humans 2004). There is substantial evidence to support this classification, including early studies 
in areas with blackfoot disease where higher standard mortality rates and cumulative mortality 
rates from cancers of the bladder, kidney, skin, lung and liver were reported (C. J. Chen et al. 
1985; C. J. Chen & C. J. Wang 1990). The prevalence of these malignancies increased in areas 
with higher arsenic contamination alluding to the indication of a dose-response relationship. 
Similar findings were also reported in a 5-year study in Córdoba – Argentina, which 
demonstrated an increase in kidney and lung cancer mortality with arsenic exposure through the 
examination of standard mortality rates for men and women (Hopenhayn-Rich et al. 1998). 
Interestingly there is a discrimination regarding the types of cancers that are induced by chronic 
arsenic exposures, where correlate more readily compared to others. Epidemiological evidence 
across the counties of Nevada – USA, with a low (<10 µg/L) to high (90 µg/L) arsenic 
contamination range demonstrated no significant correlation between arsenic exposure and 
childhood leukaemia (Moore et al. 2002).  
 
Arsenic-induced illnesses and mortalities are significant health burden globally. Currently, arsenic 
is #1 of the Agency for Toxic Substances and Disease Registry (ATSDR) substance priority list, 
which allocates points weighing the public health hazard of a toxicant against locations in the 
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USA (Naujokas et al. 2013). Mortality hazard ratios for avoidable cancer, cardiovascular and 
infectious illnesses all increase with arsenic exposure, and arsenic related illnesses could cost the 
US economy $13B USD through lost productivity over the next two decades (Argos et al. 2010; 
Flanagan et al. 2012). For the well-known exposure in Bangladesh the situation remains dire. An 
examination of 11,746 individuals over a 9-year period demonstrated that mortality rates from a 
number of illnesses combined into a hazard ratio correlated with arsenic exposure measured 
from urinary samples (Y. Chen et al. 2011). This probabilistic indicator projects that “all-cause 
mortality” is elevated with arsenic exposure and surprisingly 24% of the participants were 
exposed to concentrations less than the WHO guideline, suggesting that other countries believed 
to have “safe” levels of arsenic may still fall foul to the toxicant. Indeed a recent epidemiological 
study from Finland has confirmed such fears, where 144,627 people – 99% of which were 
exposed to arsenic concentrations less than the WHO guideline, demonstrated an elevation in 
bladder and kidney cancer incidence (Kurttio et al. 1999).   
 
These studies are on the macroscopic and epidemiological scale. The need to understand the 
underlying mechanisms driving these arsenic-induced illnesses, particularly cancer is great. It is 
clear that both time and dose are important factors in arsenic-induced deleterious outcomes, but 
these studies demonstrate that there is a significant need to investigate chronic low-level arsenic 
exposures and the associated contributory biochemical mechanisms that lead to malignancies.  
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1.4 – Metabolism of Arsenic 	  
Arsenic can accumulate in keratin-rich structures such as hair, nails, and muscle and to a lesser 
extent bone. The approximate half-life of arsenic is 4 days in humans, and around 40 – 60 % of 
the toxicant can remain in the aforementioned biological structures leading to toxic and 
carcinogenic effects (Bustaffa et al. 2014; Raab & Feldmann 2005). Arsenic metabolism in 
mammals is achieved through a series of methylation reactions. A number of tissues including 
the testes, kidneys, liver and lungs are able to readily methylate arsenic (Vahter 2001). Whilst 
there is considerable consensus regarding the fundamental role of methylation in arsenic 
metabolism, there is a continuing debate regarding the reaction scheme describing the metabolic 
process.  
iAs(V) 
iAs(III) 
MMA(V) 
MMA(III) 
DMA (V) 
DMA (III) 
GSH 
GSSG Reduction 
Oxidative methylation 
Oxidative methylation 
Reduction 
Reduction 
SAM 
SAH 
GSH 
GSSG 
SAM 
SAH 
GSH 
GSSG 
As(V)O4
3- + 2e è As(III)O3
3- + CH3
+ è CH3As(V)O3
2- + 2e è 
CH3As(III)O2
2- + CH3+(CH3)2As(V)O2
- + 2e è (CH3)2As(III)O
- + CH3
+ 
+ Figure 1.2: Classical reaction scheme describing arsenic metabolism in humans. 
Chemical intermediates are: iAs = inorganic arsenic, MMA = monomethylarsonic acid, DMA 
= dimethylarsinic acid. Enzymes and co-factors are: GSH = glutathione, GSSG = glutathione 
disulphide, SAM = S-adenosylmethionine, SAH = S-adenosylhomocysteine. A written 
reaction scheme is also shown. Adapted from Styblo et al. 2002. and Lin et al. 2002.  
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The classical mechanism describes two chemical reactions that occur in tandem; the first being 
the reduction of pentavalent arsenicals to a trivalent state, the second being oxidative methylation 
to a pentavalent metabolite (Fig. 1.2) (Stýblo et al. 2002). This occurs a number of times in 
sequence to progress from inorganic arsenic (iAs) to monomethylarsonic acid (MMA) and finally 
dimethylarsinic acid (DMA). As these metabolites have been detected in urine, this classical 
reaction scheme is widely considered to be representative of the arsenic metabolic process 
(Hopenhaynrich et al. 1992; C Hopenhayn-Rich 1996; Le et al. 2000). In addition to this, S-
adenosyl-methionine (SAM) is believed to be the methyl donor in the reactions, glutathione as 
the reducing agent and methyltransferase as the enzyme (Roy 2002). Experimental evidence 
suggests that glutathione is crucial for arsenic methylation, as hepatic depletion of this reducing 
agent results in significantly elevated toxicity in hamsters and reduced arsenic methylation (Hirata 
et al. 1988).  
 
Although these reactions were postulated to be enzymatically catalysed, they were initially 
attributed to an uncharacterised methyltransferase. This was until Lin et al. isolated arsenic 
methyltransferase from the liver cytosol of rats which is encoded by the AS3MT gene, and 
specifically transfers methyl groups from SAM to trivalent arsenicals (S. Lin et al. 2002; Waters et 
al. 2004). Detailed biochemical analysis of this enzyme not only provided a greater understanding 
of the chemical processing of arsenic, but it also began to challenge the existing classical reaction 
scheme. There is a continuing debate regarding the number of conserved cysteine residues within 
the enzyme, with the most recent data suggesting that 4 residues, Cys32, Cys61, Cys156 and 
Cys206 are conserved (Dheeman et al. 2014). Furthermore, substitutions of these residues halt 
iAs methylation. Dheeman et al. challenge the classical reaction scheme on three fronts. The first 
is that there is minimal evidence to support the formation of pentavalent products by other SAM 
methyltransferases in nature, the second is that pentavalent intermediates are more likely formed 
in complex with the enzyme and thirdly that the reducing agent glutathione (GSH), is likely 
bound to inorganic arsenic prior to enzymatic processing.   
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Recent findings appear to support the hAS3MT reaction scheme (Fig. 1.3). For example, As(GS)3 
and MAs(GS)2 bind at a faster rate to the enzyme than As(III) alone, which supports the notion 
that glutationylated arsenicals are preferred substrates for the hAS3MT (Marapakala et al. 2012). 
Prior research has also shown that the endogenous enzyme can use other reductants such as 
thioredoxin (Trx), thioredoxin reductase (TR) and nicotinamide adenine dinucleotide phosphate 
(NADPH), rather than GSH alone (Waters et al. 2004). Whilst redundancy exists in the form of 
reducing agents, GSH is still considered fundamental for arsenic metabolism.  
 
Discussions remain regarding arsenic metabolism and whether it should be considered a true 
detoxification or bioactivation process. Initially it was believed that arsenic methylation was a 
urine, exposure to air nonenzymatically oxidizes DMAs(III) to
DMAs(V). Thus, the substrates and products are all trivalent, as
predicted by Hayakawa et al., but the arsenic undergoes a cycle
of oxidation and reduction, as hypothesized by Challenger, but
only when it is enzyme-bound. GSH and Trx are involved, but
not as reductants of pentavalent intermediates. Instead,
As(GS)3 serves as the arsenic donor to the enzyme, as
hypothesized by Hayakawa et al., and Trx is a protein disulﬁde
reductase.45 Advantages of this pathway are that it explains
current results with As(III) SAM methyltranferases and
reconciles the proposals of Challenger and Hayakawa et al.
■ DISCUSSION
Arsenic is clearly a health hazard, but is it inorganic or
methylated arsenicals that produce the risk? The answer
depends in large part on the products of AS3MT, the enzyme
Figure 7. Homology structural model of human AS3MT. The cartoon diagram representation of human AS3MT model structure is colored in tan.
The location of four conserved Cys residues are shown along with the bound SAM and As(III). The expanded view shows the four conserved
cysteine residues (in ball-and-stick), with Cys32 and Cys61 in a disulﬁde bond and Cys156 and Cys206 binding the As (blue ball) atom. SAM (in
ball-and-stick) occupies its binding site with its methyl group (*) poised to be donated to the arsenic atom.
Figure 8. Proposed hAS3MT reaction scheme: (1) In the ﬁrst round of methylation, hAS3MT binds As(III) in a series of three thiol transfer
reactions from As(GS)3; (2) the methyl group of SAM is attacked by the arsenic lone pair; (3) a pentavalent MAs(V) intermediate is formed and (4)
reduced to an enzyme-bound MAs(III) intermediate by Cys32 with formation of a Cys32−Cys61 disulﬁde; (5) the disulﬁde is reduced with Trx, and
the enzyme undergoes the next round of methylation, (6) forming a pentavalent DMAs(V) intermediate, (7) which is reduced to DMAs(III) by
Cys61. This form is a Cys61−Cys156 disulﬁde, which (8) is reduced by Trx, regenerating the enzyme and releasing the major soluble product,
DMAs(III). Finally, in air, trivalent DMAs(III) is nonenzymatically oxidized to DMAs(V).
Chemical Research in Toxicology Article
dx.doi.org/10.1021/tx500313k | Chem. Res. Toxicol. 2014, 27, 1979−19891986
+ Figure 1.3: hAS3MT reaction scheme proposed by Dheeman et al (2014).  
(1) Initial methylation is carried out via three thiol transfer reactions from As(GS)3 resulting in 
the binding of As(III) to hAS3MT. (2) The SAM methyl group is attacked by the arsenic lone 
pair, (3) resulting in the formation of a pentavalent MAs(V) intermediate. (4) MAs(V) is 
reduced further to MAs(III) whilst remaining enzyme giving rise to a Cys32-Cys61 disulphide 
bond. (5) Trx reduces the disulphide bond allowing for another round of methylation. (6) The 
next methylation event forms a pentavalent DMAs(V) intermediate (7) which is reduced 
further to DMAs(III) by Cys61. (8) This results in the formation of another disulphide bridge 
with is reduced by Trx allowing for the liberation of the enzyme, ready to start the process 
again. Graphic from Dheeman et al. 2014.  
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detoxification process and that toxicity arose due to the presence of a threshold methylation 
capacity, which states that after a certain point inorganic arsenic can no longer be methylated 
leading to toxic effects. However this hypothesis was disproved by measuring the concentration 
ratios of [iAs] / [iAs] + [MMA] + [DMA] in humans, which found that 20 – 25 % of iAs remains 
unmethylated irrespective of the magnitude of exposure (Hopenhaynrich et al. 1992). A follow 
up experiment measured urinary iAs levels and demonstrated that it too was unchanged against a 
gradient of increasing arsenic exposures (C Hopenhayn-Rich 1996).  
 
Evidence for bioactivation resides in the form of in vitro toxicity measurements between arsenate, 
arsenite, MMA(V), MMA(III) and DMA(V). The cytotoxic response of Chang human 
hepatocytes was assessed by examination of lactate dehydrogenase leakage, intracellular 
potassium and mitochondrial metabolism of a tetrazolium salt XTT (Petrick et al. 2000). From 
this study it was revealed that MMA(III) is more toxic than arsenite and arsenate and that the 
pentavalent forms of MMA and DMA are both equally toxic. Another comparative study 
investigating the toxicity of arsenicals and methylated intermediates demonstrated that arsenic 
methylation did not protect the cells from acute toxicity, rather the methylation process itself 
significantly contributed to the toxicity of arsenic (Styblo et al. 2000). These studies demonstrate 
the challenge in defining arsenic metabolism as a detoxification process over bioactivation.  
 
The factors affecting the toxicity of arsenic have diverged into new areas according to recent 
research. There is now evidence to suggest that microbial metabolism of arsenic in the gut may 
also alter the speciation of arsenic (Alava et al. 2014). In the study by Alava et al. quantifiable 
differences in the generation of hazardous arsenic species, particularly monomethyl arsonite and 
monomethylmonothio arsonate were observed between high fat and protein rich Western diets 
compared to fibre rich Asian diets. Hence the authors suggested that dietary background might 
contribute to arsenic toxicity. Furthermore, sulphate-reducing bacteria have been implicated in 
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the thiolation of methylated arsenicals, with toxicologists suggesting that the activity of such 
bacteria should be considered in future toxicokinetic analyses (D C Rubin et al. 2014).  
 
Metabolic efficiency is also believed to play a role in arsenic toxicity, particularly with regards to 
the AS3MT gene. Three polymorphisms of AS3MT were associated to a statistically significant 
change in urinary MMA (Antonelli et al. 2014). Single nucleotide polymorphisms near the 
AS3MT gene also caused measurable differences in the efficacy of arsenic metabolism with 
negative health outcomes including the formation of skin lesions (Pierce et al. 2013; Schläwicke 
Engström et al. 2009).  
 
1.5 – Possible Mechanisms of Arsenic-induced Toxicity and Carcinogenicity 
 
There are a number of reported mechanisms that lead to toxic and carcinogenic outcomes 
following arsenic exposure. Some of these are in relation to the chemical reactivity of arsenic, 
such as its ability to interact with sulphurs and phosphates. Other mechanisms are dependent on 
cellular responses, such as the generation of reactive oxygen species and the activation of signal 
cascades (Table. 2).  
 
+ Table 2: A summary of proposed mechanisms through which arsenic induces cytotoxicity 
and/or carcinogenesis.  
Adapted from: (Hughes et al. 2011) (Bustaffa et al. 2014) 
 
 Mechanism Outcome 
Arsenic exposure è  Interaction with sulphur Formation of stable As-S 
complexes 
 Interaction with phosphate Formation of unstable 
arsenoesters 
 ROS Increase in H2O2, O2-, ROOH-, 
OH- and NO 
 Genotoxicity Chromosomal aberration, 
genomic instability 
 Altered DNA repair Inhibition of DNA ligase 
 Signal transduction Activation of mitogen activated 
protein kinase pathway 
 Altered DNA methylation Altered patterns of DNA 
methylation/ genomic 
imprinting.  
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Table  2 cont…   
 Histone tail modifications Impacts on gene expression 
 miRNA Impacts on gene expression 
 
Poor arsenic metabolism is a considerable hindrance in the cellular environment as arsenite is 
predicted to inhibit the activity of approximately 200 enzymes through the interaction with 
sulphydryl groups (Abernathy et al. 1999). Due to chemical similarities, arsenate can substitute 
phosphate in biochemical reactions leading to the formation of unstable arsenoesters. 
Furthermore, human erythrocytes exposed to 0.001 – 10 mM As(V) for 5 hours lead to the 
depletion of ATP which leading to cytotoxicity, plasma membrane deformation and haemolysis 
(Winski & Carter 1998).  
 
Arsenic exposure generates reactive oxygen species and oxidative stress within the cellular 
environment. This is achieved through the conversion of DMA(V) to dimethylarsine, which leads 
to the formation of a number of free radicals including the dimethylarsenic peroxyl radical, 
dimethylarsenic radical, superoxide radicals and hydroxyl radicals (Kitchin & Ahmad 2003). 
Opposing outcomes have been postulated as a result of arsenic-induced ROS generation, 
including apoptosis and cellular transformation. Arsenic-induced ROS generation leads to 
mitochondrial membrane permeability, cytochrome c release and the activation of downstream 
caspases, resulting in apoptosis induction and cell death (Banerjee et al. 2008). In contrast, ROS 
has also been shown to activate redox sensitive transcription factors, in addition to NF-ΚB, AP-
1, JUN, p38 and MAPK signalling cascades leading to increased cellular proliferation and the 
possibility for carcinogenesis (Flora 2011).  
 
Arsenic is an effective clastogen as it induces genotoxicity via chromosomal instability. Genomic 
integrity is compromised following arsenic exposure due to ineffective DNA repair, aberrant 
chromosomal segregation and lapsed cell cycle control (Bhattacharjee et al. 2013). The result is a 
significant increase in DNA damage, mitotic arrest and unfavourable epigenetic alterations – all 
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of which can contribute to carcinogenesis. A dose-response relationship between arsenic 
exposure and the formation of DNA-double strand breaks and protein-DNA adducts has been 
shown in human lung fibroblast MRC-5 cells exposed to increasing concentrations of sodium 
arsenite (Mourón et al. 2006). Chinese hamster cells exposed to 10 µM sodium arsenite for 24 
hours exhibit a chromosomal number less than 21, which is the modal number for the cell line 
(Sciandrello et al. 2002). This latter study is particularly significant, as it demonstrates the rapidity 
through which genetic instability can occur following arsenic exposure, as a 24-hour exposure 
can generate aneuploidy in cells. These changes also persisted after a 5-day recovery without the 
toxicant, suggesting that such changes are relatively irreversible. A number of in vivo studies have 
identified aberrations of DNA repair mechanisms such as nucleotide excision repair and base 
excision repair following exposure to environmental levels of arsenic, with measurable elevations 
in DNA damage (Andrew et al. 2006; Sampayo-Reyes et al. 2010). More research is needed to 
understand the severity of DNA damage induced by different arsenicals. A study by Klingerman 
et al. demonstrated that MMA(III)-induced DNA damage is mediated by ROS, leading to the 
formation of short-lived single-strand breaks, which are quickly repaired through base excision 
repair (Kligerman et al. 2010). This is in contrast to arsenic-induced aneuploidy and disrupted 
mitotic spindle effects, which remain and do not repair effectively. Arsenic-induced genotoxicity 
also arises from the inhibited function of zinc-finger dependent DNA repair enzymes such as 
PARP, that are involved in the detection of single strand breaks (Ding et al. 2008).  
 
It is likely that arsenic-induced carcinogenesis is multifactorial given the variety of perturbations 
measured within the cellular environment. Recent publications have identified a number of 
aberrant epigenetic mechanisms at play following arsenic exposure, some of which overlap with 
existing mechanisms. For example, the identification that arsenic-induced DNA hypomethylation 
exacerbates the problem of chromosomal instability and the recent finding that low-level arsenic 
exposure increases the expression of microRNAs that attenuate the expression of a number 
antioxidant genes(Sciandrello et al. 2004; Ren et al. 2015).  
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1.6 – Epigenetic Mechanisms 
 
The contemporary definition of epigenetics is the study of stable and potentially heritable 
changes in gene expression that do not arise from DNA sequence changes, whilst an epigenetic 
event is described as a structural modification of chromatin at a defined chromosomal region to 
register, signal or perpetuate an altered activity state (Y.-H. Jiang et al. 2004; Bird 2007). These 
epigenetic processes are communicated through three main epigenetic mechanisms including 
DNA methylation, histone post-translational modifications and microRNAs (miRs). Not all 
epigenetic events impinge on chromatin, rather non-coding RNAs such as microRNAs (miRs), 
can also influence gene expression through post-transcriptional control mechanisms (Ameres & 
Zamore 2013).  
 
 
1.6.1 – DNA methylation 	  
One of the most extensively studied epigenetic mechanisms is DNA methylation. It involves the 
methylation of cytosine nucleotides to create 5-methylcytosine (5mC), leading to a methyl group 
protrusion into the major groove of DNA (Virani et al. 2012). Whilst this chemical modification 
is believed to disrupt the binding of transcription factors, it is also thought to fulfil the inverse 
function by permitting the binding of additional proteins to DNA (Prokhortchouk & Defossez 
2008). Reversible methylation of cytosine usually occurs at cytosine-guanine dinucleotides 
(CpGs), where the “p” represents a phosphodiester bond (Lim & Maher 2011). The mammalian 
genome is predominantly methylated, with unmethylated CpGs occurring in groups or islands at 
gene promoters to act as a platform for transcriptional control.  
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DNA methyltransferases catalyse the addition of a methyl group to cytosine and are classified 
into two functional groups (Fig. 1.4). The first are the de novo DNA methyltransferases DNMT3A 
and DNMT3B that are involved in the methylation of fully unmethylated or “naked” DNA. The 
second group is occupied by DNMT1, which is considered a maintenance DNA 
methyltransferase as it only methylates hemi-methylated DNA, a partially methylated DNA form 
generated by DNA replication (Okano et al. 1999). The contemporary model suggests that the 
grouping of the enzymes between de novo and maintenance is oversimplified, rather specific DNA 
methylation events are dependent on the localised activity of DNA methyltransferases, DNA 
demethylases, DNA replication, and histone modifications; suggesting that a network of 
chromatin marks synergistically control DNA methylation (Jeltsch & Jurkowska 2014).  
 
DNA methylation is of considerable biological significance with well-characterised roles in 
female X-chromosome inactivation, genomic imprinting of specific alleles, the transcriptional 
repression of transposons and pre-transcriptional regulation (Dahl et al. 2011). In addition to 
traditional DNA methylation in the form of 5mC, cytosines can be modified further to form 5-
hydroxymethylcytosines (5hmC). This secondary form of DNA methylation is catalysed by 
translocation dioxygenases (TET), which oxidise 5mCs with molecular oxygen to form 5hmC. 
DNA methylation, including those responsible for X-chromosome
inactivation in females, allele-speciﬁc silencing of imprinted genes
and transcriptional repression of transposons. A number of human
syndromes are caused by disturbances in the methylation status of
imprinted genes [4] or bymutations i gene en oding components f
the DNA-methylation machinery [5,6]. In addition, alterations in DNA
methylation patterns have been implicated in autoimmune diseases
[7], neurological and psychiatric conditions [8] and cancer [9,10].
The genomes of tumor cells are generally characterized by a global
loss of methylation (hypomethylation), accompanied by focal
increases in methylation (hypermethylation) [9,10]. Although it has
been a long-standing discussion whether perturbations of DNA
methylation patterns during tumorigenesis represent “driver” events
(i.e., events that are required for the formation and maintenance of a
tumor cell) or “passenger” events (i.e., events that are not necessary
for the tumor cell) [11], there is strong evidence suggesting that
methylation events contribute to the cancer phenotype. Global
hypomethylation may lead t genomic instability (a hallmark of
cancer) [12], and hypermethylation of gene promoters may lead to
transcriptional silencing of tumor suppressor genes [9,10]. Other
methylation events may affect tissue-speciﬁc differentiation, which,
according to a prevailing model [13], is themainmechanism bywhich
epigenetic changes cause cancer.
In contrast to genetic changes, which cause permanent damage to
the genome, changes in DNA methylation patterns are potentially
reversible and, therefore, obvious targets for therapeutic intervention
[14]. This has led to an intensive search for drugs that target
components of the epigenetic machinery. Two inhibitors of DNA
methylation, 5-azacytidine and 5-aza-2’-deoxycytidine, which have
been known for decades [15], have nowhave been approved by the US
Food and Drug Administration (FDA) for tr atment of patients with
myelodysplastic syndrome (MDS). It was recently demonstrated in a
large clinical trial that 5-azacytidine, as the ﬁrst drug ever, can
improve overall survival in high-risk MDS [16], and it is now
considered the drug of choice by many institutions for treatment of
this cancer. Both 5-azacytidine and 5-aza-2’-deoxycytidine are
inhibitors of DNMTs and can reactivate silenced tumor suppressor
genes. However, recent evidence suggests that there may be other
important mechanisms of these drugs, including the degradation of
small regulatory RNAs and the stimulation of immune responses
through upregulation of cancer-testis antigens [17–19].
For more than six decades, 5mC has been recognized as “the ﬁfth
base” in mammalian DNA. However, early work suggested [20], and
recent work has conﬁrmed [21,22], the existence of a sixth base,
5-hydroxymethylcytosine (5hmC; Fig. 1). This review discusses the
known roles and implications of 5mC and the emerging roles of 5hmC.
2. The distribution and function of 5mC in mammalian genomes
Cytosinemethylation in somatic tissues of mammals occurs almost
exclusively in the context of the symmetric cytosine-guanine (CpG)
dinucleotide. Embryonic stem (ES) cells exhibit signiﬁcant levels of
non-CpG methylation (~20% of total 5mC), which disappears upon
cellular differentiation [23,24]. The distribution of methyl marks
throughout the genome is not random. The majority of 5mCs are
located in transposons, which are repeated sequences that comprise
N40% of the h man gen me and rep sent a potential threat to the
function and stability of the genome. Transposons of various types are
densely methylated and silenced in all cell types, lending support to
the hypothesis that the DNA methylation machinery evolved as a
defense mechanism to silence parasitic elements that invaded the
host genome [2].
The CpG dinucleotide is underrepresented in mammalian gen-
omes, representing only ~0.8% of all dinucleotides (expected: 4.4%),
which has been ascribed to the inherent mutability of methylated
cytosines due to spontaneous deamination to thymine [25]. In rough
estimates, 5mC represents ~1% of all the nucleotides in DNA, and ~70%
of all CpG dinucleotides are methylated [26]. The vast bulk of DNA is
methylated, whereas unmethylated CpGs are found primarily in so-
called “CpG islands”, which re N500 bp regions of DNA with high
relative densities of CpG (GC fraction N0.55; observed-to-expected
ratio of CpG N0.65) [27]. The majority of human gene promoters are
embedded within CpG islands that lack DNA methylation. These
unmethylated promoters can be either transcriptionally active or
inactive depending on other factors, including histone modiﬁcations
and the activity of cell type-speciﬁc transcription factors. CpG islands
that are normally methylated include those associated with the
promoters of imprinted genes and genes on the inactive X
chromosome in females, where mono-allelic methylation leads to a
reduction in gene dosage, as well as some tissue-speciﬁc genes.
Most research has focused so far on the methylation status of
promoter CpG islands, primarily driven by the assumption that these
regio s would be the most relevan t rgets for functionally important
DNA methylation. However, recent work has suggested that most
DNA methylation variation occurs in so-called “CpG island shores”,
which are regions close to CpG islands (b2 kb distant) but with a
comparatively lower CpG density [28,29]. Indeed, the majority of
tissue-speciﬁc differentially methylated regions (DMRs) were found
to be associated with CpG island shores and showed a great overlap
(45%) with the DMRs in cancer [28,29]. The methylation status of CpG
island shores is linked to transcriptional activity of the associated
genes as well as the usage of alternative transcriptional start sites [28].
Mouse and human tissues show similar methylation patterns at CpG
island shores [28], suggesting that methylation of CpG island shores is
an evolutionarily conserved, and thus presumably functionally
important, epigenetic mechanism. These signiﬁcant new discoveries
may open up new avenues for methylation research.
Methylation of cytosine is mediated by DNMTs, which use
S-adenosyl methionine (SAM) as a donor for the methyl group. The
mammalian DNMT family counts ﬁve members, DNMT1, DNMT2,
DNMT3a, DNMT3b and DNMT3L, but only three of these (DNMT1,
DNMT3a and DNMT3b) are catalytically active DNA methyltrans-
ferases. The active enzymes have traditionally been divided into de
novo (DNMT3A and DNMT3B) and maintenance (DNMT1) DNMTs, to
Fig. 1. Cytosine species in mammalian DNA. Cytosine exists as a free nucleotide that is incorporated into DNA during replication. 5-methylcytosine (5mC) is formed by post-
replicative addition of a methyl group to cytosine through the action of DNA methyltransferases (DNMT), which use S-adenosyl methionine (SAM) as methyl donor. 5-
hydroxymethylcytosine (5hmC) is formed through the action of TET proteins, which utilize molecular oxygen to transfer a hydroxyl group to 5mC.
832 C. Dahl et al. / Clinica Chimica Acta 412 (2011) 831–836
+ Figure 1.4: DNA methylation on the cytosin  nucleotide.  
Cytosine can be methylated by DNA methyltransferases DNMT1, DNMT3A and DNMT3B 
with the S-adenosylmethionine (SAM) methyl donor leading to the formation of 5-
methylcytosine (5mC). TET proteins catalyse the formation of 5-hydroxymethylcytosine 
through the utility of oxygen. Adapted from Dahl et al. 2011.  
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The 5hmC modification is not catalytically added or recognised by DNA methyltransferases and 
is thought to play a role in mammalian development, with the loss of 5hmC and mutations in 
TET proteins also being implicated in cancer (Pfeifer et al. 2013). DNA methyl-binding (MBD) 
proteins such as the MBD family, Kaiso protein family and the ubiquitin-like with PHD and 
ringer finger domain 1 (UHRF1) family of proteins are able to recognise DNA methylation, 
allow for further structural alterations, the recruitment of histone modifying enzymes and the 
assembly of repressive complexes at methylated CpGs (Gibney & Nolan 2010; Bogdanović & 
Veenstra 2009).  
 
1.6.2 – Histone post-translational modifications 
 
Cells package a vast amount of DNA into the nucleus. This is achieved through the 
organisational advantage of a three-dimensional structure created by wrapping linear DNA 
around histone proteins. A total of 146 base pairs are looped around an octomer of histones 
forming the basic unit of chromatin called a nucleosome. Each octomer is composed of two 
copies of four core histone variants including H2A, H2B, H3 and H4 (Virani et al. 2012). 
Nucleosomes are linked together with a short 10 to 80 base pair DNA length. A higher order of 
compaction is also achieved via the twisting of nucleosomes leading to the formation of the “30 
nm fiber” in which six nucleosomes per turn create a solenoid structure (Y. Zhang & Reinberg 
2001). This overall architecture is referred to as chromatin.  
 
Chromatin is a dynamic structure with the potential to be remodelled and dynamically 
reorganised for the purpose of carefully regulated gene expression (Felsenfeld & Groudine 2003). 
The crux of this regulatory potential relies on the large variety of post-translational modifications 
(PTMs) that can occur on histones, including acetylation, lysine/arginine methylation, 
phosphorylation, ubiquitination, sumoylation, ADP ribosylation, deiminiation and proline 
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isomerisation (Kouzarides 2007). These modifications are usually enzymatically catalysed with 
functional consequences on transcription, DNA repair, replication and condensation (Table. 3.).  
 
+ Table 3: Histone modifying enzymes and associated target residues and functional 
annotations.  
Adapted from: (Kouzarides 2007), (Virani et al. 2012), (Lachner et al. 2003), (Ropero 2007), 
(Glozak & Seto 2007), (Drogaris et al. 2012), (Baek 2011) 
 
Enzymes Target Residues Annotations 
Lysine acetyltransferases 
HAT1 H4K5/K12. Histone deposition, 
transcriptional activation 
CBP/P300 H3K14/K18. 
H4K5/K8. H2AK5. 
H2BK12/K15. 
Transcriptional activation 
PCAF H3K9/K14/K18. Transcriptional activation 
TIP60 H4K5/K8/K12/K16. 
H3K14 
Transcriptional activation, 
histone deposition 
 Lysine deacetylases  
HDAC1-11 Global H3/H4 tail 
acetylation 
- 
SIRT1 H3K9, H4K16 - 
SIRT2 H4K16 - 
   
Lysine methyltransferases 
SUV39H1, H2 H3K9 Pericentric heterochromatin 
G9a H3K9 Transcriptional repression, 
imprinting 
MLL1, 2, 3, 4, 5 H3K4 Transcriptional activation 
SET1A, 1B H3K4 Transcriptional activation, 
telomeric silencing, trithorax 
activation 
SETDB1/ESET H3K9 Transcriptional repression 
EuHMTase/GLP H3K9 Transcriptional repression 
NSD1 H3K36 Transcriptional activation 
DOT1 H3K79 DNA damage repair 
SUV420H1/H2 H4K20  
EZH2 H3K27 Implicated in the 
progression of human 
prostate cancer and 
transcriptional repression.  
Arginine methyltransferases 
CARM1 H3R2/R17/R26 Transcriptional activation 
PRMT4 H4R3 Transcriptional activation 
PRMT5 H3R8. H4R3.  - 
Lysine demethylases 
LSD1/BHC110 H3K4/K9 Transcriptional repression 
JHDM1A/B H3K36 - 
JHDM2A/B H3K9 - 
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Table  3 cont…   
JMJD2A/JMDM3A H3K9, H3K36 - 
JMJD2C/GASC1 H3K9, H3K36 Transcriptional activation 
JMJD2D H3K9 - 
JMJD2C H3K9 - 
JMJD3 H3K27 Transcriptional activation 
Serine/threonine kinases 
HASPIN H3T3 Chromatin condensation 
MSK1,2 H3S10, H3S28 Transcriptional activation 
PKCα/β H3T6 Transcriptional activation 
PKB/Akt H3S10 Transcriptional activation 
CKII H4S1 - 
MST1 H2BS14 - 
Ubiquitinases 
BMI/RING1A H2AK119 - 
RNF20/RNF40 H2BK120 - 
   
 
 
Histone post-translational modifications are recognised by domains within specific proteins that 
form intimate interactions with chromatin. These “chromatin readers” include bromodomains, 
which can detect histone acetylation events, PHD, chromo, MBT and Tudor domains that can 
recognise methylation patterns and 14-3-3 proteins that identify phosphorylated histones (Mellor 
et al. 2008; Kouzarides 2007). The post-transcriptional potential of histone tails spawned the 
“histone code hypothesis” which states that multiple histone marks can be collectively read to 
help respond to signal pathways that impinge on chromatin (Strahl & Allis 2000). An additional 
component of this hypothesis is that histone PTMs are able to work co-operatively. One such 
example is the case of histone acetylation and phosphorylation, where the former involves the 
neutralisation of a positive charge and the latter introduces a negative charge leading to an overall 
effect of chromatin decondensation through electrostatic repulsion. The “histone code 
hypothesis” was developed further through the proposal of binary switches and modification 
cassettes that remain embedded within histone PTMs (Fischle et al. 2003). Fischle et al. state that 
modification cassettes composed of histone PTMs separated only by a few amino acids may exist 
as recognition marks for other proteins to influence gene expression.  
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Histone PTMs are added and removed with the assistance of histone modifying enzymes. 
Histone acetyltransferases (HATs) are grouped into different families depending on their catalytic 
domains. HATs enzymatically transfer an acetyl group from acetyl-coenzyme A to the ε-amino 
group of specific lysines within the N-terminal region of histones. The first HATs to be 
discovered were the Gcn5 N-acetyltransferases (GNATs) GCN5, PCAF and HAT1. MYST 
family HATs include hMOF and TIP60. The remaining families include the orphaned p300/CBP 
CREB-binding protein and nuclear receptor co-activators, steroid receptor co-activator 1 (SRC1), 
nuclear receptor co-activator 3 (ACTR), transcriptional intermediary factor 2 (TIF2), all of which 
have intrinsic HAT activity (K. Lee 2007; Sterner & Berger 2000).  
 
Histone deacetylases (HDACs) are grouped into four classes spanning two families, the classical 
and the silent information regulator 2 (Sir2)-related “sirtuin” protein families. Within the classical 
family there are the following enzymes: class I, HDAC1, 2, 3, and 8; class II, HDAC4, 5, 6, 7, 9, 
and 10; class IV, HDAC11. All class I, II and IV enzymes require Zn2+ for catalytic activity. 
Within the sirtuin family reside the class III enzymes, which include SIRT1 – 7, which unlike the 
classical family, require the cofactor NAD+ for enzymatic activity (X.-J. Yang & Seto 2007; 
Grozinger & Schreiber 2002; Delcuve et al. 2012). The catalytic mechanism of histone 
deacetylation is reliant on a charge-relay system facilitated by a Zn2+ ion residing within the 
bottom of the substrate binding pocket (de Ruijter et al. 2003). This charge relay system has been 
targeted by HDAC inhibitors (HDACi) such as triochostatin A (TSA) and 
suberanilohydroxyamic acid (SAHA) to displace the Zn2+ ion leading to the disruption of the 
relay and collapse of the catalytic activity (Finnin et al. 1999). HDACs are often recruited in 
complexes for co-repression and chromatin remodelling, with some interaction with DNA 
methylation machinery. For example, the recruitment of HDAC complexes to specific DNA loci 
by MBD proteins that recognise methylated DNA (de Ruijter et al. 2003).   
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Histone methyltransferases (HMTs) target lysine residues within histone tails for mono-, di- and 
tri- methylation in addition to arginine residues for monomethylation or symmetric/asymmetric 
dimethylation. There are three enzyme families, the PMRT1 family, SET-domain-containing 
family and the non-SET-domain family (Martin & Y. Zhang 2005). Compared to histone 
acetylation, methylation events are not only considered more stable, but the variety of 
methylation opportunities is believed to facilitate additional control options such as short and 
longer chromatin imprint durations (Lachner et al. 2003). The most common lysine targets for 
methylation are histone H3 Lys 4, -9, -27, -79 and histone H4 Lys20.  
 
There are two families of histone demethylases each with distinct mechanisms of actions. The 
LSD demethylases utilise a flavin adenine dinucleotide (FAD)-dependent amine oxidation 
reaction to demethylate with substrate activity limited to mono and dimethylated lysines only 
(Bannister & Kouzarides 2005). The second family are the JMJC (jumonji C; jumonji = cruciform 
in Japanese) demethylases which a catalytic JMJC domain to allow for the demethylation of a 
number of lysines within the histone H3 and H4 termini. A total of 30 JMJD proteins have been 
identified, 18 of which have demethylase activity not only towards histone proteins but also non-
histone proteins such as p53, DNMT1, E2F1 and NF-κB (Kooistra & Helin 2012).  
 
Although dedicated enzyme families do not exist for histone-specific phosphorylation, activated 
signalling cascades can lead to phosphorylation events by other serine/threonine kinases on 
specific residues within histone tails (Baek 2011). These phosphorylation events can occur on a 
number of sites including histone H3T3/T6/S10/T11/S28/T45. Phosphorylation events on 
these residues have been implicated in chromatin condensation, transcriptional 
activation/repression and apoptosis (Baek 2011; Metzger et al. 2008). Serine/threonine kinases 
phosphorylate histone tails with some dependence on the phosphorylation status of other 
residues. One such example is H3S10 phosphorylation catalysed by Aurora kinase B (AurB), 
which then allows for the targeted phosphorylation of H3T11/T6 by CHK1 and PKC 
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respectively (Liokatis et al. 2012). This interdependence in the form of histone PTM “crosstalk” 
allows for regulatory control in the absence of specific enzymatic families focused entirely on 
histone phosphorylation, with the combined advantage of tethering modifications to signalling 
cascades that conduct complex biological functions such as mitosis and meiosis (Nowak & 
Corces 2004).  
 
Histone ubiquitination occurs on histones H2A and H2B at positions K119 and K120 
respectively. It is catalysed by a number of histone ubiquitin ligases including the polycomb 
protein RING1B, which monoubiquitinates H2A with the assistance of other RING domain 
proteins, RING1A and BMI1 (J. Cao & Yan 2012). Monoubiquitination of H2B is catalysed by 
hBRE1/RNF20 and RNF40. First discovered in yeast, the human BRE1 homolog is a E2 
ubiquitin ligase capable of altering the global H2B ubiquitination level at K120, and allowing for 
the activation of genes in concert with transcription factors (J. Kim et al. 2005). In addition to 
monoubiquitination, H2A and H2AX can be polyubiquitinated by RNF8 and RNF168 at K68 to 
mark the sites of DNA damage (Stewart et al. 2009). Histone ubiquitination is reversed by 
deubiquitnating enzymes, some of which have specific activity for H2A including 2A-DUB, 
USP21 and BAP1, whilst USP3 and USP22 can deubiquitnate H2B in addition to H2A (J. Cao & 
Yan 2012).  
 
1.6.3 – microRNAs 
 
MicroRNAs (miRs) are a class of small non-coding RNAs (ncRNAs) with implications in human 
disease – particularly cancer. There are many other ncRNAs in addition to miRs, such as 
transcribed ultraconserved regions (T-UCRs), PIWI-interacting RNAs (piRNAs), large intergenic 
non-coding RNAs (lincRNAs) and long non-coding RNAs (lncRNAs) all of which have a variety 
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of cellular functions and when deregulated can lead to a number of diseases including cancer, 
Alzheimer’s disease and Prader-Willi syndrome (Esteller 2011).  
 
MicroRNAs are relatively well characterised as small RNA molecules of approximately 22 
nucleotides in length with the primary function of post-transcriptional gene regulation via direct 
interaction with messenger RNA molecules. These interactions usually occurring in the 3’UTR 
lead to a number of outcomes including endonucleolytic cleavage at the mRNA:miRNA duplex 
binding site, translational repression by blocking of translational initiation or deadenylation, and 
mRNA turnover effects by decapping followed by 5’ to 3’ decay (Ameres & Zamore 2013). Due 
to these functions miRs are generally considered negative gene expression regulators or 
attenuators of their targets.  
 
Biogenesis of miRs begins in the nucleus, where miR transcripts are generated by RNA 
polymerase II and undergo normal capping and polyadenylation (Fig. 1.5). These transcripts can 
originate from separate transcriptional units or from the introns of protein coding genes, which 
can give rise to clusters or single miRs (Carthew & Sontheimer 2009). The transcripts form 
double stranded RNAs called pri-miRNA, which are much larger than mature miRs. These pri-
miRNAs are subjected to enzymatic processing by Drosha, an RNase III enzyme and DGCR8, a 
double stranded RNA binding protein also known as Pasha, leading to the formation of pre-
miRNAs of approximately 60 nucleotides in length. Drosha can also excise multiple pre-miRNAs 
from the double stranded pri-miRNA molecule, allowing for the processing of polycistronic 
miRNAs, whilst DGCR8 works with Drosha to improve processing by increasing affinity for the 
substrate and cleavage accuracy. (Y. Lee et al. 2003). Once the pre-miRNA is formed, a nuclear 
transport receptor called Exportin 5 detects the stem and the ends of the molecule and exports it 
to the cytoplasm.  
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processing step by Dicer (another RNase III enzyme) to
generate the final ~22-nucleotide product (see below).
Owing to compartmentalization of the two processing
events,nuclear export of pre-miRNAs is a crucial step in
miRNA biogenesis46,47. Nuclear transport occurs
through nuclear pore complexes, which are large pro-
teinaceous channels embedded in the nuclear mem-
brane48.Members of the nuclear export receptor family
bind cooperatively to a cargo as well as to the GTP-
bound form of the cofactor Ran in the nucleus.
Following export,hydrolysis of GTP to GDP results in
release of the cargo from the export complex.
Export of pre-miRNA is mediated by one of the
nuclear transport receptors, exportin-5 (REFS 49–51).When
the cells were depleted of exportin-5, the pre-miRNA
level and the mature miRNA level were reduced in the
cytoplasm49,50.Notably,pre-miRNA does not accumulate
in the nucleus subsequent to the depletion of exportin-5.
This indicates that pre-miRNA might be relatively unsta-
ble and also that pre-miRNA might be stabilized through
its interaction with exportin-5 (REF. 50). Exportin-5 was
originally known as a minor export factor for tRNAs,
because it can transport tRNAs when the primary
export factor, exportin-t, is depleted or overloaded52,53.
Considering that the affinity of exportin-5 to pre-miRNA
is much higher than to tRNA, and that miRNAs are as
abundant as 50,000 copies per cell54, pre-miRNAs are
probably the main cargo for exportin-5.
Exportin-5 can also export adenoviral RNA VA1, a
160-nucleotide ncRNA55. Analysis of cis-acting elements
for nuclear export in VA1 revealed a structural motif
known as the ‘minihelix motif ’, which consists of a
>14-bp stem and a 3–8-nucleotide 3′ overhang55. A sim-
ilar structural motif can be found in pre-miRNA
stem-loops, which typically comprise a stem of~22 bp, a
terminal loop and a 3′overhang of~2 nucleotides36,49,56,57.
By introducing mutations in the pre-miR-30a, Cullen
and colleagues confirmed that an RNA stem of >16
bp and a short 3′ overhang are significant structural
requirements for pre-miRNA export57.
Cytoplasmic processing by Dicer. Following their export
from the nucleus, pre-miRNAs are subsequently
processed into ~22-nucleotide miRNA duplexes by the
cytoplasmic RNase III Dicer58–62. Because Dicer was
originally found to function in generating siRNAs,
which are similar in size (21–25 nucleotides) to
miRNAs58,63, it was predicted that Dicer also functions
in the processing of ~70-nucleotide stem-loop RNAs
into mature miRNAs. Indeed, it was later proven that
immunoprecipitated Dicer generates ~22-nucleotide
miRNAs from in vitro synthesized ~70-nucleotide let-7
stem-loop RNAs61,62.Moreover, when the human homo-
logue and C. elegans homologue of Dicer were knocked
down or knocked out, the ~70-nucleotide pre-miRNAs
accumulated, whereas the ~22-nucleotide mature
miRNAs diminished59–62.
Dicer is a highly conserved protein that is 
found in almost all eukaryotic organisms such as
Schizosaccharomyces pombe, plants and animals. Some
organisms contain multiple Dicer homologues, in
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Transcription Pol II
Cropping Drosha–DGCR8
Dicing Dicer
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(60–100-nt stem-loop
with ~2-nt 3′ overhang)
Cap (A)n
Exportin-5–RanGTP
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Strand selection Dicer–R2D2?
Mature miRNA in miRISC
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Figure 2 | Model for microRNA biogenesis.  MicroRNA
(miRNA) genes are transcribed by RNA polymerase II (pol II) to
generate the primary transcripts (pri-miRNAs). The initiation step
(‘cropping’) is mediated by the Drosha–DGCR8 complex (also
known as the Microprocessor complex). Drosha and DGCR8
are both located mainly in the nucleus. The product of this
nuclear processing step is a ~70-nucleotide (nt) pre-miRNA,
which possesses a short stem plus a ~2-nucleotide 3′
overhang. This structure might serve as a signature motif that is
recognized by the nuclear export factor exportin-5. Pre-miRNA
constitutes a transport complex together with exportin-5 and
its cofactor Ran (the GTP-bound form). Following export, the
cytoplasmic RNase III Dicer participates in the second
processing step (‘dicing’) to produce miRNA duplexes. The
duplex is separated and usually one strand is selected as the
mature miRNA, whereas the other strand is degraded. In
Drosophila melanogaster, R2D2 forms a heterodimeric
complex with Dicer and binds to one end of the small
interfering RNA duplex. It thereby selects one strand of the
duplex. It is not known if miRNAs use the same machinery for
strand selection (see question mark). It is also unclear as to
whether an R2D2 homologue functions in other animals apart
from D. melanogaster. miRISC, miRNA-containing RNA-
induced silencing complex; NPC, nuclear pore complex.
+ Figure 1.5: microRNA biogenesis 
A model outlining microRNA biogenesis, which begins with a microRNA transcript 
processed initially in the nucleus by Drosha-DGCR8 before export to the cytoplasm for 
further enzymatic processing by Dicer and accessory proteins. This then leads to the 
formation of a RNA-induced silencing complex (RISC) for targeting mRNA attenuation. 
Graphic from Kim. 2005.  
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Pre-miRNAs are processed further in the cytoplasmic space by Dicer, another RNase III enzyme 
leading to the formation of an miRNA:miRNA duplex of 21 to 22 nucleotides in length (V. N. 
Kim 2005). Other proteins bind to Dicer to assist in its processing of pre-miRNAs, such as 
loquacious (Loqs) in fruitflies or TRBP in mammals, allowing for adjustment of cleavage points 
with the molecule (Chendrimada et al. 2005). Once enzymatic processing has ceased, the 
miRNA:miRNA duplex is loaded into an argonaute (AGO) protein, leading to the formation of 
an RNA-induced silencing complex (RISC). RISC can then bind to mRNAs leading to 
attenuation of the message as a form of post-transcriptional gene regulation.  
 
MicroRNAs are believed to play significant roles in cancer, with some microRNAs being 
classified as tumour suppressors or oncogenes and broadly referred to as oncomirs (Esquela-
Kerscher & Slack 2006). The models proposed by Esquela-Kercher & Slack, state that miRs can 
attenuate the message of oncogenes, thereby acting as tumour suppressors, or aberrantly inhibit 
the translation of tumour suppressor mRNAs, thereby acting as oncogenes.  
 
1.7 – Epigenetics: A Suitable and Challenging Approach to Interrogate Arsenic-
induced Carcinogenesis 
 
The examination of arsenic-induced cellular transformation through the scope of epigenetic 
mechanisms has gained considerable traction, with an increasing level of research overlap 
between the disciplines of mechanistic toxicology, molecular epidemiology and epigenetics. Some 
of the rationale for this is described below.  
 
Cellular metabolic states are believed to influence chromatin structure. This is due to the 
behaviour of histone modifying enzymes that are reliant on key metabolites as part of catalytic 
processes. For example, a global reduction in nuclear acetyl-CoA leads to the reduction of 
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histone acetylation, whereas the reduction of NAD+ results in the inhibition of histone 
deacetylation (Katada et al. 2012; Wellen et al. 2009; Nakahata et al. 2009). As a result, histone-
modifying enzymes represent a platform through which metabolic status can have an impact on 
histone PTMs (Fig. 1.6).  
 
 
The varied kinetics of epigenetic marks across histone termini allow for both rapid changes as 
well as slow sticky post-translational modifications which respond to environmental stimuli. 
Some of these remain long enough to allow for the propagation of gene expression patterns to 
the next generation (Barth & Imhof 2010). These fast and slow marks allow for the codification 
of information from environmental exposures, such as toxicants, which may exist as a response 
with either benign or deleterious consequences (Watson & Goodman 2002). Environmental 
factors can not only influence gene expression, but also accumulate epigenetic changes 
+ Figure 1.6: Chromatin modifying enzymes as a sensor of cellular metabolism.  
Histone post-translational modifications are represented schematically. Histone-modifying 
enzymes utilise a wide range of cellular metabolites, hence any significant disruptions to the 
levels of such metabolites may have consequences on the post-translational status of histone 
tails. Adapted from Katada et al., 2012.  
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throughout a lifetime exposure from the early intra-uterine environment onwards. This 
accumulation of epigenetic marks then leads to an aberrant phenotype (Barros & Offenbacher 
2009).  
 
Another consideration is the fact that low-level chronic arsenic exposure can lead to cancer 
phenotypes. Cancer itself can occur from the deregulation of epigenetic processes. Aberrant 
DNA methylation is a classical contributor, as tumour cells have broadly hypomethylated 
genomes in addition to locus-specific hypo/hypermethylation events on genes that regulate the 
cell cycle, tumour cell invasion, DNA repair, chromatin remodelling, transcription and apoptosis 
(Robertson 2005). Unlike DNA methylation, where the range of epigenetic modifications are 
limited, histone modifications represent an opportunity for a significant variety of post-
translational modifications and can work co-operatively in groups or antagonistically to have 
impacts on gene expression and thus cellular outcome (Fischle et al. 2003). Furthermore, the 
aberrant expression of histone modifying enzymes such as HDACs have been reported in gastric, 
prostate, breast and colon cancers (Ropero 2007).  
 
Some toxicologists and those examining environmentally derived diseases have tried to consider 
how an environmental exposure or stimulus is communicated to a health outcome. Epigenetics 
has been implicated in such models, which broadly attempt to simply the combination of effects 
that lead to complex diseases such as cancer and mental health disorders. One proposal called the 
“mixed epigenetic and genetic and mixed de novo and inherited” (MEGDI) model attempts to 
integrate variations of both de novo and inherited epigenetic and genetic varieties into an overall 
summation that leads to a complex disease outcome (Y.-H. Jiang et al. 2004). A relatively recent 
study attempted to address this issue in a similar way by presenting a dichotomous mechanistic 
approach between environmental exposure and health outcomes by nominating genetics and 
importantly epigenetics as the link between the two (Fig. 1.7) (Bollati & Baccarelli 2010). Some 
researchers have clarified this model by suggesting that epigenetic processes consisting of 
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chromatin and associated modifications, serves as an intermediary between the changing 
environment and the inherited genome (Szyf 2007). In the related field of toxicogenomics, some 
studies have already begun to routinely analyse epigenetic modifications as a result of 
environmental toxicant exposure (Reamon-Buettner et al. 2008).  	  
	  
 
There are however some challenges with using epigenetic approaches. For the most part, existing 
studies have predominantly focused on DNA methylation markers at a limited number of loci, 
without broader interrogations to characterise multiple interactions at multiple loci (Verma et al. 
2014). Furthermore most cancer epidemiology epigenetic studies have utilised blood samples, 
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+ Figure 1.7: A model of genetic and epigenetic paths leading from environmental 
exposure to health outcomes. 
In this model, exposure to environmental toxicants leads to health effects through two 
pathways – a genetic pathway and an epigenetic pathway. Adapted from Bollati & Baccarelli, 
2010. 
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which in the context of arsenic-induced cellular transformation, may not be the most ideal 
biological specimen. With regards to the challenges, epigenetic mechanisms are fundamental for 
the maintenance of cellular identity, which means cells have different epigenetic backgrounds and 
responses following exposure to an environmental toxicant. Additionally, there is considerable 
impetus to understand the degree of causality between an epigenetic mark and disease, a 
requirement to understand the duration of exposures, the design of new tests to interrogate 
epigenetic inheritance and the appropriate separation of confounding factors (Marsit 2015).  
 
1.8 – Arsenic-induced Perturbations of DNA methylation and Associated 
Outcomes.  
 
Arsenic exposure leads to the disruption of nominal DNA methylation patterns with 
repercussions on gene regulation, chromatin stability, cancer development and progression. Both 
DNA hyper- and hypo- methylation events have been reported following arsenic exposure, with 
a number of proposed mechanisms implicating alterations in DNA methyltransferases activity 
and/or expression, oxidative stress and arsenic-induced metabolic depletion of the SAM methyl 
donor (Reichard & Puga 2010).  
 
1.8.1 – Global DNA methylation levels are affected by arsenic exposure.  
 
Global DNA hypomethylation following arsenic exposure has been reported in human 
colorectal, keratinocyte and prostate cells (Bustaffa et al. 2014). There is evidence to suggest 
long-term arsenic exposure depletes S-adenosylmethionine (SAM) through metabolic processing 
of the toxicant and additionally supresses the expression of DNA methyltransferases DNMT1 
and DNMT3A resulting in global DNA hypomethylation (Reichard et al. 2007). Genome-wide 
changes in DNA methylation have also been demonstrated by digesting DNA from human 
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keratinocyte (HaCaT) and mouse testicular cells exposed to 1 ng/ml – 1000 ng/ml sodium 
arsenite with restriction enzymes sensitive to DNA methylation (Singh & DuMond 2007). The 
result is a DNA fingerprint that changes depending on the magnitude of the sodium arsenite 
dosage.  
 
The picture is not entirely clear though as global DNA hypermethylation has also been reported 
following arsenic exposure. In a study of 320 adults, a dose-response relationship was identified 
correlating water, blood and urinary arsenic with global DNA methylation in peripheral blood 
mononuclear cells (PBMCs) (Niedzwiecki et al. 2013). Global DNA hypermethylation has also 
been measured within transposable genomic elements following arsenic exposure. In a study 
composed of 581 participants, a significant increase in DNA methylation was identified in Alu 
elements, which contribute to 11% of the genome (Lambrou et al. 2012; Deininger 2011). 
Paradoxically, global hypomethylation was also identified in long interspersed elements – LINE-
1, especially in males increasing the likelihood of genomic instability and cancer due to the altered 
activity of these transposable elements (Lambrou et al. 2012).  
 
These studies suggest that there are some challenges with investigating arsenic-induced global 
DNA methylation patterns. In addition to canonical DNA methylation, global DNA 
hydroxymethylation levels are adjusted following arsenic exposure. Furthermore, both DNA 
methylation measurements have been shown to be correlated with each other in blood samples 
taken from arsenic exposed individuals suggesting that one could be a proxy measurement of the 
other and vice-versa (Tellez-Plaza et al. 2014). Tellez-Plaza et al. were able to report differences in 
DNA methylation and hydroxymethylation in individuals with differing % measurements of 
urinary arsenic metabolites including DMA, MMA and iAs, effectively opening a debate about 
which measurement is the more effective biomarker. This discussion is particularly significant as 
differences in the % of arsenic metabolites have been attributed to genetic variations in genes 
encoding for methyltransferases PRDM9, EHMT1 and AS3MT (Tellez-Plaza et al. 2013).   
Sunniyat Rahman | Imperial College London  53 	  
 
1.8.2 – Promoter-specific DNA methylation effects following arsenic exposure.  
 
Whilst the notion of arsenic-induced global hypomethylation revolves around the suggestion that 
SAM is depleted after long-term arsenic exposure, there is significant evidence of promoter-
specific DNA hypermethylation and hypomethylation occurring independently of global DNA 
methylation levels (Table. 4).  
 
+ Table 4: Gene promoter-specific DNA methylation aberrations following arsenic 
exposure. 
 
Direction of DNA 
methylation 
Study Type Arsenic 
Exposure 
Gene Annotations Reference 
↑  
Hypermethylation 
Molecular 
epidemiology 
Drinking 
water 
(>10µg/l) 
DAPK, 
p16 
Downregulated, 
in arsenic 
induced skin 
lesions and 
cancer tissues.  
(Banerjee et al. 
2013) 
 Molecular 
epidemiology 
50 – 1000 
µg/L 
arsenic in 
drinking 
water 
TP53, P16 DNA 
hypermethylatio
n of genes 
important in 
carcinogenesis.  
(Chanda 2006) 
 In vitro 100 ng/mL 
arsenic 
MLH1 Silencing of 
MLH1 lead to 
increased cell 
growth, 
decreased 
apoptosis and 
cellular 
transformation.  
(Treas et al. 2013) 
 In vitro 5 µM 
sodium 
arsenite 
ZNF 
genes 
Silencing of 
ZNF genes in 
arsenite-induced 
cellular 
transformation 
(Severson et al. 
2013) 
 In vitro 1 µM 
sodium 
arsenite 
LET-7C Leads to cellular 
transformation 
through 
disruption of 
Ras/NF-ΚB 
pathway. 
(R. Jiang et al. 
2014) 
 In vitro 1 µM 
As(III) and 
50 nM 
MMA(III) 
DBC1, 
FAM83A
, ZSCAN, 
C1QTNF
6 
Leads to cellular 
transformation.  
(Jensen et al. 2008) 
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Table 4 cont…      
↓  
Hypomethylation 
Molecular 
epidemiology 
Urinary: 
<7.2 µg/L 
(low) and > 
14.0 µg/L 
(moderate) 
AS3MT Involved in 
arsenic 
metabolism. 
(Gribble et al. 
2014) 
 Molecular 
epidemiology 
Drinking 
water: 4.37 
µg/L, 
Urine: 
18.62 µg/L, 
Nail: 0.21 
µg/g, Hair: 
0.13 µg/g. 
(mean) 
ERCC2 Involved in 
DNA repair. 
(Paul et al. 2014) 
 Molecular 
epidemiology 
Urine: 1.4 
ng/mL 
(mean) 
GAD1, 
INS, 
PDX1, 
SOCS6 
These genes are 
implicated in 
diabetes 
mellitus.  
(Bailey et al. 2013).  
 In vitro 0.08 µM 
sodium 
arsenite 
(low), 0.4 
µM sodium 
arsenite 
(intermediat
e), 2 µM 
sodium 
arsenite 
(high) 
TP53 Leads to 
disruption of a 
network of p53 
controlled 
genes, leading to 
the differential 
expression and 
carcinogenesis.  
(van Breda et al. 
2014) 
 In vitro 0.5 µM 
sodium 
arsenite 
LCN2 Leads to cellular 
transformation.  
(H.-H. Wang et al. 
2014) 
 
In the characterisation of promoter-specific DNA methylation patterns, the research agenda has 
remained focused on the promoters of genes that stimulate or control cellular transformation. In 
one such study, PBMCs were extracted for DNA methylation analysis from 72 individuals 
exposed to environmentally significant levels of arsenic. DNA hypermethylation was identified in 
the promoter regions of DAPK and p16 genes, leading to a 3.4 fold and 2.2 fold decrease in 
expression respectively (Banerjee et al. 2013). In the same study, a similar reduction in the 
expression of these genes was identified in arsenic-induced skin lesions and cancer tissues taken 
from the study site participants. Low-dose sodium arsenite exposure also leads to cellular 
transformation of human urothelial cells. These cells exhibit DNA hypomethylation at the 
lipocalin LCN2 promoter (H.-H. Wang et al. 2014). This occurs in concert with the binding of 
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the RelA and NF-ΚB1 at the hypomethylated promoter, resulting in LCN2 overexpression, 
anchorage-independent growth, resistance to serum deprivation and activation of NF-ΚB 
signalling. Chronic arsenic exposure in mouse testicular leydig cells have also demonstrated the 
increased expression of genes associated with cellular proliferation such as Pcna, CyclinD1 and 
Dnmt1, the latter gene encoding for DNA methyltransferase 1 (DuMond & Singh 2007).  
 
DNA hypermethylation has also been identified at the promoter of the canonical tumour 
suppressor gene TP53, particularly in individuals exposed to arsenic drinking water 
concentrations of <50 µg/l and 1000 µg/l, suggesting that even a very low exposure can lead to 
aberrant DNA methylation (Chanda 2006). Chanda et al. also identified a subgroup of individuals 
exposed to the higher 100 µg/l concentration of arsenic that exhibited DNA hypomethylation at 
the TP53 gene locus, alluding to the presence of hyper-to-hypo methylation switch depending on 
the magnitude of arsenic exposure. Furthermore, DNA hypermethylation at the TP53 locus was 
observed in people without malignancies giving some weight to its potential as an early 
biomarker. Treatment of human adenocarcinoma lung (A549) cells with low-level sodium 
arsenite also led to the differential methylation of a number of genes which were arranged in an 
interaction network impinging on TP53 (van Breda et al. 2014). This type of “big-data” approach 
was also applied to 16 individuals diagnosed with arsenicosis exposed to arsenic through drinking 
water. In this study PBMCs were subjected to genome-wide methylation analysis followed by 
interaction mapping of genes that were differentially methylated (Smeester et al. 2011). This not 
only led to the identification of numerous genes that were hypermethylated and implicated in 
arsenic-induced diseases such as cancer, cardiovascular disease and diabetes, but also identified a 
complex of 17 tumour suppressors that were silenced by DNA methylation (Fig. 1.8).  
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Similar studies have examined DNA methylation at the promoter-specific level allowing for the 
identification of large numbers of genes with differential DNA methylation patterns. Human 
uroepithelial (SV-HUC-1) cells exposed to 0.5 µM iAs, 0.05 µM – 0.2 µM MMA(III) and 0.2 µM 
– 0.5 µM DMA(III) led to the identification of 114 genes with differential DNA methylation 
patterns (Su et al. 2006). This methylation profile across the 114 genes was also similar to the 
transformed variant of the cell line, suggesting its importance in cellular transformation.  
 
Impaired DNA repair mechanisms are also believed to play a role in arsenic-induced 
carcinogenesis. In a sample of 157 individuals, water, urine, nail, hair and blood samples were 
taken to assess the extent of arsenic exposure (Paul et al. 2014). Those with the highest arsenic 
exposures, as determined by dermatological lesions, exhibited DNA hypomethylation at the 
excision repair cross-complementation group 2 – ERCC2 promoter. This was validated as a 
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individuals with signs of arsenicosis (Figure 1). Speciﬁcally, the
identiﬁed genes showed a statistically signiﬁcant (false discovery
rate (FDR) q-value <0.05) diﬀerence in average DNA methyla-
tion for each CpG island. This assay allowed for interrogation of
one the three genes previously identiﬁed as being hypermethy-
lated in individuals with signs of arsenicosis, e.g., p16. While the
fold change of p16 did not meet the statistical threshold for this
study, here we also observed increased promoter methylation in
individuals with signs of arsenicosis (fold change of 1.24).
Using a systems level approach, the 183 genes were analyzed
for known molecular interactions, and a large interactome of
hypermethylated genes was identiﬁed (Figure 2A). These are
enriched for their involvement in cancer-associated pathways
mediated by genes such as p53 (Figure 2B). Interestingly, we
found that many of the proteins encoded by genes with diﬀer-
entially methylated CpG islands are known players in arsenic-
associated disease, such as heart disease, diabetes, and cancer
(Supporting Information, Table 5).
Notably, we have also identiﬁed an arsenic-methylated tumor
suppressorome (Figure 2C), a pivotal clue in unravelling a
possible epigenetic mode of arsenic-induced disease. The tumor
suppressorome is a complex of 17 known or putative tumor
suppressors silenced in human cancers. It comprises the follow-
ing hypermethylated genes: C11orf70 (chromosome 11 open
reading frame 70), CENPE (centromere protein E, 312 kDa),
EEF1E1 (eukaryotic translation elongation factor 1 epsilon 1,
also known as p18), ENDOG (endonuclease G), FOXF1 (forkhead
box F1),HOXB5 (homeobox B5),HOXB9 (homeobox B9), hsa-
mir-126 (human microRNA 126), MMP15 (matrix metallopep-
tidase 15 (membrane inserted)), MSX1 (msh homeobox 1, also
known as HOX7), POLD4 (polymerase (DNA-directed), delta-4,
also known as p12), PRDM2 (PR domain containing 2, with
ZNF domain, also known as RIZ), RNF20 (ring ﬁnger protein
20), SMARCD2 (SWI/SNF related, matrix associated, actin
dependent regulator of chromatin, subfamily d, member 2),
SUFU (suppressor of fused homologue (Drosophila)), TBR1
(T-box, brain, 1), and TSC22D3 (TSC22 domain family,
member 3).
Among the members of the tumor suppressorome, of partic-
ular interest are those with known associations to arsenic-
induced diseases such as cancer of the bladder, kidney, lung, liver,
and prostate, as well as cardiovascular disease and diabetes
mellitus (Figure 2C, Supporting Information, Table 5). Interest-
ingly, the expression levels of speciﬁc members of the tumor
suppressorome have previously been shown to be altered via iAs
exposure. For example, iAs exposure in vitro results in the
downregulation of both MSX110 and CENPE.11 In this study,
we ﬁnd that the CpG islands within the promoter regions of the
identiﬁed genes are hypermethylated in individuals with skin
lesions. As mentioned, DNA hypermethylation of the promoter
regions of three genes has been reported in arsenic-induced
disease.8,9 Notably, the results from our study vastly increase this
list of gene targets. Examination of these gene targets would be
the next step in understanding how epigenetic changes regulate
gene expression and, subsequently, cause dysregulation leading
to disease.
In this study we have analyzed epigenetic changes in the
peripheral blood lymphocyte DNA from iAs exposed and
diseased individuals and do not directlymeasure alterations in target
organs. Recent studies support the utilization of lymphocyte
Figure 1. Arsenicosis-associated patterns of DNA methylation. The
heat map illustrates the average DNA methylation levels in promoter
regions of 183 genes. Data are z-score normalized for each gene. Red
represents a relative increase in CpG island methylation level, and blue
represents a relative decrease in methylation level.
Figure 2. Epigenetically modiﬁed iAs-induced networks. (A) Large interacting network of hypermethylated genes. (B) Tumor protein p53 (tp53)-
associated network. (C) The iAs-induced tumor suppressorome. P-values are shown in the top right corners of each network. Networks are displayed
with symbols representing products of hypermethylated genes (red symbols) or the proteins associated with th se genes (clear symbols).
+ Figure 1.8: Inorganic arsenic-induced tumour supressorome.  
Red symbols represent the products of hypermethylated genes; clear symbols represent other 
proteins that associate with these hypermethylated products to form an interaction network. 
Taken from: (Smeester et al,. 2011) 
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dose-dependent effect in HepG2 and HEK293T cells, leading to a two-fold increase in ERCC2 
expression with an increase in micronuclei frequency, a proxy for genotoxic damage. Further 
assays were able to demonstrate that the DNA proofreading and repair complex, TFIIH is 
regulated by ERCC2, which if overexpressed, suppresses the initiation of DNA repair at sites of 
DNA damage. This is a particularly significant finding, as it provides a mechanism for low-level 
arsenic-induced genotoxicity as a result of arsenic exposure, even though arsenic is itself 
considered a poor inducer of DNA double strand breaks at short 24 hour exposures in vitro (Mei 
et al. 2003).  
 
Variations in DNA methylation have also been connected to arsenic metabolism. Genetic 
variation of the AS3MT gene leads to differential methylation on a number of other target genes 
including C10ORF26, USMG5 and TRIM8, which suggests that AS3MT halotypes can not only 
predict methylation outcomes on other genes, but also that these genes may have an impact on 
arsenic metabolism (Engström et al. 2013). Furthermore, promoter methylation at the AS3MT 
locus in 48 participants was shown to vary with urinary arsenic levels. Those with higher arsenic 
exposures, exhibited significantly higher levels of hypomethylation at the AS3MT promoter 
allowing for the increased expression of the gene (Gribble et al. 2014). This suggests the presence 
of an epigenetic throttle for arsenic metabolism, depending on the extent of exposure.  
 
Arsenic exposure has undesirable effects on DNA methylation in concert with the steroid 
hormone oestrogen. In a unique study that examined combined arsenic and oestrogen exposure, 
DNA hypermethylation was observed at the MLH1 promoter at a greater level than the 
individual treatments between the toxicant and hormone (Treas et al. 2013). This study was 
conducted after initial experiments that examined global DNA methylation and histone 
acetylation patterns both of which are altered following combined treatment (Treas et al. 2012). 
The identification of DNA hypermethylation at the DNA mismatch repair gene MLH1 
promoter was particularly significant as it diminished an MLH1-mediated apoptotic response 
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after arsenic exposure in human prostrate epithelial cells and allowed for cellular transformation. 
This study provides an insight into aberrant DNA methylation patterns that may be exacerbated 
by individuals on hormonal therapies whilst exposed to arsenic.  
 
Other promoter-specific DNA methylation studies are not as easy to categorise or are not 
specifically relevant to carcinogenesis. In a molecular epidemiology study of 400 individuals 
exposed to arsenic contaminated drinking water, aberrant DNA methylation patterns were 
identified in white blood cells at the following loci: PLA2G2C, SQSTM1, SLC4A4, and IGH 
(Argos et al. 2014). In this study, the authors state that these genomic loci should be examined 
further as they may inform of novel pathways. Another genome-wide study conducted on a 
population from an arsenic contaminated region of Mexico, identified promoter-specific 
hypomethylation in circulating peripheral blood leukocytes at GAD1, INS, PDX, and SOCS6 
(Bailey et al. 2013). Some of these individuals exhibited symptoms related to diabetes.  
 
1.8.3 – DNA methylation effects following in utero arsenic exposure.  
 
DNA methylation is fundamental to the programming of functional genomic states, which is 
under timely regulation for mammalian development. As a result of this, a number of studies 
have focused on characterising the effects of in utero arsenic exposure upon DNA methylation to 
determine if such exposures predispose new-borns to specific illnesses.  
 
In a study by Pilsner et al. global DNA methylation patterns were examined from cord blood 
taken alongside maternal blood and maternal urinary arsenic measurements. An increase in 
maternal urinary arsenic concentration was associated with an increase in DNA methylation 
(Pilsner et al. 2012). These increases in methylation were measured by a luminometric 
methylation assay and were found specifically in Alu and LINE-1 repetitive genomic regions. 
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Prenatal arsenic exposure has led to the identification of gender-specific effects, with adverse 
DNA methylation in cord blood affecting boys in particular (Broberg et al. 2014). In boys, 74% 
of CpG islands were hypomethylated compared to 41% in girls. Long-term arsenic exposure in 
utero also alters the distribution of DNA methylation at 18% of the 385,249 CpG loci examined 
in lymphocytes, monocytes and granulocytes (Koestler et al. 2013).  
 
Whilst these reported DNA aberrations are considered “global”, another study examined the 
effect of in utero arsenic exposure on the methylation status of genes involved in the infectious 
disease response (Rager, Yosim, et al. 2014). Through the cross-comparison of two genomic data 
sets, an infectious disease gene (IDG) database and an arsenic exposure responsive gene (ERG) 
database, a total of 82 genes were identified with differential DNA methylation patterns 
following arsenic exposure in genes specifically involved in regulating a response against 
bacterial, viral and parasitic infections. These patterns were observed in PBMCs from pregnant 
women and compared against urinary and nail arsenic measurements.  
 
Some mothers take dietary supplements during pregnancy in arsenic contaminated areas. To 
examine the combinatorial effect of folate supplements and arsenic exposure, pregnant mice 
were exposed to inorganic arsenic and folate simultaneously. The combined exposure led to 
significant methylation changes of 2,931 genes within tissue samples taken from foetuses, 
including those associated with neurodevelopment, cancer, cell cycle and signalling (Tsang et al. 
2012). Furthermore, combined folate and iAs exposure reduced foetal weight, compared to single 
exposures suggesting the presence of compromised foetal development which is itself a risk 
factor for early-onset disease. This is a particularly significant finding as arsenic exposure and low 
birth weight have been previously examined in epidemiological studies, but this is the first study 
which demonstrates additional dietary supplements believed to be benign having an adverse 
effect (Guan et al. 2012; Hopenhayn et al. 2003; Huyck et al. 2007).  
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1.9 – Arsenic-induced Changes of Histone Post-translational Modifications.  
 
Unlike DNA methylation, a lot less is understood about the effects of arsenic on higher order 
chromatin structure. Some studies have been able to identify changes on histone PTMs following 
arsenic exposure including aberrations in acetylation, methylation and phosphorylation. 
 
1.9.1 – Arsenic-induced effects on global histone post-translational modifications.  
 
One of the first examples of aberrant histone acetylation and methylation following arsenite 
treatment came from an experiment using cultures of Drosophilia melanogaster (common fruit fly). 
Treatment with 50 µM sodium arsenite for 4 hours led to deacetylation and blocked methylation 
of the core histones H3 and H4 (Arrigo 1983). Although the author did not speculate on a 
mechanism for this effect, this study was significant as a “proof of concept” – that arsenic 
exposure does indeed have an effect on histone acetylation and methylation. In contrast, sodium 
arsenite treatment of hepatocarcinoma (HepG2) cells led to a significant increase in global 
histone acetylation (Ramirez et al. 2007). In this study global hyperacetylation was attributed to a 
HDAC inhibitory effect of sodium arsenite as similar changes were observed in cells treated with 
TSA – a HDAC inhibitor. Although in this study a comparison was made with TSA to imply the 
inhibitory effects of arsenic exposure, a more focused study was unable to reproduce a similar 
result. Ge et al. demonstrated global hypoacetylation in UROtsa cells treated with iAs and 
MMA(III), whilst a prolonged 12-week exposure led to increased expression and activity of 
HDACs (Ge et al. 2013). This global histone hypoacetylation led to malignant transformation 
after a 4-week arsenic exposure, which could be reversed by treatment with the HDACi SAHA.  
 
Other studies have been able to identify specific changes in histones by examining specific 
residues with clinically relevant environmental exposures. Global histone acetylation and 
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methylation changes have been identified in circulating PBMCs. In a sample of 40 participants 
exposed to arsenic contaminated water in Bangladesh, total urinary arsenic concentrations were 
correlated with H3K9me2 and inversely correlated to H3K9ac (Chervona et al. 2012). Water 
arsenic concentrations were positively correlated with H3K4me3 and H3K27me3 among 
females, but negatively in males, leading to the suggestion that differential effects can occur 
depending on the gender of individuals exposed. Another study examined in utero exposure of 
arsenic by exposing mice to 100 µg/L arsenic in drinking water 1 week prior to conception 
(Cronican et al. 2013). This study allowed for the identification of global H3K9 hypoacetylation 
in the corticies and hippocampi of newborn pups, suggesting that in utero exposure can alter 
global histone acetylation and with the potential for cognitive impairment (Cronican et al. 2013). 
Understanding the significance of the direction of these changes on specific residues is still a 
challenge. In a similar study, opposite effects were observed by examining blood leukocytes from 
steel workers exposed to inhalable arsenic compounds. This led to an increase in H3K4me2 and 
H3K9ac proportional to the number of years of employment (Cantone et al. 2011).  
 
Additional observations have been reported through the use of relevant in vitro models. 
Quantitative mass spectrometry revealed a decrease in H4K16 acetylation following 1 nM – 10 
µM As(III) treatment for 24-hours in the UROtsa cell line (Chu et al. 2011). This study also 
presented evidence to suggest that the modifications are much more pronounced in the globular 
regions of histone H3, such as K18 and K23, over tail regions such as K9 and K14. A reduction 
in histone acetylation at histone H4K5, K8, K12 and K16 was also reported. The strength of this 
study is the variety of lysines examined and the different histone environments that these lysines 
represent. Although this study did not examine the toxicity outcome of the short 24-hour 
exposure, the reduction in H4K16 acetylation observed concurs with prior research. In the study 
by Jo et al. H4K16 was not only reduced, but it was identified as the substrate of MYST. 
Furthermore, silencing of this enzyme induced sensitivity to As(III) and MMA(III) suggesting 
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that H4K16 acetylation is required for treatment resistance(Jo et al. 2009). This would suggest 
that H4K16 hypoacetylation is an effect that ultimately leads to toxicity.  
 
Exposure to tolerated As2O3 in BALB/c 3T3 cells not only led to cellular transformation and 
tumour generation in nude mice, but also a time-dependent increase in H3K27 trimethylation 
mediated by polycomb proteins BM1 and SUZ12 (H.-G. Kim et al. 2012). SiRNAs against 
messages for these enzymes supressed arsenic trioxide induced cellular transformation. Arsenite 
exposure leads to an increase in histone H3S10 phosphorylation in a time and dose-dependent 
manner in mouse epidermial JB6 CI41 cells (Z. He et al. 2003). He et al. also demonstrated 
through the use of mutations and inhibitors that H3S10 phosphorylation is mediated by AKT1, 
extracellular signal regulated kinase 2 and P90 ribosomal S6 kinase 2.  
 
1.9.2 – Arsenic-induced histone post-translational modification effects at promoter loci.  
 
There is a distinct lack of information regarding promoter specific histone PTM effects following 
arsenic exposure. Treatment of CAsE-PE cells with 5 µM sodium arsenite for 37 weeks led to no 
significant change in DNA methyltransferase expression, and no significant changes in DNA 
methylation at the KRAS gene, and yet an increase in KRAS expression was observed 
(Benbrahim-Tallaa et al. 2005). This study demonstrated that other modifications on chromatin 
at specific promoter loci might influence gene expression, independent of DNA methylation.  
 
Prior to this, histone H3 phosphoacetylation (Ser(P)-10/Ac-Lys-14) had been reported at the 
CFOS loci, but the exposure period was only for 60 minutes with a 400 µM arsenite exposure 
with no clear information on the cellular outcome (J. Li et al. 2003). Recent studies have used 
longer durations with lower concentrations. For example, promoter-specific acetylation changes 
in histone H3 were identified in cells exposed to As(III) and MMA(III) for 52 weeks leading to 
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malignant transformation. Hypoacetylation of histone H3 at the DBC1, FAM38A, ZSCAN12 
and C1QTNF gene loci was correlated with a reduction in expression (Jensen et al. 2008). 
Additionally these genes were found to be targets of increased DNA methylation, especially in 
the cells lines malignantly transformed by exposure. Promoter-specific histone acetylation 
changes can show increasing levels of complexity as highlighted by a study of histone 
modifications at the MT-3 promoter in UROtsa cells transformed by exposure to As(III). 
Transformed cells exhibit an increase in histone H4 acetylation and histone H3K4 methylation, 
both transcriptionally active marks, but also an increase in histone H3K9 and H3K27 
methylation, transcriptionally repressive marks. The investigators propose the idea that 
chromatin is in a bivalent state at the MT-3 promoter, ready to switch between an expressive or 
repressive state. In full urothelial cancer, MT-3 is present but absent in the normal cells (Somji et 
al. 2011). H3K9 hypoacetylation was also identified in the promoter regions of genes encoding 
for Krüppel associated box (KRAB) transcription factors following in utero arsenic exposure 
(Cronican et al. 2013). Inorganic arsenic induced histone H3K18 acetylation reduction co-occurs 
with a reduction in histone H4R17 methylation, this is achieved by disrupting the recruitment of 
co-activator associated arginine methyltransferase CARM1, leading to transcriptional repression 
of GR-regulated genes (Barr et al. 2009). This suggests that arsenic exposure may affect steroid 
hormone receptors via aberrations in transcriptional control.  
 
1.9.3 – Arsenic-induced interference of histone modifying enzymes and proteins that 
regulate chromatin structure.  
 
Arsenic exposure also interferes with the function of histone modifying enzymes and proteins 
that bind intimately to chromatin to regulate gene expression. HaCaT cells exposed to 1 – 200 
µM sodium arsenite exhibit perinuclear localisation of HDAC6 within 30 minutes of exposure 
along with physical interactions with ribosomes (Kappeler et al. 2012). This finding suggests that 
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HDAC6 is involved in responding to short-term arsenic-induced stress by regulating de novo 
protein translation. Kappeler et al. also demonstrated that the transcription factor NRF2, which 
exhibits elevated expression following oxidative stress, was similarly elevated following arsenite 
exposure, but treatment with Tubastatin A (TA) – a HDAC6 specific inhibitor, led to a reduction 
in NRF2 protein expression but not mRNA expression. This added evidence that HDAC6 is 
affecting de novo protein translation of NRF2. In addition to an inhibited stress response, arsenic 
exposure also leads to negative impacts on DNA repair. A recent study examined the function of 
RING finger E3 ubiquitin-ligases, which assist DNA repair mechanisms by ubiquitination of 
histone H2BK120. Cells treated with arsenite led to toxicant binding at the RING finger domain 
and impaired H2B ubiquitination (F. Zhang et al. 2014). This targeted interaction occurred at 
cysteine residues within the ubiquitin-ligases, leading to compromised DNA repair and a 
potentially carcinogenic outcome. DNA instability can also arise from an alteration in histone 
metabolism. Arsenic exposure has been shown to increase polyadenylation of the canonical 
histone H3.1 mRNA leading to altered histone mRNA metabolism (Brocato et al. 2014). The 
authors postulate that this is due to the downregulation of the stem-loop binding protein (SLBP) 
which binds to the 3’ end of the histone mRNA to alter its metabolism. Excess canonical histone 
expression leads to the elevation in sensitivity to DNA damage and genomic instability, both of 
which are favourable for carcinogenesis.  
 
1.10 – Disruptions in MicroRNA expression Following Arsenic Exposure and 
Implications.  
 
Both DNA methylation and the post-translational modifications of histones are considered pre-
transcriptional regulatory mechanisms. In contrast, microRNAs represent a significant 
opportunity for post-transcriptional control. A recent study has identified significant changes in 
gene expression following 1 µM sodium arsenite exposure, due to post-transcriptional regulatory 
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mechanisms affecting mRNA stability (Qiu et al. 2014). The differential expression of 
microRNAs has been reported in a number of contexts following arsenic exposure including 
carcinogenesis and cytotoxicity (Table. 5).  
 
+ Table 5: Differential expression of microRNAs following arsenic exposure in 
carcinogenic and treatment contexts.  
 
Context Toxicant microRNA Direction Model Reference 
Carcinogenesis Sodium arsenite 
miR-22 é Human 
immortalised 
lymphoblast 
(TK6) 
(Elamin et al. 
2011) 
(Marsit et al. 2006) 
miR-34a é 
miR-221 é 
miR-222 é 
miR-200b ê 
p53-knocked 
down human 
bronchial 
epithelial cells 
(P53 low 
HBECs) 
(Z. Wang et al. 
2011) 
(Z. Wang et al. 
2014) 
miR-222 é 
Human 
immortalised 
lymphoblast 
(TK6) 
(Ling et al. 2012) 
miR-21 é 
Human 
embryo lung 
fibroblast 
(HELF) 
miR-181b ê Fertilised 
white leghorn 
chick eggs 
(Cui et al. 2012) 
miR-9 ê 
Cytotoxic 
treatment 
Sodium 
arsenite miR-21 ê 
Acute 
myelogenous 
leukaemia 
(HL60) / 
chronic 
myelogenous 
leukaemia 
(K562) 
(J. Gu et al. 2011) 
Arsenic 
trioxide 
miR-19a ê Human 
bladder 
carcinoma 
cells (T24) 
(Y. Cao et al. 
2010) miR-222 é 
 
Human immortalised lymphoblast (TK6) cells exposed to 2 µM sodium arsenite led to the 
differential expression of a number of miRs including miR-22, -34a, and -221 (Marsit et al. 2006). 
This study also examined the effect of metabolic stress in the form of folate-deficiency by 
treating cells with sodium arsenite in folate-deficient RPMI growth medium. Under this 
circumstance miR-222 was increased, an effect that was also verified with an in vivo study. This 
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was a particularly significant finding as miR-222 has been implicated in cellular differential 
pathways of various blood cells. By using a similar treatment of 2.5 µM sodium arsenite, p53-
knockdown-human bronchial epithelial cells (HBECs) became malignantly transformed (Z. 
Wang et al. 2011). This effect also correlated with the significantly reduced expression of miR-
200b. Overexpression of miR-200b via a stable transfection was able to counteract the 
transformative effect of sodium arsenite. A follow up study demonstrated that miR-200b 
attenuated PKCα which in turn diminishes Rho GTPase RAC1 activation (Z. Wang et al. 2014). 
As a result cytoskeletal reorganisation and cell migration is impeded, both of which are contrary 
to cellular transformation behaviours.  
 
The differential expression of miRs following arsenic exposure has been implicated in pathways 
previously shown to have roles in arsenic-induced carcinogenesis, for example intracellular ROS 
and cell cycle control. In a study using human embryo lung fibroblasts (HELF) treated with 1 µM 
sodium arsenite, NF-ΚB-mediated transcriptional transactivation of the miR-21 promoter was 
identified (Ling et al. 2012). Furthermore, the activation of NF-ΚB itself was dependent on the 
activation of ROS sensitive extracellular signal-regulated kinase (ERK). Arsenic exposure 
impinges on cell cycle control via the deregulated expression of miR-2909 (Sharma et al. 2013). 
Sharma et al. found a regulatory network in which miR-2909 regulates cyclin D1 via KLF4 and 
SP1, both of which have inhibitory effects on cyclin D1. At a tolerated exposure miR-2909 is 
overexpressed, which leads to the attenuation of the negative regulators of cyclin D1 and 
deregulated cell cycle progression.  
 
Pre-natal exposure to arsenic also has an impact on the expression of a number of miRs. New 
born cord blood samples were collected and maternal urinary arsenic (U-tAs) measurements were 
conducted allowing for the identification of 12 miRs including miR-126, -16, -17, -96, which 
demonstrated increased expression in positive correlation with U-tAs (Rager, Bailey, et al. 2014). 
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Pathway analysis was able to show that these miRs were involved in signalling pathways with 
consequences in cancer, diabetes and the regulation of innate and adaptive immune responses. 
Aberrant miR expression has been identified in fertilised chicken eggs injected with 100 nM 
sodium arsenite. By using a microarray the expression of a number of miRs were evaluated, 
including miR-181b and miR-9 both of which were significantly decreased (Cui et al. 2012).  
 
1.11 – Combined Epigenetic Effects Following Arsenic Exposure.  
 
Arsenic exposure leads to the simultaneous disruption of DNA methylation, histone PTMs and 
miR expression with deleterious outcomes. Combinatorial effects are sometimes referred to as 
crosstalk events, where multiple epigenetic events interact with some independence. However 
this notion is still not a solidified idea or principle. Winter et al. has attempted to describe 
epigenetic crosstalk events as those that either positively or negatively regulate the impact of a 
subsequent epigenetic event, such as histone post-translational modification leading to the 
repulsion or enhancement of proteins at the inter- or intra- nucleosomal level (Winter & Fischle 
2010). Similar discussions have focused on the interdependence of histone PTMs (N. Lee & Y. 
Zhang 2008; J.-S. Lee et al. 2010). Whilst these reviews focus on a much more molecular 
interpretation of crosstalk, there is benefit in considering crosstalk across the epigenetic 
landscape such as DNA methylation events altering the expression of miRs, or histone PTMs 
affecting the extent of methylation at specific promoters and indeed such examples exist in the 
context of arsenic-induced cellular transformation.  
 
Human prostate epithelial (RWPE-1) cells exposed to 5 µM sodium arsenite for 33 weeks 
became transformed with elevated H3K27me3 in PCDH, HOXC and HOXD gene family 
clusters and DNA hypermethylation at the same loci (Severson et al. 2012). Chronic-arsenic-
exposed human prostate epithelial cells (CAsE-PE) also exhibited DNA hypermethylation at 
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genes marked with H3K27me3 (Severson et al. 2013). Severson et al. demonstrated that normal 
immortalised cells have elevations in H3K4me3 at the 5’ end of the genes encoding for C2H2 
zinc finger (ZNF) proteins and H3K9me3 at the 3’ end. However, this changes in malignantly 
transformed cells, where H3K4me3 methylation is switched to H3K9me3 at the 5’ end. This 
leads to DNA hypermethylation and the downregulated expression of ZNF genes. Proteins 
encoded by ZNF genes make up one of the largest families of sequence specific DNA binding 
transcription factors, suggesting that these mechanisms may have significant implications for 
transcriptional co-activation. A number of genes believed to be related to arsenic-induced cellular 
transformation including DBC1, FAM83A, ZSCAN and C1QTNF6 are hypermethylated along 
with a decrease in histone H3 pan-acetylation resulting in tight chromatin condensation and 
silencing (Jensen et al. 2008).  
 
Tolerated arsenic exposure depletes microRNA let-7c through aberrant levels of DNA 
methylation. This miR is involved in the regulation of the Ras/NF-ΚB signalling pathway, and its 
depletion leads to cellular transformation of HaCaT cells and the acquisition of cancer stem-cell 
like properties (R. Jiang et al. 2014). The methyltransferase inhibitor 5-aza-2’-deoxycytidine can 
rescue let-7c levels suggesting that aberrant DNA methylation is fundamental to this observation.  
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Human keratinocytes exposed to 0.5 µM arsenite increases H4K16 acetylation, with chromatin 
remodelling at the pri-miR-34a promoter (Herbert et al. 2014). This occurs in concert with an 
increase in H4K16 acetylation at the SIRT1 promoter (Fig. 1.9). Furthermore, DNMT1 is not 
deacetylated which has an inhibitory effect leading to a significant DNA hypomethylation at the 
pri-miR-34a promoter. This is good example of all crosstalk between histone PTMs, DNA 
methylation and miRs following arsenic exposure.  
 
1.12 – Arsenic Exposure in a Therapeutic Context and Associated Epigenetic 
Effects.   
 
Another impetus to investigate the carcinogenic mechanisms of arsenic is the fact that human 
exposure to arsenic is not limited to tolerated environmental exposures, rather human exposures 
also occur in a therapeutic context as arsenic is an effective cytotoxic anti-cancer therapy (Soignet 
et al. 1998). This paradoxical effect of arsenicals as a potent cancer treatment and carcinogenic 
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529 repression and disrupts established patterns of histone acetylation and
530 DNA methylation by suppressing SIRT1 activity (Fig. 6).
531 Further investigation is required to determine whether SIRT1 in-
532 activation by arsenic plays a role in the promotion of carcinogenic
533 change in the skin. Although keratinocytes with p53 mutations
534 have been successfully transformed by extended exposure to
535 submicromolar concentrations of arsenic (Chien et al., 2004; Sun
536 et al., 2009), similar treatment conditions were insufﬁcient to induce
537 transformation in our study. Sirtuin expression is down-regulated in
538hyperkeratotic lesions from arsenic exposed individuals (Bailey
539et al., 2009), a result which is consistent with our ﬁndings in
540keratinocytes exposed to arsenic over 10 weeks. Paradoxically,
541other groups have shown that SIRT1 is overexpressed in UV-
542induced skin cancer (Hida et al., 2007; Wilking et al., 2014), and
543when taken with our ﬁndings, this disparity in the SIRT1 expression
544proﬁle supports evidence indicating that arsenic induces carcino-
545genic transformation in keratinocytes via a mechanismwhich differs
546from UV-induced skin cancer.
Fig. 5. SIRT1 and miR-34a gene expression are modulated by altered CpG methylation during extended arsenic exposure. Bisulﬁte converted DNA from keratinocytes cultured in 0.5 μM
As(III) was ampliﬁed at the SIRT1 and pri-miR-34a gene promoterswithin the CpG island and PCR fragments were sequenced.Methylation of CpG dinucleotideswas determined from the
sequencing trace using BiQ Analyzer software (black circles, N50% methylated; white circles, b50% methylated). Panel a: SIRT1 promoter methylation; panel b: pri-miR-34a promoter
methylation. Expression of SIRT1 (panel c) and miR-34a (panel d) mRNA was assayed by qRT-PCR at each timepoint and analysed relative to passage-matched untreated controls
(n= 2).
Fig. 6.Arsenic alters patterns of gene expression by suppressing SIRT1 activity. By inhibiting the activity of SIRT1, arsenic disrupts established patterns of chromatinposttranslationalmod-
iﬁcations and cytosine methylation as part of polycomb repressive group complexes. Key: As(III) — arsenite; DNMT1 — DNA methyltransferase 1; EED— embryonic ectoderm develop-
ment protein; EZH2/SUV3-9— enhancer of zeste homologue 2;MeCP2—methyl CpG binding protein 2; Suz12— suppressor of zeste 12; RbAp46 & 48— retinoblastoma binding proteins
46 & 48.
8 K.J. Herbert et al. / Toxicology and Applied Pharmacology xxx (2014) xxx–xxx
Please cite this article as: Herbert, K.J., et al., Arsenic exposure disrupts epigenetic regulation of SIRT1 in human keratinocytes, Toxicol. Appl.
Pharmacol. (2014), http://dx.doi.org/10.1016/j.taap.2014.09.012
+ Figure 1.9: Arsenic-induced alteratio s on DNA methylation and histone acetylation 
on the pri-miR-34a promoter.   
 Arsenic inhibits the activity of SIRT1 leading to the disruption of histone acetylation and 
DNA methylation patterns. This res lts in the impedance of polycomb repressive group-
mediated gene repression. Taken from: (Herbert et al., 2014) 
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compound is still under intense investigation. 
 
In a therapeutic context arsenic leads to epigenetic disruptions with cytotoxic endpoints. In the 
treatment of chronic myeloid leukaemia (K562) cells, 2 µM As2O3 significantly restored target 
methylation-associated silencing-1 - TMS1 expression by reversing DNA hypermethylation at the 
promoter leading to apoptosis via the downregulation of BCL-2/BAX expression (H. Li et al. 
2014). Rather than an actual reversal of DNA methylation, there is some evidence to suggest that 
arsenic inhibits both DNMT1 and DNMT3B protein expression in the mouse mammary cancer 
(EMT6) cell line (Q. Li et al. 2009).  
 
Aberrations in histone PTMs have also been identified in a therapeutic context. Acute 
promyelocytic leukemia (NB4) cells exposed to As2O3 led to the induction of CASPASE-10 (J. 
Li et al. 2002). Inhibition of CASPASE-10 with a specific inhibitor was able attenuate As2O3-
induced apoptosis. Further investigation of the histone PTMs at the CASPASE-10 locus 
identified an increase in H3S10 phosphorylation and H3K14 acetylation via a crosstalk 
mechanism. An increase in the gene-activating mark of H3K4me3 was observed in human lung 
carcinoma (A549) cells after treatment with 0.1 – 1 µM arsenite (X. Zhou et al. 2009). 
Interestingly this mark remained and was inherited through a number of cellular divisions over a 
period of 7 days after toxicant removal. A prior study with the same A549 cell line also identified 
an increase in H3K9me2 and a decrease in H3K27me3, both of which are important in gene 
silencing following a very low 0.1 µM sodium arsenite exposure (X. Zhou et al. 2008). Arsenic 
trioxide has also been shown to disrupt the serine/threonine kinase TOPK mediated 
phosphorylation of H2AX, which leads to apoptosis (Tatyana A Zykova & Dong 2006). 
Conversely the same study demonstrated that H2AX phosphorylation is required for tolerance 
against arsenic trioxide exposure.  
 
Differential impacts on histone modifying enzymes following arsenic trioxide exposure have also 
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been identified in the treatment of multiple myeloma cells (Qu et al. 2012). Exposure to relatively 
low levels of As2O3 from 0.5 µM to 2.5 µM affected cellular survival, but only higher 
concentrations of 4 µM As2O3 and above led to an inhibition of HDAC activity in a dose and 
time-dependent manner, leading to an increase in α-tubulin acetylation, HSP90 acetylation and 
cytotoxicity.  
 
Arsenic trioxide is believed to have some therapeutic benefit in the treatment of bladder cancer. 
Human bladder carcinoma (T24) cells exposed to As2O3 led to the differential expression of a 
number of miRs, including the significant reduction of miR-19a expression. Knockdown of miR-
19a led to apoptosis and inhibited growth (Y. Cao et al. 2010). This research suggests that miR-
19a may be an important therapeutic target in bladder cancer, which can be influenced by arsenic 
trioxide exposure. Arsenic trioxide treatment has also demonstrated some promise in attenuating 
the migration and invasiveness of human liver cancer (MHCC97H) cells via miR-491 (X. Wang et 
al. 2014). Wang et al. showed that DNA hypomethylation at the miR-491 promoter permits an 
increase in its expression, and this miR targets NF-ΚB leading to the blocking of mesenchymal to 
epithelial transition.  
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- 2 - 
Hypothesis and Aims 
	  
The unified hypothesis of this thesis is stated below which has been explored through two closely 
related studies.  
 
Hypothesis: 
Long-term exposure to tolerated levels of As2O3 affects the relative activity and/or expression of 
HDACs, HATs, and microRNAs, leading to alterations in histone acetylation with impacts on 
gene expression favourable to cellular transformation.  
 
The aims of each study are presented below and were generated to explore the hypothesis.  
 
Study 1: Investigating mechanisms and outcomes of As2O3-induced histone acetylation 
 
1. Identify tolerated and toxic concentrations of As2O3 in HEK293T cells under short-term 
and longer-term exposures.  
2. Determine if tolerated exposure leads to cellular physiological properties concomitant 
with cellular transformation. 
3. Identify the differences in global histone acetylation on specific lysine residues as a result 
of As2O3 exposure at tolerated and toxic concentrations.  
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4. Identify the enzymes that are involved in modulating the acetylation status on specific 
lysines and evaluate their expression and/or activity under tolerated and toxic As2O3 
concentrations.  
5. Investigate the role of As2O3-induced histone acetylation and histone modifying 
enzymes in the transcriptional regulation and expression of proto-oncogenes, tumour 
suppressors and apoptotic genes.  
 
Study 2: As2O3-induced microRNA aberrations and the consequences on histone 
acetylation. 
 
 
1. Identify differentially expressed microRNAs under tolerated and toxic exposures to 
As2O3 in UROtsa cells and utilise bioinformatics to identify potential micro-
RNA:HDAC/HAT interactions.  
2. Determine microRNA and HDAC/HAT mRNA expression levels to identify inverse 
correlations between microRNA and HDAC/HAT expression.  
3. Investigate for microRNA-mediated attenuation of HDAC/HAT mRNAs by using a 
3’UTR luciferase reporter.   
4. Use antisense-RNAs against candidate microRNAs to stop the attenuation mechanism 
and determine specificity.  
5. Determine the impact of microRNA-mediated attenuation of HDAC/HAT mRNAs on 
histone acetylation. 
 
The results for each study are separated into independent sections and then unified into a single 
discussion section.  
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- 3 -  
Materials and Methods 
	  
3.1 – Cells, Culture Conditions and Harvesting 
 
Two cell lines were selected as in vitro models to investigate the hypothesis of this study. The cells 
were of a relevant species i.e. human, exhibited a good toxicity profile after exposure to As2O3 
and apart from minimal modifications to allow for continuous passaging, the cells exhibited 
normal morphological characteristics by growing adherently and as a monolayer.  
 
The first model used was the human embryonic kidney (HEK) 293T cell line provided by Dr. 
Nabil Hajji (Imperial College London). HEK293T cells are a variant of HEK293 cells, created by 
Prof. Michele Calos (Stanford University) (Public Health England, 
http://www.hpacultures.org.uk/products/celllines/generalcell/detail.jsp?refId=12022001&colle
ction=ecacc_gc, accessed 08.2013). These cells were immortalised by sheared human adenovirus 
type 5 DNA, decreasing the ability of the cells to fall into senescence and transfected with a gene 
encoding for the SV40 large T antigen (Kavsan et al. 2011). This allowed for extended exposure 
to As2O3 and subsequent experimental analysis. 
 
The second model used was the normal human urothelium (UROtsa) cell line. This cell line was 
sourced from the United States with the assistance of Prof. Scott Garret (University of Dakota) 
during the latter stages of this study due to a lack of local depositories. UROtsa cells were 
considered for this study as the cell line was of an appropriate derivation; from the urothelial 
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lining of a 12-year-old female, immortalised by the SV40 large T antigen similarly to HEK293T 
and did not form colonies in soft agar or tumours after implantation into nude mice after 6-
months (Petzoldt et al. 1995). UROtsa cells also exhibit morphological characteristics consistent 
with the normal human urothelium and are considered suitable for studying arsenic-induced 
epigenetic aberrations and carcinogenesis as the bladder is a target (Rossi et al. 2001; Eblin et al. 
2008).  
 
HEK293T and UROtsa cell lines were grown in T175 flasks with Dulbecco’s Modified Eagle’s 
Medium (Sigma – D5671) completed with 10% Fetal Bovine Serum (Sigma – F7524), 1% L-
Glutamine (Gibco – 25030) and 1% Penicillin-Streptomycin solution (Sigma – P4333). Both 
adherent cell lines were passaged twice a week by detachment from the cell culture surface with 
1X Trypsin (SAFC Bioscience – 59418C) pre-warmed to 37ºC followed by re-suspension in 20 
mL of completed DMEM for seeding. Both cell lines were cultured at 37ºC in a humid 5% CO2 
atmosphere.  
 
Cells were harvested for downstream assays by collecting all the cell culture medium for each 
treatment into separate conical tubes. Cells were detached from the cell culture surface with 1X 
Trypsin (SAFC Bioscience – 59418C), which was inspected under a light microscope to ensure 
full detachment before collection. The remaining culture surface was washed with 1X PBS 
(Gibco – 14200-67) to ensure collection of all cells. Suspensions were centrifuged at 1,000 g for 5 
minutes and the medium was aspirated. Cell pellets were washed in 1X PBS followed by 
centrifugation at 1,000 g for 5 minutes. After aspiration of the PBS, cell pellets were snap frozen 
in liquid nitrogen and stored frozen at -20ºC. This harvesting method was used for all assays 
unless stated otherwise in the subsequent methods.  
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3.2 – Toxicants and Cell Treatments 
 
Arsenic trioxide (As2O3, Sigma – 311383) was prepared into 10 mM As2O3 stocks in a 1 M 
NaOH solvent. Autoclaved solutions were used and preparations were sterilised through a 0.4 
µm filter and stored at -20ºC. For cellular treatments the culture medium was first replaced with 
pre-warmed DMEM (Sigma – D5671) and then stock toxicant preparations were diluted in pre-
warmed DMEM and added to live cell cultures to the desired concentration. Untreated controls 
were exposed to the vehicle alone. The cell culture flasks were then tilted gently to homogenise 
the toxicant solution with the medium.  
 
3.3 – Protein Extraction 
 
Harvested cells were allowed to thaw on ice. Cell pellets were re-suspended in 200 µL TGN 
buffer (1 M Tris-HCl, 2.5 M NaCl, glycerol, 0.5 M β-glycerphosphate, Tween 20 and Nonidet 
P40) completed with protease-inhibitor cocktail (Sigma – P8340) at a 1:1000 dilution. After 10 
minutes on ice the suspension was mixed and lysed by the surfactants. After three repetitions of 
this process, the mixture was centrifuged at 16,000 g at 4ºC for 10 minutes leaving the proteins in 
the supernatant. Proteins were then transferred to new micro centrifuge tubes.  
 
3.4 – Histone Extraction 
 
Harvested cells were incubated on ice for 15 minutes in lysis buffer (10 mM Tris pH = 6.5, 50 
mM sodium bisulphate, 10 mM MgCl2, Sucrose 8.6%, 5mM sodium butyrate and 1% Triton X-
100). The samples were then centrifuged at 10,000 g for 10 minutes at 4ºC. The pellets were 
washed in ice-cold Tris-EDTA (10 mM Tris pH = 7.4, 13 mM EDTA) and centrifuged. The 
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cellular material was suspended in 50 µL ice-cold miliQ H2Od. Samples were subsequently 
treated with 0.2 M H2SO4 (Sigma – 320501), homogenised by vortex and incubated on ice for 60 
minutes. Samples were centrifuged again at 10,000 g for 60 minutes at 4ºC. Histones were 
precipitated by incubating the supernatant with 1 mL acetone overnight at -20ºC followed by 
centrifugation at 10,000 g for 10 minutes at 4ºC. The supernatant was removed and the histones 
were air dried and suspended in 50 µL miliQ H2Od.  
 
3.5 – Bradford Assay of Protein 
 
Protein concentrations were determined by using a Coomassie® Brilliant Blue dye-binding 
protein assay reagent (Bio-Rad – 500-0006) against a bovine serum albumin (BSA, Sigma – 
A9418) standard. BSA stocks of 2 mg/mL were diluted 1:10 before adding in increasing 
increments to the protein assay reagent at following final concentrations: 4 x 10-3 µg/µL, 8 x 10-3 
µg/µL, 1.6 x 10-2 µg/µL, 3.2 x 10-2 µg/µL and 0.064 x 10-2 µg/µL. Extracted proteins were 
measured by adding 1 µL of each sample to 200 µL of protein assay reagent in a 96-well plate. All 
measurements were taken in triplicate. Absorbance readings at 595 nm were measured on a 
GloMax® Microplate Reader (Promega). Protein concentrations of the samples were calculated 
by interpolation of a standard curve plot of known BSA concentrations against A595.  
 
3.6 – Immunoblotting of Histones and Other Proteins 
 
Acetylation, methylation and phosphorylation post-translational modifications of core histones 
were determined by Western blotting. Proteins were separated by SDS-PAGE under reducing 
conditions and transferred to a nitrocellulose membrane (Amersham Hybond ECL 
Nitrocellulose Membrane, GE Lifesciences). Membranes were blocked with 5% non-fat dry milk 
in PBS Tween 0.1% for 30 minutes and incubated with primary antibodies overnight at 4ºC with 
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agitation. Membranes were washed with 0.1% PBS-Tween followed by incubation with 
peroxidase conjugated goat anti-rabbit IgG (1:8,000) (Sigma – A0545) and goat anti-mouse IgG 
(1:5,000) (GE Healthcare – NXA931) depending on the primary antibody host species.  
 
Primary antibodies used to identify histone post-translational modifications were as follows: anti-
acetyl Histone 3 (1:20,000) (Millipore), anti-acetyl Histone H3-Lys 9 (1:2,000) (Upstate, 
Millipore), anti-dimethyl Histone H3-Lys 9 (1:2,000) (Upstate, Millipore), anti-phospho Histone 
H3-Ser 10 (1:1,000) (Millipore), anti-acetyl Histone H4-Lys 12 (1:3,000) (Millipore) and anti-
acetyl Histone H4-Lys 16 (1:10,000) (Millipore).  
 
For intracellular protein analysis the following antibodies were used: anti-PARP (1:1000) (Cell 
Signalling), MDM2 (1:1000) (Millipore), p53 phosphorylated serine 15 (1:1000) (Cell Signalling), 
P53 (1:1000) (Cell Signalling), BID (1:1000) (Cell Signalling), CASPASE-3 (1:1000) (Cell 
Signalling) and ß-ACTIN (1:1000) (Cell Signalling). 
 
Membranes were visualised using ECL reagents composed of two solutions mixed 1:1 followed 
by exposure to ECL hyperfilm (Amersham, GE Healthcare). The two-component ECL solution 
was made of Solution A: 0.1 M Tris/HCl pH 8.5, (Sigma – T5941), 0.0091 M p-Coumaric acid 
(Sigma – C9008) and 0.00055M Luminol (Sigma – A8511) and Solution B: 0.1 M Tris/HCl pH 
8.5 supplemented with 60 µL H2O2 (Sigma – H0904). Densitometry analysis was conducted 
using the ImageJ software (National Institutes of Health, http://rsb.info.nih.gov/ij/, accessed: 
08.2013).  
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3.7 – Real-Time Quantitative Reverse Transcription PCR 
 
Total RNA was extracted from harvested cells by using the RNeasy Mini Kit (Qiagen – 74104) as 
per the manufacturer’s protocol. The lysate was homogenised using the QIAshredder (Qiagen – 
79654). All RNA samples were treated with amplification grade DNase I (Sigma - AMPD-1 Kit) 
using manufacturer instructions prior to spectrophotometric concentration determination 
(NanoDrop ND-1000 Spectrophotometer, Thermo Scientific). Two-step quantitative real-time 
PCR was performed for HDACs and a number of other genes of interest, first by synthesis of 
cDNA using the ThermoScript RT-PCR System (Invitrogen) using a 5 µg input RNA amount for 
each sample; followed by quantitative real-time PCR using the Platinum SYBR Green qPCR 
SuperMix-UDG (Invitrogen – 11733-038s) on the ABI 7500 Fast Real Time PCR System 
(Applied Biosystems). Quantification was by the standard curve method for relative 
quantification (Bookout et al. 2006).  
 
The standard curve method for relative quantification is able to determine the expression level of 
a gene of interest (GOI) against a reference standard, also known as a housekeeping gene. Plates 
were prepared with serial dilutions of cDNA to plot a standard curve for one gene of interest and 
one housekeeping gene. Serial dilutions of the cDNA were prepared at the following dilutions: 
1/5, 1/25, 1/125, 1/625, 1/3125 and 1/15,625. Using the Ct (cycle threshold) values generated 
from the serial dilutions it was possible to apply a linear regression analysis, to enable the 
interpolation of unknown quantities, which were diluted 1/125. Furthermore, this method 
allowed for a primer efficiency check by using the slope function from the linear regression. The 
equations used to plot the standard curve, quantify the expression of target mRNAs and check 
the efficiency using the exported Ct values from the PCR system are shown below:  
 
Standard curve and quantification of GOI/Reference quantity: 
 y = mx + c 
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where y = Ct of unknown sample 
m = slope 
x = quantity of the unknown sample expressed as log (GOI/Reference quantity) 
c = intercept 
 
GOI/Reference quantity was calculated by interpolation of the above plot.  
Normalised value = average GOI quantity / average reference quantity 
 
Errors: 
Standard deviation = normalised value x √(CV of reference)2 + (CV of GOI)2 
Coefficient of variation (CV) = standard deviation / average 
 
Efficiency check:  
E = 10 (-1/m)  
Perfect doubling gives an efficiency coefficient (E) of 2 
 
Primers for qRT-PCR were designed using a number of bioinformatics tools to ensure target 
specificity and to avoid primers prone to form secondary structures such as homodimers and 
heterodimers during the reaction. Coding sequences for the genes of interest were identified in 
the NBCI Nucleotide Database (National Centre for Biotechnology Information, U.S National 
Library of Medicine, http://www.ncbi.nlm.nih.gov/nuccore, accessed 08.2013). Coding 
sequences for each gene of interest was used as the input variable for the Primer-BLAST tool 
(National Centre for Biotechnology Information, U.S National Library of Medicine, 
http://www.ncbi.nlm.nih.gov/tools/primer-blast/, accessed 08.2013) and parameters were set to 
seek primers matching the following specifications: Tm = 60ºC ± 1ºC, approximate primer 
lengths of 18 to 20 nucleotides, GC content of 40% to 60% and with a projected product size of 
60 to 150 nucleotides (Udvardi et al. 2008). Primer pairs with no unintended targets were 
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analysed for secondary structures using the NetPrimer software (Premier Biosoft, 
http://www.premierbiosoft.com/netprimer/, accessed: 08.2013) and ordered as custom 
oligonucleotides (Invitrogen) (Table. 6). Primer pairs were subjected to melting curve analysis 
after each qRT-PCR reaction to check for primer dimers and the generation of products of 
multiple lengths signifying poor specificity. Although not a frequent occurrence due to the use of 
bioinformatic programs, primer pairs that exhibited symptoms of poor specificity were excluded 
and redesigned.  
+ Table 6: Primer sequences used for qRT-PCR.  
Primer pairs for each target gene of interest are detailed in this table with the associated NCBI 
reference number of each target, the co-ordinates of the coding sequences and the expected 
product length. The GC content and Tm for each primer pair are also stated.  
 
Gene of 
Interest 
NCBI 
Reference 
Sequence 
Coding 
Sequence 
Forward Primer 
5’->3’ 
Reverse Primer 
5’->3’ 
Notes: 
HDAC1 NM_00496
4.2 
64-1512 AGAATGCTG
CCGCACGCAC
C 
CGAGATGCG
CTTGTCAGG
GTCG 
Product Length: 108 
bp, F-> Tm: 60.93 
GC: 65%, R-> Tm: 
60.18 GC: 63.64% 
HDAC 2 NM_00152
7.3 
288-1754 ATAGGCCCC
ATAAAGCCAC
TGCC 
CACAGCTCCA
GCAACTGAA
CCG 
Product Length: 206 
bp, F-> Tm: 58.74 
GC: 56.52%, R-> Tm: 
58.37 GC: 59.09% 
HDAC 3 NM_00388
3.3 
67-1353 TGACGTGCC
TGCAGACCTC
C 
ATTGGGTGC
CTCTGGCCTG
C 
Product Length: 100 
bp, F-> Tm: 58.72 
GC: 65%, R-> Tm: 
59.33 GC: 65% 
HDAC 4 NM_00603
7.3 
793-4047 TTCAACTCCG
TGGCCGTGG
C 
GCCTGCTGG
GTCCCGTTTC
C 
Product Length: 107 
bp, F-> Tm: 59.90 
GC: 65%, R-> Tm: 
59.97 GC: 70% 
HDAC 5 NM_00101
5053.1 
333-3704 GAGGCCGAG
ACTGTGAGC
GC 
TCCATGGGC
TCCTCTGCCG
G 
Product Length: 107 
bp, F-> Tm: 59.84 
GC: 70%, R-> Tm: 
60.32 GC: 70%  
HDAC 6 NM_00604
4.2 
94-3741 GATGGGCCT
TGCCAGTGG
CC 
AGCAGGGGT
GGTGGGTCT
CC 
Product Length: 120 
bp, F-> Tm: 60.32 
GC: 70%, R-> Tm: 
59.82 GC: 70% 
HDAC 7 NM_01540
1.3 
196-3171 GGCACGTGC
TCCTCTACGG
C 
CAACCCCACC
ACAGGGCAG
C 
Product Length: 
114bp, F-> Tm: 59.84 
GC: 70%, R-> Tm: 
60.18 GC: 70% 
SIRT 1 NM_01223
8.4 
54-2297 GACTGGACT
CCAAGGCCA
CGG 
CAGGTGGAG
GTATTGTTTC
CGGC 
Product Length: 
118bp, F-> Tm: 59.12 
GC: 66.67%, R-> Tm: 
57.68 GC: 56.52 
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Table  6 
cont… 
     
SIRT 2 NM_01223
7.3 
303-1472 CTTGTCCGG
AGGGAGCAC
GC 
CTCGTCCTTG
GCAGGTGGC
G 
Product Length: 
108bp, F-> Tm: 59.77 
GC: 70%, R-> Tm: 
60.04 GC: 70% 
C-JUN NM_00222
8.3 
1044-2039 AAGCGCATG
AGGAACCGC
ATCG 
TCACTTTTTC
CTCCAGCCG
GGC 
Product Length: 82bp, 
F-> Tm: 60.43 GC: 
59.09%, R-> Tm: 
59.34 GC: 59.09% 
C-FOS NM_00525
2 
206-1348 TCGGGCTTC
AACGCAGAC
TACG 
AAGGAGTCT
GCGGGTGAG
TGGT 
Product Length: 
101bp, F-> Tm: 59.24 
GC: 59.09%, R-> Tm: 
59.53 GC: 59.09% 
MDM2 NM_00239
2.5 
307-1800 ATGGTGAGG
AGCAGGCAA
AT 
AGGGTCTCT
TGTTCCGAA
GC 
Product Length: 98bp, 
F-> Tm: 59.67 GC: 
50%, R-> Tm: 59.68 
GC: 55% 
P300 NM_00142
9.3 
396-7640 GACCCTCAGC
TTTTAGGAAT
CC 
TGCCGTAGC
AACACAGTG
TCT 
Product Length: 
301bp, F-> Tm: 52.57 
GC: 50%, R-> Tm: 
56.38 GC: 52.38% 
KAT2B 
(PCAF) 
NM_00388
4.4 
447-2945 TCAGCCTCTT
CCAGAACCA
GCCA 
GACTGCTGC
TCCCTGCGTT
T 
Product Length: 
127bp, F-> Tm: 59.55 
GC: 56.52%, R-> Tm: 
57.55 GC: 60% 
KAT8 
(HMOF) 
NM_18295
8.2/ 
NM_03218
8.2 
19-1422/ 
19-1395 
ACCGCAAGA
GCAACATCTC
CGT 
AGTCAGGAT
GTAAAAGAC
GAACGGC 
Product Length: 
146bp, F-> Tm: 58.84 
GC: 54.55%, R-> Tm: 
57.38 GC: 48.00% 
CREB 
(CBP) 
NM_00437
9.3/ 
NM_13444
2.3 
252-1235/ 
252-1277 
ACATTAGCCC
AGGTATCTAT
GCCAG 
CCTGAATGAC
TCCATGGACT
TGAAC 
Product Length: 112, 
F-> Tm: 55.97 GC: 
48%, R-> Tm: 55.65 
GC: 48% 
KAT5 
(TIP60) 
NM_00120
6833.1/ 
NM_18271
0.2/ 
NM_18270
9.2/ 
NM_00638
8.3 
267-1751/ 
267-1907/ 
267-1652/ 
267-1808  
ATGAGCGGC
TGGACCTAA
AGAAGA 
AGTCCTCATC
AGTGCCCAA
ACAAT 
Product Length: 261, 
417, 261, 417. F-> 
Tm: 57.67 GC: 50%, 
R-> Tm: 56.51 GC: 
45.83% 
α-
TUBULI
N 
NM_00608
2.2 
222-1577 GCCAAGCGT
GCCTTTGTTC 
CACACCAACC
TCCTCATAAT
CC 
Product Length: 
114bp, F-> Tm: 55.05 
GC: 57.89%, R-> Tm: 
52.58 GC: 50% 
PPIA NM_02113
0.3 
84-581 CTGCACTGCC
AAGACTGA 
GCCATTCCTG
GACCCAAA 
Product Length: 
109bp, F-> Tm: 57.21 
GC: 55.56, R-> Tm: 
57.14 GC: 55.56 
 
For the microRNA qRT-PCR experiments, microRNA was extracted from total RNA by using a 
miRNeasy Micro Kit (Qiagen) as per the manufacturer’s protocol. Two-step quantitative real-
time PCR was performed, first by the synthesis of cDNA by utilising the miScript II RT Kit with 
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the HiFlex Buffer followed by quantitative real-time PCR. Data was quantified by utilisation of 
the Pfaffl method (Pfaffl 2001). Full list of microRNAs assayed on the miR PCR array can be 
found at the following address:  
http://www.sabiosciences.com/mirna_pcr_product/HTML/MIHS-102Z.html, accessed: 
03.2014. Proprietary primer pairs used to validate miR expression were purchased from Qiagen.  
 
3.8 – Clonogenic Assay 
 
Cells were seeded into six-well dishes at 500 cells per well and incubated overnight in DMEM 
(Sigma – D5671). After a medium change cells were then exposed to As2O3. Upon conclusion of 
the exposure period, cells were washed with PBS and fixed with 100% methanol for 10 minutes 
at -20ºC. Cells were stained with a 5% Giemsa, 25% methanol and 70% PBS solution. Colonies 
were counted under a stereomicroscope using a hand counter. The survival fraction was 
calculated by taking into consideration the plating efficiency of each cell line. The equations used 
to quantify each component are stated below (Franken et al. 2006):  
 
Plating Efficiency = no. of colonies formed / no. of colonies seeded 
 
Survival Fraction = no. of colonies formed after treatment / no. of cells seeded × plating efficiency 
 
Average colony size was quantified using the ImageJ software (National Institutes of Health, 
http://rsb.info.nih.gov/ij/, accessed 08.2013). Plates were first scanned and processed within 
ImageJ to the parameters stated below:  
 
Image Adjustments – Image Type: 8 bit, Threshold: Default + B&W 
Analyse Particles – Size (pixel^2): 20 – Infinity, Circularity: 0 – 1.0, Show: Ellipses 
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Using these parameters the ImageJ software (National Institutes of Health, 
http://rsb.info.nih.gov/ij/, accessed 08.2013) was able to provide an area measurement for each 
colony; from this an average was calculated for each treatment.  
 
3.9 – Cell Proliferation Assay 
 
Cells were seeded into a 96-well plate at 4 × 103 cells per well, with six wells per treatment and 
incubated overnight in 100 µL DMEM (Sigma – D5671). Cells were then exposed to As2O3 for 
the desired exposure period. After conclusion of this exposure period, 10 µL of the Cell 
Proliferation Reagent WST-1 (Roche) was added to each well and incubated for 4 hours at 37ºC 
and 5% CO2. WST-1 is converted to Formazan (A450) by mitochondrial dehydrogenases, which 
directly correlates with the number of metabolically active cells in culture (Roche, 
https://cssportal.roche.com/LFR_PublicDocs/ras/11644807001_en_11.pdf, accessed: 08.2013). 
Medium was homogenised on a plate shaker for 1 minute before absorbance measurement at 450 
nm with a reference wavelength of 600 nm in a spectrophotometer (FLUOstar OPTIMA, BMG 
Labtech). The proliferative index in arbitrary units was calculated using the following equation: 
 
Assumption: Absorbance reading of Formazan is correlated to the number of metabolically active cells in culture. 
  
Proliferative Index = A450 – A600 
 
Average proliferative indices were calculated for each treatment and plotted accordingly.  
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3.10 – Flow Cytometry Assays: Quantification of Mitochondrial ROS, 
Mitochondrial Membrane Potential (∆ψm), Cell-Cycle analysis and Caspase 
Activation 
 
All flow cytometry-based assays started with cells cultured and treated with As2O3 in 6 well plates, 
using 3 wells per treatment to obtain triplicate measurements. Cells were harvested by removing 
the culture medium first into 15 mL conical tubes. Cells were detached with incubation with 1X 
Trypsin (SAFC Bioscience – 59418C) and also added to each respective 15 mL conical tube. 
Cells were then pelleted by centrifugation at 1,000 g for 8 minutes. After removal of the 
supernatant, cells were washed with 1X PBS (Gibco – 14200-67) and added to round bottom 
flow cytometry tubes (BD Bioscience) and spun at 2,000 g for 5 minutes. The PBS supernatant 
was aspirated and pellets were suspended in 1mL of PBS and placed into flow cytometry tubes. 
Different aspects of cellular physiology were examined using different dyes. Preparation and 
description of methods for each dye is stated below.  
 
Mitochondrial ROS was identified in live cells using the MitoSOX Red (Invitrogen – M36008) 
flourogenic dye. Cells were harvested and washed with PBS and suspended into 250 µL of 2.5 
mM Mitosox Red (Invitrogen) flourogenic dye dissolved in PBS. This suspension was allowed to 
incubate for 20 minutes under cell culture and light protected conditions. Cellular fluorescence 
for MitoSOX Red was measured using the FL2 channel on a flow cytometer (FACSCalibur, BD 
Biosciences).  
 
Mitochondrial membrane potential (∆ψm) and apoptosis was assayed by incubating cells with a 
DiOC6(3) (Invitrogen – D273) and propidium iodide (Sigma – 81845) co-stain. Cells were 
harvested and washed with PBS and suspended into 50 µM propidium iodide spiked with 2.5 µL 
of 80 µM DiOC6(3) and incubated for 40 minutes under cell culture and light protected 
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conditions. Cellular fluorescence was measured using the FL1 channel for DiOC6(3) and the FL3 
channel for propidium iodide on a flow cytometer (FACSCalibur, BD Biosciences).  
 
Cell cycle analysis was performed on fixed cells. At the end of the exposure period cells were 
prepared for fixation. Briefly, cells were harvested and washed with PBS then suspended in 1 mL 
of 70% ethanol added drop-wise during vortex. Tubes were stored at -20ºC overnight to 
complete the fixation. Cells were pelleted by centrifugation at 1,000 g for 8 minutes and then 
stained in 300 µL of 50 µM propidium iodide (Sigma – 81845) solution prepared with PBS and 
allowed to incubate for 40 minutes at room temperature. Cell fluorescence was measured using 
the FL2 channel on a flow cytometer (FACSCalibur, BD Biosciences).  
 
Activation of Caspases-3, -7 and -8 was measured with the use of a CaspaTag Caspase 3,7 In Situ 
Assay Kit (Millipore – APT423) and a CaspaTag Caspase 8 In Situ Assay Kit (Millipore – 
APT408). Both of these kits employ the use of carboxyfluorescein (FAM)-labelled peptide with 
an associated fluoromethylketone (FMK) caspase inhibitor. For Caspase-3 and -7 a FAM-
DEVD-FMK inhibitor was used, and for Caspase -8 a FAM-LETD-FMK inhibitor was used. 
These inhibitors work by entering cells and covalently binding to active caspases, remaining 
bound within the cell whilst giving a fluorescent green signal which can be measured on a flow 
cytometer 
(http://www.celltechnology.com/fileuploader/download/download/?d=0&file=custom%2Fupl
oad%2FFile-1388908941.pdf, accessed: 07.2014, 
http://www.emdmillipore.com/INTL/en/product/CaspaTag-Caspase-8-In-Situ-Assay-Kit%2C-
Fluorescein,MM_NF-APT408#anchor_UG, accessed: 07.2014, 
http://www.emdmillipore.com/INTL/en/product/CaspaTag-Caspase-3%2C7-In-Situ-Assay-
Kit%2C-Fluorescein,MM_NF-APT423#anchor_UG, accessed: 07.2014). Each assay was 
completed as per manufacturer’s instructions. Cells were harvested and centrifuged at 1,500 rpm 
for 5 minutes and re-suspended in 300 µL of PBS. A 10 µL volume of 30X FLICA reagent 
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containing the fluorochrome inhibitors was added for 1 hour at 37ºC and 5% CO2. Cells were 
protected from light with aluminium foil. Cells were washed twice with the provided buffers to 
remove any unbound fluorescent inhibitors and cells were re-suspended in 250 µL of wash buffer 
and analysed by flow cytometry. Flourescein was measured on the FL1 channel. Caspase-negative 
cells were observed within the first log decade, whilst caspase-activated cells were scored as a 
separated peak to the right of the negative peak.  
 
All samples were analysed on flow cytometer (FACSCalibur, BD Biosciences) and the raw data 
was analysed using Cyflogic Version 1.2.1 (Perttu Terho, Mika Korkeamäki, CyFlo Ltd). 
 
3.11 – Transfections of Cells. 
 
Transient transfections were achieved using filter-sterilised polyethylenimine (PEI) reagent 
(Polysciences, Inc Cat # 23966) made up to a concentration of 1 mg/mL in H2O and adjusted to 
pH 6.8. Transfection reagent and plasmid complex was synthesised using a 1:4 DNA to PEI 
weight/volume ratio. The remaining volume was made up to 200 µL in non-FBS supplemented 
DMEM (Sigma – D5671). Cells were cultured up to 60% confluence and transfected through the 
drop-wise addition of the complex in 10 cm tissue culture dishes overnight in 5 mL of DMEM. 
Cells were rested the next day in fresh DMEM for 24-hours followed by treatment with arsenic 
trioxide for the desired exposure period after which cells were harvested for assays.  
 
Plasmids used were HDAC1 (Addgene # 13820), HDAC3 (Addgene # 13819) both from 
Addgene. HDAC2 and HDAC4 generously provided by Dr. Ito Kazuhiro (Imperial College 
London). PCAF, HMOF, TIP60 and P300 kindly provided by Dr. Bertrand Joseph (Karolinska 
Institutet).  
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3.12 – 3’UTR Luciferase Reporter.  
 
Two 3’UTR luciferase reporters were obtained via Active Motif from SwitchGear Genomics 
including a PCAF 3’UTR reporter and a control PPIA 3’UTR reporter. UROtsa cells were 
transfected using PEI in 24 well plates with 1 µg of plasmid for each well overnight. Cells were 
rested for 24 hours in fresh medium before arsenite treatment. Cells were harvested with trypsin, 
washed with PBS transferred in 100 µL aliquots into a white 96 well plate. A 100 µL cellular lysis 
and luciferase substrate reagent mixture (Promega – E2710) was added to each aliquot and 
incubated for 10 minutes prior to luminescence measurement in a GloMax 96 Microplate 
Luminometer. Readings were normalised against the PPIA control plasmid as per manufacturers 
guidelines 
(http://switchgeargenomics.com/sites/default/files/pdf/LightSwitch_3UTRnorm.pdf, accessed: 
03.2014).  
 
3.13 Bacteriology – Plasmid Preparation 
 
Plasmid preparations were used for all transfections. First, 50µL of highly competent Escherichia 
coli cells (Invitrogen – 10268-019) were thawed on ice and transformed by using 1 µL of the 
plasmid to be cloned. After 30 minutes of incubation on ice, the cells were subjected to heat 
shock for 25 seconds in a 42ºC heat block and immediately placed on ice a further 2 minutes. 
Transformed cells were cultured in 900 µL SOC medium (Invitrogen – 15544-034) at 37ºC with 
agitation for 90 minutes.  
 
Cultures were spread evenly over LB Agar plates supplemented with the appropriate antibiotic 
for each plasmid to ensure the presence of an adequate selection pressure. The plates were 
incubated overnight in an incubator kept at 37ºC. Single colonies were then selected and 
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incubated overnight with agitation in 5 mL of LB Broth supplemented with the appropriate 
antibiotic. Using 1 mL of this overnight culture 500 mL of LB Broth with antibiotics was 
inoculated for overnight culture with agitation at 37ºC.  
 
Plasmid purification was achieved by utilising the PureLink HiPure Plasmid Maxiprep Kit 
(Invitrogen – K2100-06) as per the manufacturers guidelines. Briefly, cultures were first pelleted 
and then lysed. In this column based purification process, the lysis mixture was first precipitated 
and the supernatant was allowed to bind to the chemically equilibrated column. After a number 
of wash steps, the DNA was eluted from the column, subjected to an isopropanol and 70% 
ethanol wash. After centrifugation the pellet was air dried for 10 minutes and then the plasmid 
DNA was re-suspended in 200 µL TE Buffer (Invitrogen – 12090-015).  
 
3.14 – Sensitivity of DNA to Micrococcal Nuclease (MNase) 
 
Micrococcal nuclease induces DNA double-strand breaks between nucleosomal linker regions 
(Anon 2005). Due to this, the relative sensitivity of DNA to MNase digestion is a proxy 
measurement for chromatin relaxation. Cells were exposed to As2O3 for the desired exposure 
period. Harvested cells were then pelleted and lysed in 5 mL NP-40 lysis buffer on ice for 5 
minutes. NP-40 lysis buffer is composed of: 10 mM Tris-HCl pH 7.4 (Sigma – T5941), 10 mM 
NaCl (Sigma – S3014), 3 mM MgCl2 (Sigma – M8266), 0.5% Nonidet NP-40 (Sigma – 74385), 
0.15 mM spermine (Sigma – S3256) and 0.5 mM spermidine (Sigma – S2626). Nuclei were 
pelleted by centrifugation at 1,000 g refrigerated to 4ºC for 10 minutes. After removal of the 
supernatant the pellet was washed in 2.5 mL of MNase digestion buffer and pelleted again at 
1,000 g and at 4ºC. MNase digestion buffer is composed of: 10 mM Tris-HCl pH7.4, 15 mM 
NaCl, 60 mM KCl (Sigma – P9541), 0.15 mM spermine and 0.5 mM spermidine. The extracted 
nuclei were then suspended in 500 µL MNase digestion buffer containing 1mM CaCl2 of which 
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100 µL was taken forward for digestion. MNase (Sigma – N3755) of was added to each sample, 
specifically 0.025 units and incubated at 15-20ºC for 5 minutes. The reaction was stopped by the 
addition of 80 µL MNase digestion buffer, 20 µL MNase stop buffer: 100 mM EDTA (Sigma – 
EDS) and 10 mM EGTA (Sigma – E3889) pH 7.5, 3.75 µL proteinase K (Invitrogen – 4333793) 
and 20% SDS (Sigma – L3771) followed by overnight incubation in a 37ºC water bath.  
 
MNase digested DNA was extracted the next day by standard phenol/chloroform extraction 
methods followed by ethanol precipitation overnight at -20ºC. Samples were centrifuged at 
16,000 g at 4ºC for 30 minutes. MNase digested DNA was dissolved in 50 µL TE Buffer 
(Invitrogen – 12090-015). The concentration of the DNA was determined using a 
spectrophotometer (NanoDrop ND-1000 Spectrophotometer, Thermo Scientific). For each 
sample 4 µg was loaded into a 1% agarose gel supplemented with GelRed (Biotium – 41002) and 
visualised under a UV lamp. This method was adapted from (Anon 2005).  
 
The number of units to be used in each reaction was standardised by using a range of MNase 
units for digestion and checking the digestion pattern (Fig. 3.1).  
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+ Figure 3.1: MNase digestion profile of HEK293T nuclear lysates. 
HEK293T nuclear lysates were digested with increasing units (U) of MNase and run on a 1% 
agarose gel stained with GelRed for visualisation under a UV lamp. The first lane (L1) is the 
ladder. Each subsequent lane was incubated with 0.025 U, 0.5 U, 1 U and 2 U MNase 
respectively. 
 
 
By observing the digestion pattern it was clear that the 0.025 units (L2) was suitable to use for the 
MNase sensitivity analysis as it did not fully digest the chromatin leaving only mononucleosomal 
fragments at approximately 150 bp. Clear separation was also observed between the mono-, di- 
and trinucleosomal fragments at 0.025 units. In contrast, using 2 units (L5) over digested the 
chromatin leaving only mononucleosomal fragments.  
 
3.15 – Cell Growth in Soft Agar 
 
Anchorage-independent growth was measured by suspending cells exposed to As2O3 in soft agar. 
Cells were first pre-treated for the desired duration with As2O3. Plates were prepared using two 
layers of agar at differing densities. The base agar was made of 0.8% Noble Agar (Sigma – 
L1 L2 L3 L4 L5 
500 bp 
750 bp 
1,000 bp 
1,500 bp 
10,000 bp 
250 bp 
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A5431) dissolved in H2O and DMEM (Sigma – D5671) 1:1 ratio solvent and allowed to solidify 
at 4ºC for 20 minutes. The plate was then brought up to the ambient cell culture conditions i.e. 
37ºC and then the cells were seeded in falcon tubes with a 0.4% Noble Agar prepared by diluting 
the previous 0.8% Noble Agar mixture in DMEM at a 1:1 ratio and added to the base agar. A 
total of 2,500 cells were used per well of a 6 well plate. Cells were supplemented with DMEM to 
avoid nutrient depletion. Plates were stained with 0.5 mL 0.005% Crystal Violet (Sigma – V5265) 
and 20% methanol (Sigma – 322415) diluted in 1X PBS (Gibco – 14200-67) for 2 hours. 
Colonies were counted under a stereomicroscope with a hand counter.  
 
3.16 – Chromatin Immunoprecipitation. 
 
Cells were grown in 100 mm cell culture dishes, with 4 dishes for each treatment. At the end of 
the treatment duration cells were fixed for 10 minutes in 1% formaldehyde (Sigma – F8775) and 
quenched with 1M glycine (Sigma – G8898) for 5 minutes at room temperature. The 
formaldehyde/glycine mixture was aspirated followed by two washes of ice-cold 1X PBS (Gibco 
– 14200-67). Cells were detached by scraping and re-suspended in PBS. The cell suspension was 
centrifuged at 3,000 g for 5 minutes. 
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The remaining part of the experiment involved the utilisation of a Pierce Agarose ChIP Kit 
(Thermofisher – 26156, http://www.piercenet.com/instructions/2162216.pdf, accessed: 10.13). 
Briefly, cells were lysed and chromatin was sheared using 1 U of MNase per reaction to yield an 
optimum digestion pattern of 200 to 1,000 base pairs (Fig. 3.2). Chromatin digestion was stopped 
by the addition of a stop reagent and incubation on ice for 5 minutes. The nuclei were pelleted 
after centrifugation at 9000 g for 5 minutes. The nuclei were suspended in lysis buffer 
supplemented with protease/phosphatase inhibitors and incubated on ice for 15 minutes, with 
mixing for 15 seconds every 5 minutes by vortex. The mixture was centrifuged at 9000 g and the 
supernatant containing the digested chromatin was transferred to a new tube.  
 
250 bp 
500 bp 
750 bp 
1,000 bp 
3,000 bp 
1 2 4 8 0.25 0.5 MNase units (U).  
+ Figure 3.2: MNase shearing profile of fixed HEK293T lysates for chromatin 
immunoprecipitation. 
HEK293T lysates were digested with increasing units (U) of MNase to optimise the shearing 
for chromatin immunoprecipitation and run on a 1% agarose gel stained with GelRed for 
visualisation under a UV lamp. The optimum digestion pattern to be identified needed to 
generate fragments between 1 kb and 200 bp in size. Digestion with 1 U of MNase provided a 
compatible shearing profile.  
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Immunoprecipitation was carried out by transferring 5 µL of the digested chromatin to a separate 
tube as the 10% total input sample for one ChIP. The remaining 45 µL was added to 450 µL of 
1X IP dilution buffer and incubated overnight at 4ºC with a positive control antibody, anti-RNA 
polymerase II, a negative control normal rabbit IgG and an antibody against the target of 
interest. After incubation an A/G agarose resin was used to purify the antibody/chromatin 
complex over a 1-hour period at 4ºC with rotation in a spin column. The complex was washed a 
number of times with an IP Wash Buffer before elution. 
 
The elution process involved the addition of 150 µL of 1X IP elution buffer to each spin column 
and incubation at 65ºC for 40 minutes with agitation every 10 minutes. The total 10% input 
samples were supplemented with 150 µL 1X IP elution buffer and samples in the columns were 
spun for 1 minute at 6,000 g and incubated with 6 µL of 5 M NaCl and 2 µL of 20 mg/mL 
Proteinase K for 1.5 hours at 65ºC.  
 
DNA was recovered using a column-based method by placing each eluted IP and total input 
sample into 750 µL of a DNA binding buffer. This was then loaded into a DNA clean-up 
column. Through the utilisation of a number of wash steps, the purified DNA was eluted in a 
final volume of 50 µL of DNA elution buffer for subsequent qRT-PCR analysis. The primers 
used for the qRT-PCR analysis are listed below (Table. 7) 
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+ Table 7: Primer sequences used for ChIP-qRT-PCR promoter analysis.  
Primer pairs for each target promoter of interest and exon1 are detailed in this table with the 
associated NCBI reference number of each target, the co-ordinates of the amplification sequences 
and the expected product length. The GC content and Tm for each primer pair are also stated.  
 
Target Chromosome 
and NCBI 
reference.  
Forwa
rd co-
ordina
tes 
Forward 
Primer 
5’->3’ 
Reverse 
co-
ordinates 
Reverse 
Primer 
5’->3’ 
Notes: 
CFOS_P
ROMOT
ER 
Chromosome: 
14; 
NC_000014.8 
757450
10 - 
757450
29 
GGTAA
AAAGG
CGCTC
TCTGC 
75745298 - 
75745279 
GATGA
GGGGT
TTCGG
GGATG 
Product Length: 289 
bp, F-> Tm: 59.55 
GC: 55%, R-> Tm: 
60.18 GC: 60% 
CMYC_P
ROMOT
ER 
Chromosome: 8; 
NC_000008.11  
127735
885 
-  
127735
904 
 
CTAGA
GCTAG
AGTGC
TCGGC 
 
127736047 
- 
127736028 
 
ATTATA
AAGGG
CCGGT
GGGC 
 
Product Length: 163 
bp, F-> Tm: 59.41 
GC: 60%, R-> Tm: 
60.18 GC: 55% 
PUMA_P
ROMOT
ER 
Chromosome: 
19; 
NC_000019.10 
472329
15 
-  
472329
35 
 
CAACA
TTGGG
AACTCC
TCAGC 
47233011 
 -  
47232990 
 
AAACA
CCAGG
AAGAA
GGAAG
GG 
Product Length: 97 
bp, F-> Tm: 59.18 
GC: 52.38%, R-> 
Tm: 60.16 GC: 50% 
BAX_PR
OMOTE
R 
Chromosome: 
19; 
NC_000019.10 
489545
84 
 -  
489546
03 
 
GCTAA
TTCCTT
CTGCG
CTGG 
 
48954725 
 -  
48954706 
 
AGCAT
CTCCC
GATAA
GTGCC 
 
Product Length: 142 
bp, F-> Tm: 59.34 
GC: 55%, R-> Tm: 
59.61 GC: 59.61 
TP53_PR
OMOTE
R 
Chromosome: 
17; 
NC_000017.11 
768767
6 
 -  
768769
5 
 
CCGAC
CTGGT
GCCGT
AGATA 
 
7687835 
 -  
7687816 
 
GATCC
AGCTG
AGAGC
AAACG 
 
Product Length: 160 
bp, F-> Tm: 61.11 
GC: 60%, R-> Tm: 
58.99 GC: 58.99 
 
ChIP-qPCR data analysis was achieved by using the percentage input method as described in the 
SA Bioscience tech sheet (http://www.biomol.de/details/SA/chipqpcrmanual.pdf, accessed: 
07.11.13). In summary, ChIP-qPCR data was presented as “% input” by the following 
quantification process. 
 
Normalisation: 
∆Ct [normalised ChIP] = (Ct [ChIP] – (Ct [input] – Log2 (Input Dilution Factor))) 
Input dilution factor = fraction of the input chromatin saved ^ -1 
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Normalised ChIP Ct values were averaged for replicate samples.  
 
% Input = 2 ^ (-∆Ct [normalised ChIP]) 
 
A melting curve analysis was performed after each run to ensure the amplification of a single 
product.  
 
3.17 – Immunocytochemistry 
 
Immunocytochemistry was used to visualise the presence of specific proteins within cells. Cells 
were grown on pre-sterilised glass coverslips. Coverslips were sterilised using a microwave, where 
an 800 mL volume of H2O was heated at the same time as the coverslips. Once the water started 
to boil the coverslips were considered sterilised. Cells were grown on the coverslips in 6 well 
plates under standard tissue culture conditions. Once cells were adherent, they were treated with 
the desired toxicant. 
 
At the end of the treatment period, cells were washed twice with 1X PBS (Gibco – 14200-67) at 
room temperature. The PBS was then aspirated and 4% (v/v) paraformaldehyde (Sigma – P6148) 
was added to fix the cells for 10 minutes at 4ºC. After fixation cells were rinsed three times with 
1X PBS and allowed to stand in 1 mL/well of methanol (Sigma – 322415) for 10 minutes at -
20ºC. Cells were rinsed again two times with 1X PBS and then exposed to 
blocking/permeabilisation buffer composed of: 10 mM HEPES (Sigma – H3375), 0.3% Triton 
X-100 (Sigma – T8787), BSA (Sigma – A2153), pH 7.4 for 1 hour. Coverslips with adherent cells 
were incubated in a humid chamber by addition of 5 µL of the primary antibody with 600 µL of 
blocking/permeabilisation buffer. Each coverslip was placed cell-side down into the antibody 
and blocking/permeabilisation buffer mixture overnight at 4ºC. Secondary antibody incubation 
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was achieved by addition of 3 µL of secondary antibody to 600 µL 1X PBS to create droplet. 
Each antibody was used depending on the host species in which the primary antibody was raised 
in combination with the requirements of the staining to ensure that there was no overlap 
between the excitation and emission wavelengths. The secondary antibodies used were: Alexa 
Fluor 633 Goat Anti-Mouse IgG (H+L) (Invitrogen – A21050) and Alexa Fluor 633 Goat Anti-
Rabbit IgG (H+L) (Invitrogen – A21070) 
.  
The coverslips were then placed cell side down onto the droplet in the humid chamber and 
allowed to incubate for 30 minutes at room temperature. Coverslips were mounted on slides by 
using Vectashield Mounting Media (Vector Laboratories) to resist fading of the fluorescence. The 
gap between the coverslip and the glass slide was sealed with clear nail varnish. Slides were stored 
at 4ºC.  
 
Images of the slides were captured on a confocal microscope (Leica SP5/SP5II) and processed 
using the LAS AF (Leica, http://www.leica-microsystems.com/products/microscope-
software/life-sciences/las-af-advanced-fluorescence/, accessed: 08.2013) and ImageJ software 
respectively (National Institutes of Health, http://rsb.info.nih.gov/ij/, accessed: 08.2013).  
 
3.18 – Statistical Analysis 
 
All statistical analysis was carried out using an unpaired two-tailed Student’s T-Test. Data was 
analysed in Microsoft Excel for Mac 2011 Version 14.3.6 to generate a p-value after the 
comparison of two normally distributed data sets. Two groups were compared for each analysis, 
a control group versus treatment group. The null and alternative hypothesis used in all analyses 
are stated below:  
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H0 = there is no difference between the treatment and the control.  
H1 = there is a difference between the treatment and the control.  
 
Observations were considered statistically significant when the p value was below 0.05 i.e. at the 
95% confidence level.  
 
3.19 – Bioinformatics Analysis 
 
A number of bioinformatic tools were used to support different components of this study. This 
information is detailed below (Table. 8).  
 
+ Table 8: Bioinformatic tools used in the project.  
Bioinformatic tools were used at various points within the project to develop accurate 
methodologies to assist in experimental design and help yield accurate data.  
 
Utilisation Software 
Gene ontology. NCBI Gene, http://www.ncbi.nlm.nih.gov/gene, accessed 
04.10.2013. 
NCBI Nucleotide, http://www.ncbi.nlm.nih.gov/nuccore, 
accessed 04.10.2013. 
Ensembl, http://www.ensembl.org/index.html, accessed 
04.10.2013. 
Gene Cards, http://www.genecards.org, accessed 
04.10.2013. 
Primer design. Primer-Blast, http://www.ncbi.nlm.nih.gov/tools/primer-
blast/, accessed 04.10.2013. 
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Table  8 cont…  
Primer secondary 
structure analysis. 
Oligonucleotide Properties Calculator, 
http://www.basic.northwestern.edu/biotools/oligocalc.html, 
accessed 04.10.2013. 
MicroRNA ontology. miRBase, http://www.miRbase.org, accessed 04.10.2013. 
MicroRNA/3’UTR 
target prediction & 
identification of 
validated targets. 
miRWalk, http://www.umm.uni-
heidelberg.de/apps/zmf/miRwalk/, accessed 04.10.2013. 
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- 4 - 
Results: Investigating Mechanisms and 
Outcomes of As2O3-induced Histone 
Acetylation 
 
4.1 – Identification of Tolerated and Toxic Concentrations of Arsenic Trioxide 
(As2O3) to Human Embryonic Kidney (HEK293T) cells. 
 
The first step of this course of research was to identify tolerated and toxic concentrations of 
arsenic trioxide (As2O3) to human embryonic kidney (HEK293T) cells. This would ensure that 
epigenetic and mechanistic information gathered would be anchored to an appropriate 
phenotypic outcome.  
 
Two variables were investigated, the magnitude of the concentration and the duration of 
exposure. These were measured against a number of sensitive biochemical parameters that 
allowed for detailed evaluation of As2O3-induced toxicity. The first was poly(ADP-ribose) 
polymerase-1 (PARP) cleavage; a DNA repair enzyme that is rapidly targeted for proteolytic 
cleavage as an end-point of apoptotic cell death (Duriez & Shah 1997). The second was caspase 
activation including the initiator Caspase-8 and the effector Caspases-3 and -7. Examination of 
both initiator and effector caspases allowed for the explicit quantification of the intracellular 
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apoptotic signal (Taylor et al. 2008; Riedl & Y. Shi 2004). The third analysis interrogated 
mitochondrial health after As2O3 exposure with specific focus on the loss of mitochondrial trans-
membrane potential (∆Ψm) and the generation of mitochondrial reactive oxygen species, both of 
which are part of the apoptotic program (Christensen et al. 2013; Fleury et al. 2002). Collectively 
these assays ensured appropriate identification of toxic and tolerated exposures. 
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Additional in vitro assays were utilised to examine cellular hallmarks of cancer, to ensure that a 
tolerated exposure was not just tolerated, but one that exhibited properties concomitant with 
cellular transformation. A clonogenic assay was used to quantify cellular survival and resistance to 
cell death. A WST-1 proliferation assay was used to measure cellular proliferation in response to 
sustained toxicant exposure in subconfluent cells. Flow cytometry based cell-cycle analysis was 
used to assess the cell-cycle distribution, particularly S-phase commitment and progression 
through the G2/M checkpoint both of which are un-regulated in cancer cells (Kastan & Bartek 
Candidate dosage and 
duration of  arsenic 
trioxide exposure 
Toxicity analysis- 
PARP cleavage, caspase 
activation and 
mitochondrial health 
(ROS, Δψm) 
Toxic Tolerated 
Transformation 
analysis- clonogenic 
assay, WST-1 
proliferation assay, cell-
cycle analysis and 
anchorage-independent 
growth assay. 
Tolerated and leads 
to cellular 
transformation  
Tolerated and does 
not lead to cellular 
transformation 
+ Figure 4.1: Schematic detailing the tolerated and toxic concentration selection 
framework utilised in this study. 
This framework provides an overview of the initial experiments carried out to select the 
concentrations and durations of As2O3 exposure.  
Sunniyat Rahman | Imperial College London  103 	  
2004). The soft-agar analysis allowed for the assessment of anchorage-independent growth, 
which is a strong indicator of malignant growth potential (Raptis & Vultur 2001). These cellular 
parameters including cell death resistance, sustained proliferation, elevated replicative potential 
and anchorage-independent growth are all considered as hallmarks of cancer (Hanahan & 
Weinberg 2011). The combined use of toxicity and in vitro cellular transformation assays together 
allowed for the identification of toxic and tolerated exposures to As2O3 (Fig. 4.1).  
 
4.1.1 – HEK293T cells tolerate 0.25 µM and 0.5 µM As2O3 concentrations, but do not 
tolerated concentrations greater than 2.5µM As2O3. 
 
To begin the toxicity analysis HEK293T cells were exposed to increasing concentrations of 
As2O3 and increasing time scales. For the initial 24-hour exposure, cells were treated with a range 
of concentrations from 2.5 µM – 80 µM As2O3 (Fig. 4.2, A). PARP cleavage was observed in 
concentrations from 5 µM – 80 µM As2O3 and these concentrations were considered toxic. Only 
the 2.5 µM As2O3 was tolerated with no PARP cleavage. This exposure and lower concentrations 
including 0.25 µM and 0.5 µM As2O3 were analysed at a longer 72-hour exposure to check for 
PARP cleavage (Fig. 4.2, B). In contrast to the 24-hour time-point, 2.5 µM As2O3 led to PARP 
cleavage after a 72-hour exposure. This suggests that As2O3-induced toxicity is both time and 
dose-dependent. Lower concentrations of 0.25 µM and 0.5 µM As2O3 did not lead to PARP 
cleavage, suggesting that these concentrations were tolerated. Further examination of the 0.25 
µM and 0.5 µM As2O3 exposures were undertaken at a longer 168-hour (1-week) time-point (Fig. 
4.2, C). No PARP cleavage was observed for 0.25 µM and 0.5 µM As2O3 exposures, whilst the 
2.5 µM As2O3 exposure was toxic at this time-point. By using PARP cleavage analysis alone, 0.25 
µM and 0.5 µM As2O3 was tolerated whilst the 2.5 µM As2O3 was toxic in exposures up to 1-
week.  
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+ Figure 4.2: Immunoblotting for poly(ADP) ribose polymerase cleavage after a 24-hour, 
72-hour and 168-hour exposure to As2O3 in HEK293T cells.  
 (A) HEK293T cells were exposed for 24 hours to 2.5 µM, 5 µM, 10 µM, 20 µM, 40 µM and 
80 µM As2O3. (B) HEK293T cells were exposed for 72 hours to 0.25 µM, 0.5 µM and 2.5 µM 
As2O3. (C) HEK293T cells were exposed to 168 hours (1 week) to 0.25 µM, 0.5 µM and 2.5 
µM As2O3. A total of 80 µg of protein was loaded in each well for immunoblotting. 
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4.1.2 – A minimum toxic exposure for HEK293T cells is 2.5 µM As2O3. 
 
Concentrations of 2.5 µM As2O3 and higher were examined further to identify a minimum toxic 
dosage. This would ensure that the toxic exposure selected would not lead to exaggerated 
artefacts such as necrotic cell death, protein degradation and DNA fragmentation. By utilising a 
minimum toxic concentration, rather than significantly higher toxic dosage it also provided 
adequate cellular material over longer exposures to complete downstream assays and allow for 
suitable comparisons against the tolerated dosage. To achieve this additional cytotoxicity analysis, 
the status of a number of proteins implicated in cell death was profiled in greater detail including 
MDM2 degradation, Caspase-3 cleavage, truncation of the pro-apoptotic factor BID, p53 
stabilisation and activation by phosphorylation at serine 15 (Fig. 4.3) (Taylor et al. 2008; Chène 
2003; Loughery et al. 2014).  
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+ Figure 4.3: Immunoblotting of cytotoxic sensitive proteins including MDM2, P53, P53 
serine 15 phosphorylation, BID, CASPASE-3 and PARP after a 1-week exposure to 
As2O3. 
 HEK293T cells were exposed to 2.5 µM, 5 µM and 10 µM As2O3 for 1-week. A total of 80 µg 
was of protein was loaded into each well for immunoblotting.  
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A 1-week exposure to 2.5 µM As2O3 led to MDM2 degradation – the negative regulator of P53. 
At higher concentrations of 5 µM and 10 µM As2O3 the levels of MDM were reduced further in 
a dose-dependent manner. Exposures from 2.5 µM to 10 µM As2O3 also led to the increased 
stabilisation of P53 and the pro-apoptotic phosphorylated serine 15 form. At concentrations of 
2.5 µM As2O3 and higher, the full-length pro-apoptotic protein BID is cleaved. Apoptosis 
induction was clearly observed for all exposures as signified by cleavage and activation of the 
Caspase-3 and PARP cleavage. These blots collectively suggest that 2.5 µM As2O3 sits within the 
minimum cytotoxicity barrier, as higher dosages are significantly more toxic.  
 
4.1.3 – Increased Caspase-3, -7 and -8 activation is observed after exposure to 2.5 µM 
As2O3 and reduced Caspase-3 and -7 activation after exposure to 0.5 µM As2O3 in 
HEK293T cells.  
 
Further toxicity analysis was achieved by the detailed evaluation of caspase activation. Caspases 
are required for the transduction of apoptosis from early initiation stages to final execution with 
the cleavage of crucial cellular proteins (Riedl & Y. Shi 2004). Previous studies have been able to 
demonstrate caspase activation and apoptosis as a result of arsenic trioxide exposure in cancer 
cell lines, particularly Caspase-3, -7 and -9 activation in addition to the cleavage of PARP by 
Caspase-3 (X. Li et al. 2004; X. Li et al. 2003; Perkins et al. 2000). Similar caspase activation 
measurements were used in this study for detailed toxicity evaluation.  
 
HEK293T cells were exposed to 0.5 µM and 2.5 µM As2O3 for 72 hours followed by flow-
cytometry based analysis of caspase activation. This was achieved by the use of fluorescent 
inhibitors of the activated caspases, which bind only to active caspases and fluoresce. The 
fluorescence signal is proportional the amount of active caspases within the cell (see materials 
and methods section for additional details).   
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After a 72-hour treatment with 0.5 µM As2O3 there was a significant reduction in the activated 
form of Caspase-3 and -7 (Fig. 4.4). Although a significant increase in Caspase-8 activation was 
also observed at this dosage, no PARP cleavage was identified as shown previously. A significant 
increase in activated Caspase-3, -7 and -8 was observed with 2.5 µM As2O3. This data suggested 
that 2.5 µM As2O3 led to caspase activation, whilst the 0.5 µM As2O3 dosage led to only minimal 
activation of Caspase-8 and no activation of Caspase-3 and -7.  
  
+ Figure 4.4: Activated caspase -3, -7 and -8 assessment by flow-cytometry in HEK293T 
cells. 
HEK293T cells were exposed to 0.5 µM and 2.5 µM As2O3 for 72 hours. Caspase-3, -7 and -8 
activation was measured. Activated caspase % was calculated by scoring the population of 
caspase-activated cells only. All bars shown are ± SD. * p< 0.05, N=3. 
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4.1.4 – No mitochondrial transmembrane potential (∆ψm) loss or increase in 
mitochondrial superoxide generation is observed after exposure to 0.5 µM As2O3 for 72 
hours, whilst exposure to 2.5 µM As2O3 leads to ∆ψm hypo-polarisation and the 
generation of mitochondrial superoxide in HEK293T cells.  
 
Additional interrogation of As2O3-induced apoptosis was achieved by the assessment of two 
aspects of mitochondrial function. Mitochondria are able to produce adenosine 5’ triphosphate 
(ATP) with the assistance of an electrical potential across the inner mitochondrial membrane. It 
has been demonstrated that the loss of mitochondrial transmembrane potential (∆ψm) is a 
hallmark event of apoptosis and it can be measured effectively via flow cytometry (Christensen et 
al. 2013). This was measured with lipophillc dye 3’3 di-hexyloxacarbocyanine iodide – DiOC6(3), 
which accumulates in healthy mitochondria with a large membrane potential, but is released 
when mitochondria experience membrane potential loss and cell death. This is observed as hypo-
polarisation(Ozgen et al. 2000).  
 
The generation of mitochondrial reactive oxygen species (ROS) was also assessed as it is involved 
in the initial and late steps of apoptosis. When apoptosis occurs the mitochondrial redox 
potential becomes more oxidised in contrast to periods of cellular survival during which anti-
apoptotic factors such as BCL-2 and BCL-XL adjust the redox potential to a more reduced state 
(Fleury et al. 2002). The measurement of mitochondrial superoxide with flow cytometry has been 
shown to be effective, precise and sensitive with the MitoSOX Red probe (Mukhopadhyay et al. 
2007). Both the ∆ψm and mitochondrial ROS were measured following As2O3 exposure.  
 
Propidium iodide (PI) was also used with DiOC6(3) in a co-labelling process. PI is a nuclear acid 
dye that cannot transverse the cellular membrane unless cells are undergoing apoptotic cell-death 
leading to the lack of membrane integrity and PI uptake (Ozgen et al. 2000). This co-labelling 
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process allowed for the identification of PI positive and PI negative cells, which represent 
apoptotic and viable cells respectively.  
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+ Figure 4.5: Assessment of mitochondrial function after exposure to 0.5 µM and 2.5 µM 
As2O3 for 72 hours in HEK293T cells.  
HEK293T cells were exposed for 72 hours to 0.5 µM and 2.5 µM As2O3. (A) Three coloured 
overlay histogram showing the FL1 signal proportional to DiOC6(3) uptake in the 
mitochondria for an untreated control, 0.5 µM As2O3 and 2.5 µM As2O3 exposure. (B) 
Percentage of cellular population in the hypo-polarised DiOC6(3) range after treatment with 
0.5 µM As2O3 and 2.5 µM As2O3 (C) Quantification of mitochondrial superoxide by flow 
cytometry. (D) Percentage of PI positive cells in late apoptosis and cell death. All bars shown 
are ± SD. * p< 0.05, N=3. 
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HEK293T cells were treated for 72 hours with 0.5 µM and 2.5 µM As2O3 prior to mitochondrial 
function assessment. Treatment with 0.5 µM As2O3 led to similar levels of mitochondrial 
transmembrane potential as the untreated control (Fig. 4.5, A, B). In contrast, treatment with 2.5 
µM As2O3 led to significant hypo-polarisation in greater than 80% of cells. No changes were 
observed in mitochondrial superoxide levels after treatment with 0.5 µM As2O3 compared to the 
untreated control (Fig. 4.5, C). However, exposure to 2.5 µM As2O3 led to the generation of large 
amounts of mitochondrial superoxide, which was significantly higher than that of the untreated 
control. PI staining was able to show no discernable differences in cell death after treatment with 
0.5 µM As2O3, this was coupled with no significant changes in the mitochondrial transmembrane 
potential or mitochondrial superoxide. In contrast, 2.5 µM As2O3 initiated cell death in 70% of 
the cellular population, with mitochondrial transmembrane hypo-polarisation and an increase in 
mitochondrial superoxide. This mitochondrial function assessment suggested that 0.5 µM As2O3 
was not toxic and disruptive to mitochondrial function unlike the 2.5 µM As2O3. The latter 
concentration led to significant disruption of mitochondrial function and ultimately an increase in 
cell death.  
 
The mitochondrial function analysis concluded the assays used to identify toxic dosages. By 
considering PARP cleavage, caspase activation and mitochondrial function all together it was 
clear the 2.5 µM As2O3 concentration was toxic and that concentrations <0.5 µM As2O3 were 
not toxic. Although the 0.5 µM As2O3 dosage was not toxic, additional assays were conducted to 
evaluate if this dosage was tolerated and one that would lead to cellular transformation.  
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4.1.5 – HEK293T cells tolerate both 0.25 µM and 0.5 µM As2O3, however only the latter 
leads to increased cellular survival. 
 
As PARP cleavage analysis led to the identification of two tolerated (0.25 µM and 0.5 µM) 
concentrations of As2O3 further assays were required to identify a dose that would lead to cellular 
transformation as per the aforementioned framework (Fig. 4.1).  
 
To begin this analysis a clonogenic assay was used to assess the impact of sustained As2O3 
exposure on cellular survival and colony size. This in vitro method allowed for the evaluation of 
cytotoxicity by examining the growth of single cells in colonies made of 50 cells and greater, and 
effectively tests the ability of the cellular population to undergo division and growth (Franken et 
al. 2006). HEK293T cells were exposed for 15-days to 0.25 µM, 0.5 µM and 2.5 µM As2O3 (Fig. 
4.6).  
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+ Figure 4.6: Clonogenic assay of HEK293T cells exposed to As2O3. 
HEK293T cells were exposed for 15-days to 0.25 µM, 0.5 µM and 2.5 µM As2O3. (A) 
Photographs of wells taken post-treatment after staining with 5% Giemsa, 25% methanol and 
70% PBS solution. (B) Survival fraction after seeding 500 cells per well followed by As2O3 
exposure. (C) Average colony size after seeding 500 cells per well followed by As2O3 
exposure. Full calculation methods for both survival fraction and average colony size are 
provided in the methods section. All bars shown are ± SD. * p< 0.05, N=3. 
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Analysis by clonogenic assay in HEK293T cells identified increased cellular survival after a 0.5 
µM As2O3 exposure for 15 days (Fig. 4.6, A, B). A lower dose exposure of 0.25 µM As2O3, 
although tolerated was unable to stimulate increased cellular survival. Furthermore, exposure to 
0.5 µM As2O3 not only generated more colonies but also larger colonies, suggesting the presence 
of rapid cellular proliferation compared to the untreated controls within the same exposure 
duration (Fig. 4.6, C).  
 
4.1.6 – Exposure to 0.5 µM As2O3 leads to increased cellular proliferation in HEK293T 
cells.  
 
Although elevated cellular survival was observed, an additional assay was required to examine the 
proliferative potential of the cells exposed to 0.5 µM As2O3. This was achieved by using the 
WST-1 Cell Proliferation reagent (Roche) which has an advantage over other tetrazolium dyes 
such as MTT as the water soluble formazan product can be assayed colorimetrically without the 
requirement of another detergent solubilisation step and it has enhanced sensitivity (Buttke et al. 
1993; Gieni et al. 1995).  
 
HEK293T cells were exposed to 0.5 µM and 2.5 µM As2O3 for 3 hours, 72 hours and 1 week 
(Fig. 4.7). This allowed for the focused assessment of proliferation over the course of a full 1-
week exposure.  
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+ Figure 4.7: WST-1 proliferation assay was used determine the proliferative index of 
HEK293T cells treated with As2O3 at 3 hours, 72 hours and 168 hours.   
HEK293T cells were treated with 0.5 µM and 2.5 µM As2O3. Full calculation methods for the 
proliferative index are to be found in the material and methods section. All bars shown are ± 
SD. * p < 0.05, N = 6. 
 
*	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No significant differences in the proliferative index were observed at the shorter time-points of 3 
hours and 72 hours after treatment with 0.5 µM As2O3. However after a 72-hour exposure the 
proliferative index was significantly reduced as a result of a 2.5 µM As2O3. Between the 72-hour 
and 1-week time-point the rate of proliferation increased with the 0.5 µM As2O3 exposure 
making the final proliferative index measurement significantly higher than the control.  
 
These results suggested that the 0.5 µM As2O3 concentration led to an increase in overall 
proliferation and rate after 72 hours. In contrast the 2.5 µM As2O3 led to a decrease in 
proliferation.  
 
4.1.7 – Exposure to 0.5 µM As2O3 leads to increased progression through the G1/S and 
G2/M cell cycle checkpoints.  
 
A cell cycle analysis was performed on HEK293T cells exposed to 0.5 µM and 2.5 µM As2O3, to 
gather additional evidence of cellular properties associated with transformation. Transformed 
cells are capable of uncontrolled cellular proliferation. This requires the subversion of cell cycle 
checkpoints and sustained commitment to replicate genetic material during the synthetic phase, 
and separate cellular components into two daughter cells during the M phase (Malumbres & 
Barbacid 2001). Prior to the S phase, cells go through a sustained G1 “growth” phase during 
which nutrients and growth factors stimulate cells to enter the cycle from the quiescent G0 phase 
and continue onwards to the G1/S checkpoint.  
 
Another crucial checkpoint is the G2/M checkpoint. This is particularly important as cells are 
under sustained surveillance for DNA damage in the form of double strand breaks (DSB) or 
single stranded DNA breaks (SSB). Under such circumstances the cell cycle is paused at the 
G2/M checkpoint. Recent research has suggested that the G2/M checkpoint is negligent as a 
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pause in the cell cycle is only introduced after a defined threshold of DNA damage (Löbrich & 
Jeggo 2007). This leaky G2/M checkpoint is believed to be significant in environmentally derived 
cancers. 
 
To investigate the impact of arsenic trioxide exposure on the cell cycle, propidium iodide was 
used to stain fixed and permeabilised cells. This would allow for scoring of cellular populations 
within the G1, S and G2/M parts of the cell cycle. The sub G1 population was also measured via 
the same method which allows for the identification of internucleosomal DNA fragmentation; a 
hallmark of apoptosis to show the proportion of cells that are not only outside of the normal cell 
cycle but are undergoing cell death (Kajstura et al. 2007).  
 
 
Treatment with 2.5 µM As2O3 led to a significant increase in the percentage of cells within sub 
G1 (Fig. 4.8). This finding was expected, as this dosage is toxic. There was no difference 
observed between the untreated control and 0.5 µM As2O3 in the sub G1 population, with less 
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+ Figure 4.8: Cell cycle analysis of HEK293T cells treated with 0.5 µM and 2.5 µM As2O3 
for 72 hours.  
HEK293T cells were treated for 72 hours with 0.5 µM and 2.5 µM As2O3, fixed and 
permeabilised before staining with propidium iodide (see materials and methods for detailed 
information). All bars shown are ± SD. * p < 0.05, N = 3. 
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than 10% of cells undergoing apoptosis similar to the untreated control. A significant reduction 
in the percentage of cells undergoing G1 growth was observed with 0.5 µM As2O3 and this was 
coupled with a significant increase in the percentage of cells in the S phase with doubled genetic 
material. In contrast the 2.5 µM As2O3 exposure had no significant impact on the percentage of 
cells occupying the G1 growth phase, but a significant reduction in the percentage of cells in the 
S phase and G2/M phase. This finding was aligned to the cell death observed at this dosage. The 
0.5 µM As2O3 exposure resulted in a significant increase in the percentage of cells passing 
through the G2/M checkpoint. 
 
This data suggested that the 0.5 µM As2O3 concentration allowed for sustained and increased 
cellular cycling over the untreated control, whereas the 2.5 µM As2O3 concentration led to 
increased drop out of the cell cycle with a significant increase in the percentage of cells occupying 
the sub G1 fragmented DNA population.  
 
4.1.8 – Exposure to 0.5 µM As2O3 induced anchorage-independent growth of HEK293T 
cells as determined by colony formation in soft agar.  
 
Multiple cellular transformation indicators were evaluated with the 0.5 µM As2O3 concentration 
including cellular survival, cellular proliferation and cell-cycle distribution. Another significant 
indicator of cellular transformation is anchorage-independent growth. Normal cells undergo a 
form of apoptosis called anoikis when a growth surface is removed (Kopnin 2000; Frisch & 
Screaton 2001). In contrast, transformed cells continually grow independent of a surface anchor. 
This is routinely examined amongst a repertoire of cellular transformation assays to predict 
cellular transformation and carcinogenic potential (Creton et al. 2012).  
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To investigate if 0.5 µM As2O3 was able to induce anchorage-independent growth in vitro, a soft-
agar colony formation assay was used. In this assay soft-agar was used to cover the bottom 
hydrophilic plastic coating of a tissue culture dish and then cells were seeded in semi-solid media 
after a 3-month exposure. This assay is considered an ideal in vitro indicator of malignant growth  
potential (Raptis & Vultur 2001).  
 
HEK293T cells were pre-exposed to As2O3 for a period of 3 months prior to seeding into soft 
agar (Fig. 4.9). Treatment with 0.5 µM As2O3 resulted in a visibly clear increase in the number of 
colonies compared to the untreated control (Fig 4.9, A). Furthermore, inspection of the colonies 
under a 10 x optical zoon demonstrated that the colonies were not only larger, but some colonies 
had protrusions and projected growth away from the main growth colony (Fig. 4.9, B). Finally, 
the number of colonies in each well was counted. The 0.5 µM As2O3 exposure induced a 
significant increase in the number of colonies formed over the untreated control (Fig. 4.9, C). 
This suggested that 0.5 µM As2O3 was able induce anchorage-independent and potentially 
malignant growth of HEK293T cells.  
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+ Figure 4.9: Anchorage-independent growth assay as determined by soft-agar colony 
formation in HEK293T cells treated with 0.5 µM As2O3 for 3 months.  
(A) Photograph of HEK293T cells growing in soft agar after exposure to 0.5 µM As2O3 for 3 
months. Colonies were stained with 0.005% Crystal Violet. See materials and methods for 
additional staining details. (B) Colonies formed in soft agar visualised under a 10 x optical 
magnification. (C) Number of soft agar colonies counted under a 10 x optical magnification 
with a hand counter. All bars shown are ± SD. * p < 0.05, N = 3. 
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4.1.9 – Summary: identification of a tolerated and toxic exposure of arsenic trioxide 
(As2O3) in human embryonic kidney (HEK293T) cells. 
 
The concentration selection framework (Fig. 4.1) was used to identify a tolerated and toxic 
exposure of As2O3 in HEK293T cells. This two-step framework used a collection of assays to 
identify a tolerated exposure as 0.5 µM As2O3 for exposures up to 3 months and a toxic exposure 
as 2.5 µM As2O3 up to 72 hours. A summary of the results to determine this concentration 
selection is shown below:  
 
+ A 1-week exposure to 2.5 µM As2O3 led to PARP cleavage, whereas a 0.5 µM As2O3 
dosage did not (Fig. 4.2). 
+ A 1-week exposure to 2.5 µM As2O3 and higher doses including 5 µM and 10 µM As2O3 
led to gradual caspase-3 cleavage, truncation of the pro-apoptotic factor BID, 
phosphorylation of p53 at serine 15, decrease of MDM2 – the negative regulator of p53 
and subsequently p53 stabilisation, suggesting that 2.5 µM As2O3 was a minimal toxic 
dosage (Fig. 4.3). 
+ Increased Caspase 3,7 and 8 activation is observed after a 72-hour exposure to 2.5 µM 
As2O3, whilst reduced Caspase 3,7 activation is observed after exposure to 0.5 µM As2O3 
(Fig. 4.4).  
+ A 72-hour exposure to 2.5 µM As2O3 led to mitochondrial hypo-polarisation, a 
significant increase in mitochondrial superoxide generation and elevated cell death as 
observed by propidium iodide staining. In contrast the 0.5 µM As2O3 exposure had no 
effect on the aforementioned parameters for the same exposure duration (Fig. 4.5) 
+ A 15-day exposure to 0.5 µM As2O3 led to increased cellular survival and the formation 
of larger colonies, whereas the 2.5 µM As2O3 exposure gave no colony growth (Fig. 4.6).  
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+ A 1-week exposure to 0.5 µM As2O3 led to a significant increase in the proliferation of 
HEK293T cells. In contrast a 2.5 µM As2O3 exposure led to a significant decrease in 
proliferation (Fig. 4.7).  
+ A 72-hour exposure to 0.5 µM As2O3 altered progression through cell-cycle checkpoints, 
with an increase in cells passing the G1/S and G2/M checkpoints. The 2.5 µM dosage 
led to a significant increase the number of cells undergoing apoptotic cell death and cell-
cycle exist as observed by the increase in the sub G1 population for this exposure (Fig. 
4.8).  
+ A 3-month exposure to 0.5 µM As2O3 led to anchorage-independent growth as observed 
by a soft agar colony formation assay, with more and larger colonies compared to the 
untreated control (Fig. 4.9).  
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4.2 – Characterisation of Global Histone Acetylation Patterns as a Result of 
Tolerated and Toxic As2O3 Exposure in HEK293T Cells. 
 
Once the tolerated (0.5 µM) and toxic (2.5 µM) As2O3 exposures were identified with the 
associated exposure durations, the next stage of this study was to characterise global histone 
acetylation patterns in HEK293T cells. The aim of this experiment was to assess whether or not 
differential histone acetylation patterns occur as a result of As2O3 exposure, reflecting the 
magnitude and duration of exposure, and the phenotypic outcome in the cells. In particular, the 
possibility that there are specific histone acetylation marks indicative of the carcinogenic process 
was investigated. 
 
Although a wide variety of covalent modifications occur on histone tails including acetylation, 
methylation and phosphorylation, to name but a few, this study focused specifically on histone 
acetylation as it has functional consequences that impinge on transcriptional control, DNA 
repair, replication and condensation, making it a functionally dense chromatin mark (Kouzarides 
2007). Aberrations in histone acetylation have also shown great promise as a suitable biomarker 
to investigate cancer progression, stratification and prognosis (Baylin & Jones 2011; Seligson et 
al. 2005).  
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4.2.1 – As2O3 exposure induces a temporally sensitive increase in H3K9 and H4K12 
acetylation between 3 and 72 hours and a reduction in H4K16 acetylation after 72 hours.  
 
For this present study histone H3K9, H4K12 and H4K16 acetylation was measured globally at a 
short-term exposure of 3 hours and compared to a longer-term exposure of 72 hours after 
treatment with a tolerated (0.5 µM) and toxic (2.5 µM) dosage of As2O3. The histone acetylation 
status was evaluated by immunoblotting (Fig. 4.10). 
 
Two time points were used to identify specific arsenic-induced histone acetylation changes and to 
evaluate the plasticity of such events in HEK293T cells. At 3 hours, an elevation of H3K9 and 
H4K12 acetylation was observed upon exposure to a 0.5 µM and 2.5 µM As2O3. There was no 
change in H4K16 acetylation at 3 hours. Hypoacetylation of H4K16 was also identified at both 
tolerated and toxic dosages after a 72-hour exposure, with little change at the 3-hour exposure on 
this residue.  
 
This experiment suggests that As2O3 exposure leads to temporally sensitive changes in histone 
acetylation as the initial increase in H3K9 and H4K12 acetylation reduces below nominal levels at 
72 hours. Whilst no change is observed within 3 hours on the H4K16 acetylation status, this 
residue is then hypo-acetylated at 72 hours. Furthermore it suggests that the magnitude of the 
dosage, i.e. tolerated and toxic, has no separated direction of acetylation and rather both tolerated 
and toxic exposure lead in the same direction of acetylation change – hyper or hypo.  
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+ Figure 4.10: Global histone H3K9, H4K12 and H4K16 acetylation in HEK293T cells 
exposed to As2O3 for 3 hours and 72 hours.  
HEK293T cells were exposed to As2O3 for 3 hours and 72 hours to both tolerated and toxic 
dosages followed by histone extraction and immunoblotting. Relative expression ratios were 
determined by quantification of bands by densitometry analysis (see materials and methods 
for additional details). All concentrations along the x-axis are of As2O3. All bars shown are ± 
SD. N = 3. 
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4.2.2 – As2O3 exposure also leads to global changes in total histone H3 acetylation, 
H3K9 di-methylation and H3S10 phosphorylation. 
 
Other histone post-translational modifications were also examined including total histone H3 
acetylation, H3K9 di-methylation and H3S10 phosphorylation after tolerated and toxic As2O3 
exposure. This is due to a growing body of evidence that suggests that some histone post-
translational modifications may be more or less likely to occur due to a previous event. This post-
translational modification interdependency is called “crosstalk” and such events have been 
implicated in transcriptional control(Winter & Fischle 2010).  
 
One such example of crosstalk is the phosphorylation of H3S10, which is believed to also assist 
in the acetylation of H4K16. This generates a binding site for Brd4 and P-TEFb which 
subsequently allows for the phosphorylation of the C-terminal domain of RNA Pol II to facilitate 
transcriptional elongation (J.-S. Lee et al. 2010). Furthermore, H3S10 phosphorylation is believed 
to be an important event in neoplastic cellular transformation (Choi et al. 2005).  
 
H3K9 dimethylation is also in direct competition with H3K9 acetylation and forms one of the 
simplest examples of exclusion crosstalk as both methylation and acetylation in this case occur 
on the same residue (Winter & Fischle 2010). H3K9 dimethylation was also investigated, as this 
post-translational modification requires the availability of S-adenosylmethionine (SAM) a methyl-
donating factor utilised for the metabolism of arsenic trioxide.  
 
HEK293T cells were exposed for 3 hours and 72 hours with 0.5 µM and 2.5 µM As2O3 followed 
by histone extraction and immunoblotting for total H3K9 acetylation, H3K9 dimethylation and 
H3S10 phosphorylation (Fig. 4.11).  
  
Sunniyat Rahman | Imperial College London  127 	  
 
 
 
A 3-hour exposure to 0.5 µM and 2.5 µM As2O3 resulted in a significant increase in total histone 
H3 acetylation. After 72 hours this increase was no longer observed. A dose-dependent increase 
in H3K9 di-methylation was observed at 3 hours. However at 72 hours, a reduction of H3K9 di-
methylation occurred after treatment with 2.5 µM As2O3. At 3 hours a 0.5 µM and 2.5 µM dosage 
both increased the level of H3S10 phosphorylation and this increase was maintained at 72 hours 
for both dosages.  
 
Both H3K9 acetylation and di-methylation increase after a 3-hour As2O3 exposure (Fig. 
4.10/4.11). It is therefore unlikely that As2O3 exposure leads to post-translational variations on 
these residues via a crosstalk mechanism. However, it is important to note that due to the small 
sample size of this experiment these observations are only open to very limited interpretation.  
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+ Figure 4.11: Global histone H3 acetylation, H3K9 di-methylation and H3S10 
phosphorylation in HEK293T cells exposed to As2O3 for 3 hours and 72 hours.  
 HEK293T cells were exposed to 0.5 µM and 2.5 µM As2O3 for 3 hours and 72 hours 
followed by histone extraction and immunoblotting. A total of 10 µg of proteins were added 
in each well. Total histone 3 was used as a loading control. Representative blot shown of two 
repeats. 
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4.2.3 – As2O3-induced changes in H3K9, H4K12 and H4K16 acetylation are potentially 
reversible.  
 
The reversibility of histone acetylation changes induced by As2O3 was assessed. This is because 
reversibility is a good marker for the causality of a specific effect, along with additional 
measurements such as specificity, biological gradients and consistency(Swaen & van Amelsvoort 
2009).  
 
To examine the reversibility of the global histone acetylation changes previously observed, 
HEK293T cells were exposed for 72 hours to 0.5 µM and 2.5 µM As2O3, after which the growth 
medium was changed for fresh medium with no toxicant present for a further 72 hours (Fig. 
4.12). This was then followed by histone extraction and immunoblotting to evaluate histone 
acetylation status.  
 
Both H3K9 and H4K16 were hypo-acetylated at 72 hours. After a 72-hour rest period without 
As2O3, the levels of acetylation appeared to normalise. H4K12 acetylation also appeared to be 
nominal levels after a 72-hour exposure with no real change in the acetylation status after a 72-
hour rest period. 
 
This suggests that As2O3-induced H3K9 and H4K16 hypoacetylation are potentially reversible 
events. Furthermore this data suggests that H4K12 acetylation changes may not play a significant 
role in As2O3-induced cellular transformation, rather it may have a possible involvement in an 
early response to the toxicant, particularly as a 72-hour exposure and a rest period does not 
generate substantial changes in histone acetylation.  
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+ Figure 4.12: Histone acetylation profile examining the reversibility of H3K9, H4K12 
and H4K16 acetylation after a 72 hour exposure to As2O3 followed by a 72 hour rest in 
HEK293T cells.  
HEK293T cells were exposed to 0.5 µM and 2.5 µM As2O3 for 72 hours followed by 72 
hours in fresh medium without the toxicant, followed by histone extraction and 
immunoblotting. Relative expression ratios were determined by quantification of bands by 
densitometry analysis (see materials and methods for additional details). All concentrations 
along the x-axis are of As2O3. All bars shown are ± SD. N = 3. 
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4.2.4 – Summary: characterisation of global histone acetylation patterns as a result of 
tolerated and toxic As2O3 exposure in HEK293T cells. 
 
Both tolerated (0.5 µM) and toxic (2.5 µM) dosages of As2O3 were used to investigate the effect 
of toxicant exposure on the histone acetylation status on H3K9, H4K12 and H4K16 in 
HEK293T cells. Additional post-translational modifications on the histone tails were also 
investigated, including total H3 acetylation, H3S10 phosphorylation and H3K9 di-methylation. 
Finally a reversibility assay was conducted to investigate the plasticity of the histone acetylation 
changes. The results are summarised below: 
 
+ Temporally sensitive changes in H3K9, H4K12 and H4K16 acetylation were observed in 
HEK293T cells after As2O3 exposure (Fig. 4.10). 
+ At 3-hours, hyperacetylation of H3K9 and H4K12 acetylation was observed with both 
0.5 µM and 2.5 µM As2O3, with no change in H4K16 acetylation. In contrast, a 72-hour 
exposure resulted in hypoacetylation in H3K9 and H4K16 acetylation with a return to 
nominal levels for H4K12 acetylation at both tolerated and toxic dosages (Fig. 4.10). 
+ No dosage-specific effects in histone acetylation were observed, i.e. the direction of 
acetylation change was the same for both tolerated and toxic dosages at both time points 
(Fig. 4.10).  
+ A 3 hour exposure to tolerated and toxic dosages of As2O3 led to an increase in total H3 
acetylation, H3K9 di-methylation and H3S10 phosphorylation. Some of these changes 
were temporally sensitive, as at 72 hours, total H3 acetylation returned to nominal levels. 
H3K9 di-methylation was reduced specifically at the toxic exposure of 2.5 µM As2O3 
and the profile of dose-dependent H3S10 phosphorylation remained the same at this 
exposure period. There was minimal evidence of epigenetic crosstalk, however due to 
the small sample size, these observations are limited in their significance (Fig. 4.11).  
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+ H3K9 and H4K16 hypoacetylation at 72-hours is potentially reversible after a 72-hour 
rest period without the toxicant, as the acetylation tended to return back to nominal 
levels (Fig. 4.12).  
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4.3 – Identification of the Enzymes That Control Histone Acetylation in 
HEK293T Cells.  
 
A number of lysines including H3K9, H4K12 and H4K16 were identified as being sensitive to 
As2O3 exposure. Although the separated outcomes of tolerance and toxicity were not reflected as 
directional differences in histone acetylation on the residues examined, there was still an impetus 
to identify the enzymes involved in driving the recorded acetylation changes. The reason for this 
was two fold. The first was that the enzymes that drive arsenic-induced global histone acetylation 
events have not been clearly identified, and secondly histone-modifying enzymes are involved in 
the transcriptional control of genes and the acetylation of other proteins; so further investigation 
had the potential to uncover additional mechanistic insights. Hence the next step in this study 
was to identify the enzymes that may be involved in facilitating the acetylation changes on these 
residues.  
 
Prior research from this group identified target substrates of histone modifying enzymes by 
utilising transient transfections to overexpress histone deacetylases (HDACs) and histone 
acetyltransferases (HATs) (Hajji et al. 2010). Cells were lysed after the transfection followed by 
immunoblotting to identify the histone acetylation status. A similar approach was utilised in the 
present study.  
 
4.3.1 – HDAC 1 and 2 deacetylate H3K9 in HEK293T cells. 
 
HEK293T cells were transiently transfected with plasmids constitutively expressing HDAC1, 2, 3 
and 4 (Fig. 4.13). The impact of overexpressing each histone deacetylase was measured on 
specific lysines of interest, namely H3K9, H4K12 and H4K16. The acetylation status was 
compared to a no-insert control.  
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HDAC1 and HDAC2 were effective at deacetylating H3K9 in HEK293T cells. H4K12 
acetylation was not deacetylated by most of the enzymes, except for HDAC4. None of the 
enzymes used were effective at deacetylating H4K16 suggesting that the deacetylation of this 
residue is controlled by other HDACs not used here.  
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+ Figure 4.13: Identification of histone acetylation control by histone deacetylases in 
HEK293T cells.  
HEK293T cells were transfected with plasmids that overexpress HDAC1, 2, 3 and 4. 20 µg of 
each plasmid was added to each well (see materials and methods for additional details). After 
transfection cells were harvested after 48-hours to ensure optimum expression of the plasmid 
and then subjected to histone extraction and immunoblotting to assess the histone acetylation 
status of H3K9, H4K12 and H4K16. All bars shown are ± SD. N = 3. 
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4.3.2 – PCAF and HMOF acetylate H3K9 whilst PCAF, TIP60 and P300 acetylate 
H4K16 in HEK293T cells.  
 
HEK293T cells were transiently transfected with plasmids constitutively expressing PCAF, 
TIP60, HMOF and P300 (Fig. 4.14). This allowed for the identification of enzymes that acetylate, 
rather than deacetylate specific lysines. The impact of overexpressing each histone 
acetyltransferase was measured on the same lysines as before (H3K9, H4K12 and H4K16). The 
acetylation status was compared to a no-insert control.  
 
Both PCAF and HMOF readily acetylated H3K9 in HEK293T cells. HMOF significantly 
increased the acetylation status on the H4K12 residue. H4K16 acetylation was the most sensitive 
to transfections with the HATs as PCAF, TIP60 and P300 all acetylated this residue effectively. 
Some redundancy was present in HEK293T cells as multiple enzymes were able to fulfil the 
same functional outcome in the case of both H3K9 and H4K16.  
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+ Figure 4.14: Identification of histone acetylation control by histone acetyltransferases 
in HEK293T cells.  
HEK293T cells were transfected with plasmids that overexpress PCAF, TIP60, HMOF and 
P300. 20 µg of each plasmid was added to each well (see materials and methods for additional 
details). After transfection cells were harvested after 48-hours to ensure optimum expression 
of the plasmid and then subjected to histone extraction and immunoblotting to assess the 
histone acetylation status of H3K9, H4K12 and H4K16. All bars shown are ± SD. N = 3. 
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4.3.3 – Summary: identification of the enzymes that control histone acetylation in 
HEK293T cells. 
 
HEK293T cells were transfected with plasmids constitutively overexpressing enzymes that 
deacetylate and acetylate histone residues with the intention to identify the enzymes that control 
the acetylation status on H3K9, H4K12 and H4K16. Cells were transfected with histone 
deacetylases HDAC1, 2, 3 and 4 and the histone acetyltransferases PCAF, TIP60, HMOF and 
P300. Cells were also transfected and treated with tolerated and toxic exposure of As2O3 to 
elucidate the impact of toxicant exposure on the functional ability of the histone modifying 
enzymes. The results of these assays are summarised below:  
 
+ HDAC1 and 2 deacetylate H3K9 in HEK293T cells (Fig. 4.13).  
+ PCAF and HMOF acetylate H3K9 whilst PCAF, TIP60 and P300 acetylate H4K16 in 
HEK293T cells (Fig. 4.14).  
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4.4 – Gene Expression Analysis of HDACs and HATs Under Tolerated and Toxic 
As2O3 Exposure in HEK293T Cells. 
 
Prior experiments were able to identify the enzymes involved in the acetylation and deacetylation 
of specific lysines in HEK293T cells. HDAC1 and HDAC2 were shown to deacetylate H3K9 
whilst PCAF and HMOF were shown to fulfil the opposing function by acetylating this residue. 
Both, TIP60 and P300 also had an effect on the acetylation of H4K16 in HEK293T cells.  
 
Whilst the function of these enzymes appeared to be disrupted in the presence of As2O3 further 
assays were conducted to investigate the mRNA expression levels of these enzymes under 
tolerated and toxic exposure conditions and to see whether these levels could explain the 
variance in global histone acetylation levels observed previously. This was carried out in an 
attempt to understand the driving factors behind the changes in As2O3-induced global histone 
acetylation observed on the residues of interest, most notably the H3K9 and H4K16 
hypoacetylation events as these residues remain hypo-acetylated after 72 hours. 
 
4.4.1 – Increased expression of HDAC2 contributes to As2O3-induced H3K9 
hypoacetylation at 72 hours. 
 
HEK293T cells were exposed to tolerated (0.5 µM) and toxic (2.5 µM) dosages of As2O3 for 72 
hours. A shorter 3-hour exposure was also used. Cells were then harvested and subjected to a 
two-step qRT-PCR process, firstly total RNA was extracted followed by a reverse transcriptase 
reaction to convert the RNA into cDNA. To ensure effective reverse transcription of all RNA, a 
reverse transcriptase with a higher thermal stability which allowed for a higher reaction 
temperature and effective denaturation of RNA secondary structures. The cDNA formed was 
then used as a template for the qRT-PCR reactions. To quantify the expression of the enzymes 
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of interest, primers were designed to target only relevant cDNA molecules that have been 
synthesised from the target mRNA molecules.  
 
Initially the expression levels of HDAC1, 2, 3 and 4 was evaluated at 72 hours. The expression 
levels of HDAC1 and 2 were also examined at 3 hours as these enzymes were identified 
previously as being instrumental in controlling H3K9 acetylation status (Fig. 4.15).  
 
HDAC1 expression was significantly reduced at 72 hours after tolerated and toxic exposure to 
As2O3 (Fig. 4.15, A). Given that HDAC1 was previously shown to deacetylate H3K9, this finding 
challenged the possibility of As2O3-induced H3K9 hypoacetylation to be a HDAC1 mediated 
event. However, at the tolerated exposure there is a significant increase in the expression of 
HDAC2 and a slight increase in expression at the toxic exposure (Fig. 4.15, B). This suggests that 
As2O3-induced H3K9 hypoacetylation is driven by HDAC2. Both HDAC3 and HDAC4 
expression was significantly reduced at the tolerated exposure (Fig. 4.15, C, D).   
 
HDAC1 and 2 expression levels were also measured after a shorter 3-hour exposure (Fig. 4.15, 
E, F). At this time point global H3K9 acetylation was previously shown to be elevated. HDAC1 
expression was significantly elevated at 3-hours after a 0.5 µM As2O3 dosage. HDAC2 expression 
was slightly reduced at both dosages and significantly reduced at the 2.5 µM As2O3 dosage. The 
reduction in HDAC2 expression levels at 3 hours is likely to assist in the global H3K9 
hyperacetylation event due to reduced deacetylation.  
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+ Figure 4.15: Gene expression profiles of HDAC1, 2, 3 and 4 at 72 hours and HDAC1 
and 2 at 3 hours after a tolerated and toxic exposure to As2O3 in HEK293T cells.  
(A) HDAC1 mRNA expression level at 72 hours, (B) HDAC2 mRNA expression level at 72 
hours, (C) HDAC3 mRNA expression level at 72 hours, (D) HDAC4 mRNA expression level 
at 72 hours, (E) HDAC1 mRNA expression level at 3 hours and (F) HDAC2 mRNA 
expression level at 3 hours. A total of 5 µg of extracted RNA was converted into cDNA. Data 
was quantified via the standard curve method. Primers were designed by utilising the Primer-
BLAST bioinformatic tool. See materials and methods for additional details. Data presented is 
fold change normalised to the untreated control. All bars shown are ± SD. N = 3. 
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4.4.2 – Increased expression of PCAF drives As2O3-induced H3K9 hyperacetylation at 3 
hours and reduced expression at 72 hours assists H3K9 hypoacetylation.  
 
HEK293T cells were exposed to tolerated and toxic exposures of As2O3, followed by RNA 
extraction, reverse transcription and qRT-PCR as mentioned previously. To begin, the expression 
levels of HMOF, TIP60, P300 and PCAF were evaluated at 72 hours (Fig. 4.16). The expression 
level of PCAF was also examined at 3 hours, as this enzyme was able to acetylate H3K9. 
 
Whilst some gene expression changes were observed for HMOF, TIP60 and P300 these were not 
significant (Fig. 4.16, A, B, C). PCAF expression however was significantly reduced at 72 hours 
after tolerated and toxic As2O3 exposure (Fig. 4.16, D). Given that PCAF was shown to acetylate, 
H3K9 the reduced expression of this enzyme was potentially responsible for the hypoacetylation 
of this residue at 72 hours. To investigate this further a 3-hour exposure was able to show a small 
increase PCAF expression after treatment with 0.5 µM As2O3 and a significant increase in 
expression after a 2.5 µM As2O3 treatment (Fig. 4.16, E). This occurs in concert with global 
H3K9 hyperacetylation at the 3-hour time point.  
 
By examining the data from the gene expression assays together, it becomes clear that HDAC2 
and PCAF fulfil functionally opposing enzymatic actions on the H3K9 substrate. At 3 hours the 
reduced HDAC2 expression combined with the elevated PCAF expression allows for H3K9 
hyperacetylation. This is inverted at 72 hours with an increase in HDAC2 expression and a 
reduction in PCAF expression leading co-operatively to H3K9 hypoacetylation.  
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4.4.3 – Summary: gene expression analysis of HDACs and HATs under tolerated and 
toxic exposure to As2O3 in HEK293T cells. 
 
In an effort to understand the enzymes driving histone acetylation changes on specific lysines the 
relative levels of HDACs and HATs were quantified by qRT-PCR following As2O3 exposure. Of 
particular interest were the enzymes involved in deacetylating and acetylating H3K9, which were 
previously shown to be HDAC2 and PCAF. The results of these experiments are summarised 
below:  
 
+ Elevation of the HDAC2 mRNA levels assists H3K9 hypoacetylation at 72 hours (Fig. 
4.15). 
+ Reduction of the PCAF mRNA at 72 hours occurs in concert with an elevation of 
HDAC2 mRNA leading to H3K9-hypoacetylation (Fig 4.15, 4.16).  
+ Elevation of the PCAF mRNA levels assist H3K9 hyperacetylation at 3 hours (Fig 4.16, 
E).  
  
+ Figure 4.16: Gene expression profiles of HMOF, TIP60, P300 and PCAF at 72 hours 
and PCAF at 3 hours after a tolerated and toxic exposure to As2O3 in HEK293T cells.  
(A) HMOF mRNA expression level at 72 hours, (B) TIP60 mRNA expression level at 72 
hours, (C) P300 mRNA expression level at 72 hours, (D) PCAF mRNA expression level at 72 
hours, (E) PCAF mRNA expression level at 3 hours. A total of 5 µG of extracted RNA was 
converted into cDNA. Data was quantified via the standard curve method. Primers were 
designed by utilising the Primer-BLAST bioinformatic tool. See materials and methods for 
additional details. Data presented is fold change normalised to the untreated control. All bars 
shown are ± SD. N = 3. 
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4.5 – Unifying Histone Modifications and Histone Modifying Enzymes to Gene 
Promoters via Chromatin Immunoprecipitation and Global Chromatin 
Conformation Analysis.  
 
Prior experiments were able to identify a number of specific events, including As2O3-induced 
changes in H3K9 acetylation and variations in HDAC2 and PCAF mRNA expression levels. To 
explicitly assess the consequence of these changes on gene expression a chromatin 
immunoprecipitation assay was conducted. The assay determines the presence and relative 
enrichment of proteins binding to specific gene loci. Through the utility of this method it is then 
possible to investigate the transcriptional control and activation of specific promoters with a 
particular focus on genes that have consequences between apoptosis and cellular proliferation.  
 
To do this a candidate transcriptional factor was also selected, as histone acetylation and histone-
modifying enzymes alone would be unlikely to initiate transcription. E2F1 was chosen as it has 
been shown to influence decisions between cellular proliferation and cell death (Hallstrom et al. 
2008). E2F1 and H3K9 acetylation interactions were examined at a number of gene promoters 
including the tumour suppressor (TP53), apoptotic genes (BAX & PUMA) and proto-oncogenes 
(MYC & FOS).  
 
4.5.1 – As2O3-induced H3K9 acetylation and E2F1 transcription factor binding co-
occurs on the FOS gene promoter.  
 
HEK293T cells were exposed to As2O3 for 3 and 72 hours. Treatment with 0.5 µM As2O3, 
followed by anti-acetylated H3K9 antibody precipitation significantly enriched the FOS promoter 
fragment (Fig. 4.17, A). This suggested the presence of a localised increase of H3K9 acetylation 
at the FOS promoter. Using the same duration of exposure and an anti-E2F1 antibody, 
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enrichment at the FOS promoter was observed at both 0.5 µM and 2.5 µM As2O3 exposures, 
which was indicative of increased E2F1 binding at the FOS promoter (Fig. 4.17, C). After 72-
hours, dosage specific responses were identified as significantly elevated binding to the FOS 
promoter occurred specifically at the tolerated 0.5 µM As2O3 exposure, with both E2F1 and 
H3K9 acetylated antibody pull-downs (Fig. 4.17, B, D). 
 
The relative enrichment of PCAF and HDAC2 at the FOS promoter was also investigated after a 
72-hour exposure to determine if these enzymes are involved in the maintenance of H3K9 
acetylation (Fig. 4.17, E, F). Tolerated 0.5 µM As2O3 exposure increased binding of PCAF at the 
FOS promoter and also at the toxic 2.5 µM As2O3 treatments. No significant difference in 
HDAC2 binding was observed at either exposure.  
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4.5.2 – Tolerated exposure to As2O3 leads to E2F1 recruitment, PCAF binding and 
H3K9 acetylation at the FOS promoter leading to an increase the FOS mRNA transcript. 
 
At 72 hours and only at the tolerated dosage of 0.5 µM As2O3 a number of proteins (E2F1, 
PCAF and acetylated H3K9) are co-localised at the FOS promoter. QRT-PCR was carried out to 
investigate if these interactions are sufficient for gene expression by measurement of FOS 
mRNA. In addition to this a number of other proto-oncogenes were also investigated including 
JUN and MDM2 as these genes are synonymous with cancer stem cell expansion, p53 regulation 
and proliferation (Ito et al. 2002; Jiao et al. 2010).  
 
HEK293T cells were exposed to 0.5 µM and 2.5 µM As2O3 for 3 hours and 72 hours followed by 
RNA extraction, cDNA synthesis and qRT-PCR as described previously.  
  
+ Figure 4.17: Tolerated As2O3 exposure leads to the recruitment of E2F1 and PCAF 
with H3K9 co-occurrence at the FOS promoter.  
(A, B, C, D) Chromatin immunoprecpitation of H3K9ac and E2F1 using anti-acetylated 
H3K9 and anti-E2F1 antibodies after exposure to 0.5µM and 2.5µM As2O3 at two time-
points, 3 hours and 72 hours. (E, F) Chromatin immunoprecipitation with anti-HDAC2 and 
PCAF antibodies at 72 hours. Precipitated chromatin was then subjected to qRT-PCR 
promoter analysis. Statistical significance is depicted by * for p<0.05 calculated by a two-tailed 
Student’s T test compared to the untreated control group with N=3. All bars plotted are 
mean ± SD.  
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After 3-hours of exposure, the expressional changes observed are subtle with a significant 
increase only in JUN expression with the 2.5 µM As2O3 treatment (Fig. 4.18). After 72-hours of 
exposure the differences are more pronounced between the tolerated and toxic exposures. This is 
highlighted by the expression of FOS, which is highly elevated at the 0.5 µM As2O3 exposure. 
This increase was dosage-specific, as the toxic 2.5 µM As2O3 exposure resulted in no significant 
elevation. A similar expression pattern was observed for JUN. The expression of MDM2 mRNA 
was significantly increased at the tolerated 0.5 µM As2O3 exposure in the HEK293T.  
 
4.5.3 – Global chromatin conformation analysis via MNase sensitivity assay demonstrates 
time dependent chromatin and dosage-specific chromatin conformation changes as a 
result of As2O3 exposure.  
 
Whilst perturbations in histone acetylation have significant consequences on transcriptional 
control it also has an impact on global chromatin architecture. To investigate this further cells 
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+ Figure 4.18: Tolerated exposure induces the expression of JUN, FOS and MDM2. 
Normalised expression ratios are shown for JUN, FOS and MDM2 mRNA. Total RNA was 
isolated from 0.5 µM and 2.5 µM As2O3 treated HEK293T cells to be used for the qRT-PCR 
analysis. Statistical significance is depicted by * for p<0.05 calculated by a two-tailed Student’s 
T test compared to the untreated control group with N=3. All bars plotted are mean ± SD.  
Sunniyat Rahman | Imperial College London  150 	  
treated with As2O3 were subjected to an MNase sensitivity assay which is an effective method to 
chart changes in higher-order chromatin structure (V. W. Zhou et al. 2010). The method relies 
on the relative compactness and density of nucleosomes, where areas of lower nucleosome 
densities are more susceptible to MNase digestion, which introduces a double strand break 
within nucleosomal linker regions (Anon 2005).  
 
HEK293T cells were exposed to 0.5 µM and 2.5 µM As2O3 for 3 hours and 72 hours followed by 
MNase digestion after each time-point (Fig. 4.19). Rapid relaxation occurred after 3-hours with 
0.5 µM and 2.5 µM As2O3 exposures as the digestion pattern was positively skewed towards the 
250 to 500 base pair size range, relative to the 2,000 base pair size (Fig. 4.19, A). The 2.5 µM 
As2O3 treatment led to greater chromatin relaxation than the 0.5 µM As2O3 treatment after 3-
hours. This relaxation was reversed after 72-hours, where the toxic 2.5 µM As2O3 treatment led 
to chromatin condensation (Fig. 4.19, B). At 72-hours the tolerated 0.5 µM As2O3 exposure has 
the same digestion pattern as the control, with the majority of the DNA in the 2,000 base pair 
size range, with a small elevation in the 250 base pair range compared to the control.  
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+ Figure 4.19: MNase sensitivity assay on HEK293T cells treated with 0.5 µM and 2.5 
µM As2O3 at 3 and 72 hours.  
 MNase sensitivity assay was used to assess the relative levels of chromatin relaxation between 
two treatments 0.5µM and 2.5µM As2O3. A total of 0.025 units of MNase were used to carry 
out digestions. (A) 3-hour time point. (B) 72-hour time point. Digested chromatin was 
separated on an agarose gel, photographed under a UV lamp and digitally analysed using 
ImageJ to plot the signal intensity against the DNA ladder.  
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4.5.4 – Summary: unifying histone modifications and histone modifying enzymes to gene 
promoters via chromatin immunoprecipitation. 
 
Chromatin immunoprecipitation was used to unify the previous findings that As2O3 exposure 
leads to global H3K9 hypoacetylation and disruption in the expression levels of the enzymes 
regulating the acetylation status of this residue, namely PCAF and HDAC2. This assay was also 
used to investigate the recruitment of E2F1 at apoptotic and proto-oncogenic promoters. The 
data from these experiments are summarised below:  
 
+ A 3-hour 0.5 µM As2O3 exposure increased H3K9 acetylation at the FOS promoter (Fig. 
4.17, A). 
+ A 3-hour 0.5 and 2.5 µM As2O3 dosage leads to the recruitment of E2F1 at the FOS 
promoter (Fig. 4.17, C) 
+ At 72 hours, only a tolerated (0.5 µM As2O3) dosage led to H3K9 hyperacetylation and 
E2F1 binding at the FOS promoter, which remains contrary to the global H3K9 
hypoacetylation (Fig. 4.17, B, D).  
+ Increased binding of PCAF at the FOS promoter was observed at the tolerated and toxic 
exposures at 72 hours, with no difference in HDAC2 binding (Fig. 4.17, E, F).  
+ At 72 hours, only a tolerated (0.5 µM As2O3) dosage leads to the co-occurrences of 
E2F1, PCAF and H3K9 acetylation at the FOS promoter and FOS induction with a 
measurable increase in FOS mRNA (Fig. 4.18).  
+ At 72 hours, only a tolerated (0.5 µM As2O3) dosage leads to the increased expression of 
JUN and MDM2 (Fig 4.18).  
+ As2O3 exposure at 3 hours leads to global chromatin relaxation in contrast to 72 hours 
where a tolerated exposure leads to nominal chromatin conformation and the toxic 
exposure leads to chromatin condensation (Fig. 4.19). 	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- 4 - 
Results: As2O3-induced MicroRNA 
Aberrations and the Consequences on 
Histone Acetylation. 
 
4.6 – Identification of a Tolerated and Toxic Exposure of Arsenic Trioxide 
(As2O3) in Human Urothelial (UROtsa) Cells. 
 
The identification of tolerated and toxic dosages of As2O3 in UROtsa cells utilised PARP 
cleavage analysis, cell cycle analysis and a WST-1 proliferation assay. Similar to before, two time-
points were investigated, 3 hours and 72 hours. As previously mentioned (see materials and 
methods), UROtsa cells are a preferential choice to investigate arsenic-induced toxicity and 
cellular transformation, but were only acquired towards the latter stages of this present research 
due to a lack of local depositories.  
 
4.6.1 – At 3 hours, 5 µM and 80 µM As2O3 dosages are tolerated and toxic respectively, 
whereas 1 µM and 5 µM As2O3 dosages are tolerated and toxic respectively at 72 hours in 
UROtsa cells.  
 
Time-dependent tolerated As2O3 exposures were identified through PARP cleavage analysis. At 
the 3-hour time point, 5 µM As2O3 was tolerated and 80 µM As2O3 was toxic (Fig. 4.20, A). At 
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the 72-hour time point, 1 µM As2O3 was tolerated and 5 µM As2O3 was toxic (Fig. 4.20, B). After 
72-hours, a 1 µM As2O3 exposure led to a significantly redistributed cell cycle, particularly an 
elevated commitment to S-phase and progression through the G2/M checkpoint (Fig. 4.20, C). 
This was in contrast to the 5 µM As2O3 toxic exposure, that led to a significant increase in the 
sub-G1 cell population and reduced S-phase commitment and migration through the G2/M 
checkpoint. Positive proliferation was observed after a 72 hours and 1-week exposure to a 1 µM 
As2O3 dose, whilst 5 µM led to a reduced proliferative index compared to the untreated control 
(Fig. 4.20, D).  
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+ Figure 4.20: Identification of tolerated and toxic dosages of As2O3 in UROtsa cells at 3 
hours and 72 hours.  
(A) UROtsa cells were exposed to increasing dosages of As2O3 for 3 hours starting from 1 µM to 
160 µM followed by protein extraction and immunoblotting for PARP cleavage. (B) UROtsa cells 
were exposed to increased dosages of As2O3 for 72 hours starting from 1 µM to 10 µM As2O3 
followed by protein extraction and immunoblotting for PARP cleavage. Total amount of protein 
loaded was 80 µg. (C) UROtsa cells were treated for 72 hours with 1 and 5 µM As2O3, fixed and 
permeabilised before staining with propidium iodide (see materials and methods for detailed 
information). Bars shown are ± SD. * p < 0.05, N = 3. (D) UROtsa cells were treated with 1 µM 
and 5 µM As2O3. Full calculation methods for the proliferative index are to be found in the 
material and methods section. Curves shown are ± SD. * p < 0.05, N = 6. 
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4.6.2 – Summary: – identification of a tolerated and toxic exposure of arsenic trioxide 
(As2O3) in human urothelial (UROtsa) cells. 
 
Tolerated and toxic dosages of As2O3 were identified in the UROtsa cell line via PARP cleavage 
analysis, cell cycle analysis and a WST-1 proliferation assay. Dosages were identified for both 3 
and 72 hours. The results are summarised below:  
 
+ At 3 hours, 5 µM and 80 µM As2O3 dosages are tolerated and toxic respectively.  
+ At 72 hours, 1 µM and 5 µM As2O3 dosages are tolerated and toxic respectively.  
 
4.7 – Differential Expression of MicroRNAs and Bioinformatic Assisted 
prediction of miR:HDAC/HAT interactions. 
 
A central component of this second study was to identify novel As2O3 sensitive microRNA 
mediated attenuation mechanisms of the HDAC or HAT machinery. Such mechanisms would 
have an explicit impact on histone acetylation. A framework was devised to identify such 
interactions with the assistance of bioinformatic prediction (Fig. 4.21).  
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Identification of  the 
differential expression of  
microRNAs through the 
utility of  a broad screen. 
Bioinformatic prediction 
of  miR:HDAC/HAT 
interactions. 
Validations via gene 
expression analysis of  
miRs and HDAC/HAT 
targets, 3'UTR analysis and 
siRNAs knockdown of  
miRs to check specificity.   
+ Figure 4.21: Framework to identify differentially expressed microRNA with potential 
interactions with HDAC/HATs through a bioinformatic prediction.  
 This research framework was used to identify differentially expressed microRNAs, predict 
potential interactions with HDACs and/or HATs and validate such interactions through 
qRT-PCR, 3’UTR reporting and siRNA knockdown of candidate microRNAs.  
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4.7.1 – 26 microRNAs exhibit elevated expression after tolerated exposure to 1 µM 
As2O3 for 72 hours of which 6 were predicted to interact with histone acetylation 
machinery.  
 
Using the tolerated As2O3 exposure identified for the 72-hour exposure a miR PCR array was 
used to measure the differential expression of 89 miRs against an untreated control (Fig. 4.22). A 
total of 26 miRs exhibited elevated expression after tolerated As2O3 exposure. There is a 4-fold 
boundary marked on the scatter plot in both directions. MiRs that are up-regulated and fall 
outside of the boundary are marked as red. The 26 miRs identified were then passed through the 
miRWalk bioinformatic program to predict HDAC and HAT targets. This predicted gene-
miRNA interaction search was limited to 3’UTR miRNA binding sites for each gene, a minimum 
seed length of 7 and a p-value stringency set at 0.05. The miRWalk prediction was enhanced by 
an additional 5 prediction programs capable of similar comparative analysis including DIANA-
mt, miRanda, miRDB, RNA22 and TargetScan. MiRs that were cumulatively predicted to interact 
by 5 or more programs are listed (Table. 9). Of the 26 miRs that exhibited increased expression, 
4 miRs were predicted to interact with the HDAC4 mRNA, 1 miR was predicted to interact with 
the HDAC5 mRNA. All 6 programs predicted the PCAF mRNA as a potential target of miR-
372. To identify other microRNAs that may not be covered by the PCR array, a bi-directional 
prediction approach was employed, where the PCAF mRNA was put through the miRWalk 
program as a target to identify additional predicted microRNA interactions. This process led to 
the identification of miR-106b in addition to miR-372 as potential attenuators of the PCAF 
mRNA (Table. 10).  
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+ Figure 4.22: Scatter plot showing the differential expression of 89 microRNAs between 
an untreated control and a 1 µM As2O3 treatment in UROtsa cells.  
UROtsa cells were exposed to 1 µM As2O3 for 72 hours followed by RNA extraction, reverse 
transcription of mature microRNAs followed by qRT-PCR. The broad screen PCR array used 
was the Human Cancer PathwayFinder (Qiagen/ SA Biosciences – CAT# MIHS-102Z). Data 
was processed and analysed using the Qiagen Data Analysis Centre 
(http://www.qiagen.com/us/products/genes%20and%20pathways/data-analysis-center-
overview-page/, accessed: 10.10.14). Symbols in red are for those miRNAs that were up-
regulated following treatment with As2O3. A 4-fold boundary is marked on the scatter plot in 
both directions. N=1. 
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+ Table 9: MicroRNAs up regulated as a result of tolerated exposure to 1 µM As2O3 for 72 
hours and the associated in  s i l i co  predicted targets of the HDAC and HAT machinery.  
Key: 1 = predicted target, 0 = no predicted interactions.  
 
Mature ID Fold 
Regulati
on 
Gene DIAN
AmT 
miRa
nda 
miRD
B 
miR
Walk 
RNA2
2 
Targe
tscan 
SUM 
hsa-miR-
372 
15.6 PCAF 1 1 1 1 1 1 6 
hsa-miR-
206 
116 HDAC4 1 1 1 1 0 1 5 
hsa-miR-
373-3p 
104 HDAC4 1 1 0 1 1 1 5 
hsa-miR-
143-3p 
23.9 HDAC4 1 1 0 1 1 1 5 
hsa-miR-1 22.1 HDAC4 1 1 1 1 0 1 5 
hsa-miR-
138-5p 
4.07 HDAC5 1 1 0 1 0 1 4 
 
+ Table 10: Highest scoring predicted microRNA interactions with the target PCAF mRNA 
as generated by the miRWalk bioinformatic tool.  
Key: 1 = predicted target, 0 = no predicted interactions.  
 
Gene Mature 
ID 
DIANAmT miRanda miRDB miRWalk RNA22 Targetscan SUM 
PCAF 
 
hsa-miR-
372 
1 1 1 1 1 1 6 
hsa-miR-
106b 
1 1 1 1 1 1 6 
  
Sunniyat Rahman | Imperial College London  161 	  
4.7.2 – Summary: differential expression of microRNAs and bioinformatic assisted 
prediction of miR:HDAC/HAT interactions. 
 
Through the utility of a PCR array combined with bioinformatics it was possible to identify 
differentially expressed microRNAs and then predict miR:HDAC/HAT interactions. The results 
are summarised below:  
 
+ 26 microRNAs exhibit elevated expression after tolerated exposure to 1 µM As2O3 for 
72 hours (Fig. 22). 
+ 6 were predicted to interact with histone acetylation machinery (Table 8).  
+  All 6 programs predicted the PCAF mRNA as a potential target of miR-372 (Table 8). 
+  miR-106b was also identified as a potential attenuator of the PCAF mRNA (Table 9). 
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4.8 – Seeking an Inverse Correlation between the Expression of the MicroRNA 
and the Expression of its Target mRNA. 
 
MicroRNAs are small nucleotide sequences that often act as negative regulators of gene 
expression by binding to the 3’UTR of target mRNAs (Krol et al. 2010). Hence a simplified 
hypothesis would be that the expression of a particular microRNA would be inversely correlated 
to that of its target. This particular relationship was investigated in the context of miR-372 and 
miR106b with the potential PCAF mRNA target.  
 
4.8.1 – As2O3 exposure leads to a time-dependent increase in miR-372 expression and 
decrease in PCAF mRNA levels. 
 
To examine the possibility of miR-mediated attenuation mechanisms occurring after As2O3 
exposure, the relative abundance of PCAF mRNA, miR372 and miR106b was validated by qRT-
PCR. Specifically there was a focus to determine the relationship between expression of the 
effector microRNA and its target. There was no significant change in PCAF mRNA levels after a 
3-hour exposure to both tolerated and toxic doses of As2O3 (Fig. 4.23, A). After a 72-hour 
exposure PCAF mRNA levels were significantly decreased at both tolerated and toxic As2O3 
exposures (Fig. 4.23, B). After 3-hours a significant reduction in miR-372 levels with tolerated 5 
µM As2O3 exposure and toxic 80 µM As2O3 (Fig. 4.23, C). In contrast, after a 72-hour exposure 
miR-372 expression is significantly elevated at the tolerated 1 µM As2O3 exposure and although 
not statistically significant, an elevation at the toxic 5 µM As2O3 exposure is observed too (Fig. 
4.23, D). MiR-106b expression was significantly reduced at 3 hours, with no significant changes 
at 72 hours (Fig. 4.23, E, F).  
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+ Figure 4.23: MiR372, miR106b and PCAF mRNA expression levels as quantified by 
qRT-PCR in UROtsa cells exposed to tolerated and toxic exposure of As2O3 at 3 hours 
and 72 hours.  
 (A, B) PCAF mRNA levels after exposure to tolerated and toxic dosages of As2O3 at 3 hours 
and 72 hours. Data presented as expression ratios from the standard curve relative 
quantification method. (C, D, E, F) miR372 and miR106b-5p levels after exposure to 
tolerated and toxic dosages of As2O3 at 3 hours and 72 hours. Data was presented as fold 
change and quantified via the Pfaffl method. Bars shown are ± SD. * p < 0.05, N = 3. 
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4.8.2 – Summary: seeking an inverse correlation between the expression of the 
microRNA and the expression of its target. 
 
The expression levels of miR372, 106b and the potential target PCAF were evaluated to seek 
inverse correlations as a potential marker for targeted interactions. The results are summarised 
below:  
 
+ The expression level of miR372 and PCAF are inversely correlated at 72 hours (Fig. 
4.23, A, B, C, D).  
+ The expression profile of miR106b was reduced at 3 hours, with no change at 72 hours 
(Fig 4.23, E, F).  
 
4.9 – Checking for MicroRNA-mediated Attenuation of Histone Modifying 
Enzymes and the Outcomes on Histone Acetylation. 
 
As an inverse relationship between the expression of miR372 and PCAF mRNA was identified at 
72 hours, further experiments were conducted to check for PCAF mRNA attenuation via the 
3’UTR. The impact of this attenuation on histone acetylation was also investigated.  
 
4.9.1 – A temporally dependent PCAF attenuation mechanism leads to global H3K9-
hypoacetylation after tolerated and toxic As2O3 exposure. 
 
UROtsa cells were transfected with a PCAF 3’UTR luciferase reporter and treated with tolerated 
and toxic dosages of As2O3. At the 3-hour time point after As2O3 exposure no significant 
binding occurred at the PCAF 3’UTR leading to no significant change in luminescence from the 
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luciferase reporter (Fig 4.24, A). At the 72-hour time-point a significant reduction in 
luminescence was observed after tolerated and toxic exposure (Fig. 4.24, B). This data suggests 
the PCAF mRNA is attenuated by a 3’UTR dependent mechanism and it is time-dependent due 
to the lack of attenuation at 3-hours.  
 
Global H3K9 acetylation levels were also investigated. A significant decrease was observed after 
a 3-hour exposure to 80 µM As2O3 (Fig. 4.24, C). No significant changes were noted for the 
tolerated exposure. At 72 hours, both the tolerated and toxic dosages led to hypoacetylation of 
H3K9 and this occurred together with PCAF 3’UTR attenuation (Fig. 4.24, D).  
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4.9.2 – Elevated HDAC2 expression potentially leads to global H3K9-hypoacetylation 
after a 3-hour toxic 80 µM As2O3 exposure. 
 
At 3 hours there was PCAF 3’UTR attenuation yet there was a reduction in H3K9 acetylation 
after a toxic 80 µM As2O3 exposure. To investigate the possibility that this is mediated through 
HDAC-dependent mechanism, the gene expression profiles of a number HDACs were 
investigated.  
 
UROtsa cells were exposed for 3 hours to 5 µM and 80 µM As2O3 dosages. The expression of 
HDAC1, 2 and 3 was investigated via qRT-PCR.  
 
+ Figure 4.24: PCAF 3’UTR attenuation assay and global H3K9 acetylation levels after 
tolerated and toxic As2O3 exposure in UROtsa cells.  
(A, B) UROtsa cells were transfected with a PCAF 3’UTR luciferase reporter and a control 
PPIA 3’UTR luciferase reporter in a separate plate. Both were treated with tolerated and toxic 
exposures of As2O3. Luminescence measurements were taken in a GloMax 96 Microplate 
Luminometer. Bars shown are ± SD. * p < 0.05, N = 6. Luciferase activity was normalised to 
the PPIA 3’UTR luciferase reporter, on the second plate. A reference to the normalisation 
details can be found on page 88. (C, D) UROtsa cells were exposed to tolerated and toxic 
dosages of As2O3 followed by histone extraction and immunoblotting. Graphs shown were 
calculated by a densitometry analysis. Bars shown are ± SD. * p < 0.05, N = 3 
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No significant change in HDAC1 and 3 expression levels are observed at 3 hours (Fig. 4.25, A, 
B). HDAC2 expression levels are significantly elevated at 3 hours after a toxic exposure to 80 µM 
As2O3 (Fig. 4.25, C). This is inverted at 72 hours where the HDAC2 expression levels are 
significantly reduced at the toxic exposure (Fig. 4.25, D). This suggests that the H3K9 
hypoacetylation observed after a toxic exposure to As2O3 at 3 hours is potentially driven by 
HDAC2 and is independent of the PCAF 3’UTR attenuation mechanism.  
 
4.9.3 – Summary: checking for microRNA mediated attenuation of histone modifying 
enzymes and the outcomes on histone acetylation. 
 
MicroRNA mediated attenuation of PCAF was evaluated by transfecting UROtsa cells with a 
PCAF 3’UTR luciferase reporter followed by As2O3 treatment. Global H3K9 acetylation was also 
evaluated to establish the impact of potential attenuation mechanisms. The results are 
summarised below:  
 
+ PCAF 3’UTR mediated attenuation occurs after tolerated and toxic exposure to As2O3 at 
72 hours only and this is likely to be microRNA-mediated (Fig. 4.24).  
+ H3K9 is hypo-acetylated at 72 hours after tolerated and toxic exposure to As2O3 (Fig. 
4.24, D). 
+ Toxic exposure to As2O3 leads to H3K9 hypoacetylation at 3 hours (Fig. 4.24, C).  
+ Figure 4.25: HDAC1, 2 and 3 mRNA expression levels as quantified by qRT-PCR in 
UROtsa cells.  
(A, B, C) HDAC1, 3 and 2 expression levels at 3 hours after exposure to 5 µM and 80 µM 
As2O3. (D) HDAC2 mRNA expression level at 72 hours after exposure to 5 µM and 80 µM 
As2O3. Bars shown are ± SD. * p < 0.05, N = 3 
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+ Toxic exposure to As2O3 potentially leads to HDAC2 driven H3K9 hypoacetylation at 3 
hours (Fig. 4.25, C).  
+ H3K9 hypoacetylation after toxic exposure to As2O3 at 3 hours is likely to be 
independent of microRNA mediated attenuation mechanisms.  
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- 5 - 
Discussions 
 
5.1 – Summary  
 
This thesis describes two studies designed to explore the core hypothesis that tolerated As2O3 
exposure leads to disruptions in HDACs, HATs, and miRs, which contribute to aberrations in 
histone acetylation and gene expression favouring cellular transformation. Whilst the first study 
examined histone acetylation explicitly, the second study focused on identifying novel “crosstalk” 
mechanisms between microRNAs and histone modifying enzymes, which ultimately impinge on 
histone acetylation.  
 
A number assays identified concentrations of As2O3 that were either tolerated (0.5 µM) or toxic 
(2.5 µM) to HEK293T cells following exposure for 72 hours. Exposure of cells to a tolerated 
concentration of As2O3 led to increased cellular survival, anchorage-independent colony 
formation, cell-cycle progression and proliferation. At the same time, these cells maintained 
nominal mitochondrial function and intracellular function as determined using a number of 
markers, including but not limited to caspase activation, P53 stabilisation and PARP cleavage. 
This tolerated and toxic exposure led to changes in the HDAC2/PCAF mRNA expression ratio 
and as both of these enzymes target the H3K9 residue, As2O3 exposure gave rise to temporally 
dependent changes in global H3K9 acetylation. Global H3K9 hypoacetylation occurred at 72 
hours for both tolerated and toxic exposures, giving poor mechanistic differentiation between 
these separated cellular outcomes. Further study led to the identification of PCAF recruitment, 
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E2F1 binding and H3K9 acetylation at the FOS proto-oncogenic promoter leading to an 
elevation in FOS mRNA levels at the tolerated concentration compared to the untreated control. 
This assembly of protein factors at the FOS promoter did not occur at the toxic concentration, 
and there was no significant induction of the gene and no cellular survival. Hence at the 
promoter-specific level it is possible to identify an epigenetic mechanism with a trajectory of 
cellular transformation over toxicity. These assays collectively address the aims of the first study.  
 
Using the human urothelial UROtsa cell line, tolerated and toxic concentrations of As2O3 were 
identified for two exposure durations – 3 hours and 72 hours. A limited repertoire of assays was 
used to identify these exposures focusing on PARP cleavage analysis, cell-cycle progression and 
cellular proliferation. Nevertheless, 5 µM and 80 µM As2O3 concentrations were considered 
tolerated and toxic respectively at a 3-hour exposure. At 72 hours 1 µM and 5 µM As2O3 were 
considered tolerated and toxic respectively. Using the longer exposure duration and a tolerated 
concentration of As2O3, a broad PCR screen was utilised to quantify the differential expression 
of microRNAs that have significant roles in human cancers. Whilst microRNAs may have lots of 
different targets within the cell, this second study focused on identifying microRNA-mediated 
attenuation of histone modifying enzymes. Bioinformatic analysis of the differentially expressed 
miRs, of which there were 26, allowed for the identification of 6 predicted interactions with the 
histone acetylation machinery. Two of the six predicted interactions impinged on the histone 
acetyltransferase PCAF. The miRs predicted to interact were miR372 and miR106-b. Both were 
chosen for further analysis, as these were not previously reported to interact with PCAF. This 
not only helped to narrow the research profile of this study, but at the time it was considered a 
valuable avenue to explore given role of PCAF in the prior study. By utilising qRT-PCR it was 
shown that miR372 and PCAF were inversely correlated at 72 hours for both tolerated and toxic 
exposures, giving rise to the possibility of an attenuation mechanism. Further analysis of cells 
transfected with a PCAF 3’UTR luciferase reporter, demonstrated a decrease in luminescence, 
suggesting that a microRNA was binding to the PCAF 3’UTR leading to its degradation. 
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Combined with the global H3K9 hypoacetylation observed in UROtsa cells at 72 hours at both 
tolerated and toxic doses, it became clear that this microRNA-mediated attenuation of PCAF had 
consequences on global H3K9 acetylation. This study did fall short of connecting this 
attenuation mechanism specifically to miR372, due the absence of a combined anti-miR372 
siRNA and PCAF 3’UTR luciferase reporter assay. Nevertheless, it is worth postulating that 
miR372 attenuates PCAF after As2O3 exposure for the purpose of future investigations. These 
experiments address the aims of the second study. A summary of the mechanistic data generated 
in this thesis is shown below (Fig. 5.1).  
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+ Figure 5.1: Global and promoter-specific mechanisms in As2O3-induced cellular 
transformation.  
Schematic mechanism outlining HDAC2 and PCAF mediated global acetylation changes in 
H3K9 followed by subsequent E2F1 recruitment to the FOS promoter. Tolerated and toxic 
dosages lead to separated mechanistic outcomes after 72 hours of exposure where a toxic 
dosage leads to cytotoxicity and chromatin condensation, whilst tolerated exposure leads to 
continued FOS expression. Tolerated and toxic dosages are abbreviated to the following: 
“Tol” for 0.5 µM As2O3, “Tox.p” (toxic pathway) for 2.5 µM As2O3 at 3 hours and “Tox” for 
2.5 µM As2O3 at ≥ 72 hours in this schematic. “Tol” and “Tox” for the miR372 are 1 µM and 
5 µM As2O3 respectively.  
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5.2 – The Concentration Selection Framework.  	  
Central to this course of research was to identify As2O3-induced epigenetic perturbations, with an 
awareness of the associated physiological outcomes of these changes. An in vitro framework was 
used to choose a tolerated concentration of As2O3 prior to epigenetic characterisation; this would 
ensure epigenetic information is appropriately contextualised with a given outcome.  
 
This framework was designed to identify suitable concentrations and durations of exposure to 
use when investigating the epigenetic events contributing to arsenic-induced carcinogenesis. 
Whilst many studies have investigated mechanisms of arsenic-induced carcinogenesis in cellular 
models, a wide range of concentrations have been used, such as 0.001 – 10 µM for As(III) and 
0.05 – 3 µM for MMA(III) (Arrigo 1983; Jensen et al. 2008; J. Li et al. 2003; Chu et al. 2011; Jo et 
al. 2009). The key rationale behind some of these concentrations is that 1 – 10 µM As(III) 
equates to a real-world plasma level of 250 – 1000 µg/L, associated with arsenic-induced illnesses 
(X. Zhou et al. 2008). 
 
Some studies have focused on using low concentrations and longer exposures. For example, 
human keratinocytes (HaCaT) treated with 0.5 µM and 1 µM arsenite for 20 passages allowed for 
the detection of chromosomal abnormalities (Chien et al. 2004). Treatment of human 
uroepithelial cells (SV-HUC-1) with a variety of concentrations and arsenic species for 25 
passages led to the identification of 11 hypermethylated genes, whilst treatment of UROtsa cells 
with 50 nM MMA(III) for 12 weeks revealed global hypoacetylation of histones (Chien et al. 
2004; Su et al. 2006; Ge et al. 2013). These studies were anchored in cellular transformation as an 
endpoint, as shown by cellular aggregation assays, cellular size measurements, anchorage 
independent growth, colony formation and tumour formation on injection of arsenic treated cells 
into nude mice.  
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There is no fixed paradigm of cellular transformation assays to use when constructing a 
concentration selection framework for such studies. Rather than focusing purely on cellular 
transformation, this thesis utilised a two-component framework in which toxic exposures (pro-
anticancer) were distinguished from those associated with tolerance and transformation (pro-
cancer). This approach allowed for a scientific contribution to the debate regarding the 
paradoxical effects of arsenic trioxide as both a potent anticancer agent and a carcinogen. Whilst 
it may be effective for some malignancies, As2O3 treatment may not be appropriate for kidney 
and urothelial cancers as studies reported here have shown tolerated exposures may lead to 
cellular transformation rather than cell death. The dichotomy of arsenicals as potent cancer 
treatments and as cancer-causing compounds is still under intense investigation; hence any 
insights into epigenetic aberrations leading to toxicity over tolerance and vice versa would be 
advantageous.  
 
5.3 – Cellular Physiological Outcomes After Tolerated and Toxic As2O3 Exposure.  
 
One of the clearest outcomes of toxic As2O3 exposure is caspase activation and cell death. 
Arsenic trioxide-induced cell death is well studied as its a very effective chemotherapeutic 
particularly in the treatment of leukaemia (Soignet et al. 1998). Exposure of cells to 6.25 µM 
As2O3 leads to the activation of a number of caspases including Caspase-3, -7 and -9, PARP 
cleavage and cell death in pancreatic cancer cells (X. Li et al. 2003). A similar response was 
observed in this study with a toxic 2.5 µM As2O3 exposure for 72 hours, resulting in an increase 
in Caspase-3, -7, -8 activity, PARP cleavage and cell death. This suggested that the HEK293T cell 
line had a nominal apoptotic response to a toxic exposure of As2O3. At a tolerated exposure, 
there was no significant increase in Caspase-3 and -7 activation, rather a significant reduction was 
observed at this concentration. This physiological effect is a favourable outcome for cellular 
survival and transformation.  
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Although a significant reduction in Caspase-3 activity following arsenic exposure has not been 
reported before, one study investigated apoptotic mechanisms in normal human keratinocytes 
(NHK) using both low and higher concentrations of As2O3. This study demonstrated that at 0.5 
– 32 nM As2O3 exposure there was no change in Caspase-3 activation compared to the untreated 
control, whereas higher exposure of 0.5 µM - 10 µM As2O3 leads to Caspase-3 activation and 
cell-cycle arrest at the G2/M checkpoint (Bi et al. 2010). However, the role of Caspase-3 in 
As2O3-induced cell death has been shown to be less important than previously expected. In the 
study by Scholz et al. they demonstrated the presence of a caspase-independent necrotic cell 
death pathway that propagates via the mitochondria as a result of As2O3 exposure (Scholz et al. 
2005). Similarly in the present study, Caspase-3 processing and activation are weak after As2O3 
exposure and z-VAD-fmk, a broad-spectrum inhibitor of caspases did not inhibit cell death. This 
suggests that an alternative caspase-independent cell death pathway is available, but in the case of 
a tolerated exposure, neither the core-apoptotic or necrotic pathways are utilised by the exposed 
cells to initiate cell death and avoid cellular transformation.  
 
An increase in Caspase-8 activation is also observed at the tolerated concentration, yet the data 
suggests that this is not sufficient to continue the cascade further to Caspase-3 activation, PARP 
cleavage and cell death. Prior research has demonstrated that As2O3-induced apoptosis does 
indeed occur via the FAS/FAS ligand pathway (G.-F. Yang et al. 2010; Liao et al. 2004). 
Although the initiator Caspase-8 is upstream to the effector Caspase-3 in this pathway, it has 
been shown that moderate activation of Caspase-8 can occur without further activation of 
Caspase-3 – specifically after a 48-hour exposure to 1 µM sodium arsenite in normal human 
keratinocytes (Liao et al. 2004). Together these findings suggest that tolerated As2O3 exposure 
leads to a partial apoptotic response that is not sufficient to initiate cell death via the executioner 
activity of Caspase-3, hence cells remain alive in the presence of As2O3.  
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Tied intimately with caspase activation is mitochondrial dysfunction. As expected, a tolerated 0.5 
µM As2O3 exposure does not lead to mitochondrial depolarisation or the generation of 
mitochondrial reactive oxygen species. Therefore at the tolerated exposure mitochondrial 
function is nominal. In contrast, the toxic 2.5 µM As2O3 exposure significantly increases 
mitochondrial ROS in addition to mitochondrial membrane depolarisation. Under this 
circumstance mitochondrial ROS and depolarisation led to cell death. In the review by Shi et al., 
the two prevailing ideas regarding the source of arsenic-induced ROS are that it originates from 
the mitochondria, as arsenic-induced intracellular ROS can be diminished by treatment with 
rotenone and inhibition of NADH oxidase or from arsenic-derived intermediates that originate 
from the metabolic processing of the toxicant (H. Shi et al. 2004). Arsenic-induced ROS is 
believed to contribute to both carcinogenicity and toxicity. In the context of carcinogenicity, 
normal murine keratinocytes (HEL30) exposed to 10 µM and 50 µM sodium arsenite 
demonstrate elevated proliferation via interleukin-1α, a growth factor which is transcribed with 
the assistance of redox sensitive transcription factors AP-1 and NFκB (Corsini et al. 1999). With 
regards to toxicity, exposure of human hepatocellular carcinoma cells to 2.5 – 50 µM As2O3 leads 
to the increased induction of ROS within 24 hours, DNA damage as measured by comet assay, 
and cytotoxicity (Alarifi et al. 2013). As the data presented in this thesis focused purely on 
measuring the mitochondrial ROS, it does not contribute to the debate regarding the origin of 
the ROS, however it does demonstrate that at the tolerated exposure, an elevation of 
mitochondrial ROS is not required for cellular transformation.  
 
The remaining cellular physiological outcomes after As2O3 exposure were measures of cellular 
transformation including cellular survival, proliferation, colony formation in soft agar and cell 
cycle analysis. Similar to this thesis, some studies have utilised an XTT assay, which is similar to 
the WST-1 assay to measure cellular proliferation, clonogenic assays to investigate cellular 
survival and the soft-agar assay to examine anchorage-independent growth. Human keratinocytes 
exposure to 1 µM arsenic for 72 hours led to an increase in cellular proliferation as demonstrated 
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by XTT assay and BrdU assimilation (C.-H. Lee et al. 2011). A significant proliferative increase 
was observed after tolerated 0.5 µM As2O3 exposure in the HEK293T cell line after 1 week. 
Although this is a longer exposure to the mentioned study, similar results were observed when 
using the UROtsa cell line, where a 1 µM As2O3 exposure for 72 hours also resulted in a 
significant increase in proliferation. HaCaT cells exposed to 100 nM arsenite for 20 weeks 
showed an increase in soft agar colony formation, and the increased expression of 
metalloproteinase-9 an enzyme crucial in assisting the ability of cells to invade the extra-cellular 
matrix (Sun et al. 2009). Human airway epithelial (NuLi-1) cells exposed to 1 µM As2O3 for 34 
weeks also exhibited anchorage-independent growth (Y. Liu et al. 2014). These findings agree 
well with what is presented in this thesis, as HEK293T cells exposed for 12 weeks to 0.5 µM 
As2O3 exhibited anchorage-independent growth with significantly more colonies than passage 
matched untreated controls.  
 
The data presented in this thesis regarding cellular proliferation and the magnitude of arsenic 
exposure can be classified as a hormetic response due to the non-linear relationship between the 
variables (Cook & Calabrese 2006). It is hypothesised that a hormesis signalling circuit is 
structured so that the a variable – such as cellular proliferation, can be altered via a sensor protein 
that can detect the environmental stress and recruit transcription factors to specific genes to 
modulate a physiological response (Q. Zhang et al. 2008). In the case of a toxicant such as 
arsenic, this response may counteract the toxic response seen at higher doses. Some recent 
research using C. elegans suggests that a hormetic response following arsenic exposure is related to 
a transient increase in ROS, as the use of a ROS scavenger was able to attenuate a C. elegans 
survival response (Schmeisser et al. 2013). Schmeisser et al., also reported an increased 
expression of mitochondrial and stress response genes following a 48 hour 100 nM arsenite 
exposure. Furthermore, 67.1% of the genes also had transcription factor consensus motifs for 
SKN-1, an orthologue of NRF2. Zhang et al., state that NRF2 can bind to antioxidant response 
elements which are situated in the promoter regions of many antioxidant genes allowing for 
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elevated antioxidant capacity and the restoration of a redox equilibrium (Q. Zhang et al. 2008). It 
is possible that the mitochondrial ROS profile seen at 72 hours following a 0.5 µM As2O3 
presented in this thesis is actually the restored redox equilibrium. Interrogation at an earlier time 
point may have been able to capture the ROS levels in flux prior to restoration. The increased 
expression of PGC1-α, NRF1 and mtTFA all of which have been implicated in mitochondrial 
biogenesis and function has been observed in biopsies collected from patients with arsenic-
induced skin cancers (C.-H. Lee et al. 2011). Chih-Hung Lee et al., also demonstrate a similar 
effect in primary keratinocytes treated with arsenic at concentrations less that 1 µM, along with 
an elevation in mitochondrial biogenesis, intracellular ATP levels and mitochondrial oxygen 
consumption rate all of which contribute to aberrant proliferation. 
 
Tolerated exposure to As2O3 led to a redistributed cell cycle, with significant increases in the 
proportion of cells progressing through the G1/S and G2/M checkpoints for both HEK293T 
and UROtsa cell lines. This tessellates with existing evidence that demonstrates how low dose 
(0.01 – 1 µM) As2O3 exposure leads to cell cycle progression in normal breast epithelial cells 
(MCF10A) via the expression of CDC6 and cyclin D1 (Y. Liu et al. 2010). There is also emerging 
evidence to suggest that cells that are in late G1 or S-phase of the cell cycle are more sensitive to 
MMA(III)-induced chromosomal aberrations compared to cells that are in the G0 or early G1-
phases (Kligerman et al. 2010). This is due to the presence of efficient base excision repair 
mechanisms in the initial growth phase of the cell cycle. Prior research with the UROtsa cell line 
was also able to identify elevated S-phase cellular populations with a 2 µM and 4 µM 
iAs3+exposure for 72 hours (Simeonova et al. 2000). This occurred in concert with an associated 
decrease in the G0/G1 phase populations, which was also found in the present study. Whilst 
these aberrations in the cell cycle assist in cellular transformation, a redistributed cell cycle has 
also been reported in cancer cell lines exposed to 6.25 µM As2O3 in the context of toxicity (X. Li 
et al. 2004). In this study human pancreatic, colonic and breast cancer cell lines all demonstrated 
an increase in the sub-G1 apoptotic population after a 72-hour exposure to 6.25 µM As2O3 and a 
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reduction in cellular survival and viability. This elevation in the sub-G1 population is also 
observed after a toxic exposure to As2O3 in HEK293T and UROtsa cell lines.  
 
Another interpretation of the cell cycle data is the possibility of a transient arsenic-induced cell 
cycle pause leading to acute synchronisation followed by progression through the cell cycle. 
When cells are synchronised by serum starvation and then released, an increase in cells occupying 
S and G2/M phases can be observed towards the latter end of the doubling time (M. Chen et al. 
2012). The doubling times of HEK293T and UROtsa cells are 24 hours and 30 hours 
respectively (http://www.lgcstandards-atcc.org/products/all/ACS-
4500.aspx?geo_country=gb#specifications, accessed 07.2015) (Rossi et al. 2001). Given that the 
cell cycle data is at 72 hours, this should have allowed for 3 complete cycles for the HEK293T 
cells and 2.4 cycles for the UROtsa cells. So with the UROtsa cells at least, the accumulation of 
cells in S and G2/M phases may represent the latter 0.6 of the cycle, if arsenic-induced cell cycle 
synchrony occurred. Whilst this remains a possibility this is difficult to corroborate without data 
at multiple time points, and indeed this may be a consideration for future investigations. There is 
some data to suggest that arsenic exposure leads to cell cycle arrest in immortalised human 
fibroblasts and that exit from cell cycle arrest at the G2/M checkpoint is contingent on a p53-
mediated response(McNeely et al. 2006). Cells negative for p53, exhibited reduced kinetics 
through the G2/M checkpoint. In addition to pausing, arsenic-induced stretching of the cell 
cycle period has been observed in human myeloid leukaemia cells treated with 5 µM sodium 
arsenite, where progression through each checkpoint takes longer, during the observation period 
of 24 to 48 hours post-treatment (McCollum et al. 2005).  
 
If acute synchrony were to occur, such evidence should be observable in immediately after 
treatment. Human TK6 lymphoblastoid cells exposure to low level arsenic trioxide, 0.1 µM – 5 
µM for 24 hours, did not lead to any significant changes in the cell-cycle distribution compared 
with untreated controls, with only the 5 µM exposure generating an increase in G2/M, but not at 
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a statistically significant level. The authors suggest that partial synchrony is not a physiological 
response to As2O3 exposure (Danaee et al. 2004).  
 
Interestingly accumulation cells within the S and G2/M phases of the cell cycle has also been 
observed in cells undergoing apoptosis, in contrast to the data presented in this thesis. Acute 
promyeolytic leukemia (NB4-R1) cells exposed to 25 µM tetra-arsenic tetra-sulphide (As4S4), 
demonstrated a gradual increase in the percentage of cells occupying S and G2/M phases of the 
cell cycle, through measurements taken at T=0 hours, T=24 hours and T=48 hours (Y. Wang et 
al. 2015). These cells exhibited PARP cleavage, Caspase-3 cleavage, apoptotic cell death and 
internucleosomal DNA fragmentation. Whilst HEK293T and UROtsa cells treated with tolerated 
As2O3 did lead to an accumulation of cells in the S and G2/M phases of the cell cycle, the WST-
1 proliferation assay demonstrated that these cells proliferate faster than untreated controls and 
do not undergo apoptosis.  
 
An additional factor that may affect the cellular response to As2O3 exposure is the transport of 
the toxicant into the cellular environment and its metabolic processing. A number of active and 
passive transporters are involved in the influx and efflux of arsenicals depending on its speciation 
and methylation state (Zangi & Filella 2012). Arsenic trioxide transport is primarily facilitated by 
aquaglycoporins, AQP 3, 7, 9 and 10, glucose permeases, GLUT1, GLUT2 and GLUT5 and 
organic anion transporting polypeptides, OATPB and OATPC (Maciaszczyk-Dziubinska et al. 
2012). One of the better-characterised influx mechanisms is the uptake of As2O3 via AQP9. Site-
directed mutagenesis of AQP9 affected the uptake of glycerol and As2O3 equally, suggesting that 
the translocation of both compounds is potentially via the same pathway (Porquet & Filella 2007; 
Z. Liu et al. 2004). Although many aquaporins are bidirectional transporters As2O3 can be 
methylated by AS3MT and SAM, leading to the formation of additional metabolites that are 
exported via glucose permeases and ABC transporters with the latter involved in the efflux of 
glutathione-S-conjugated forms of arsenic (Maciaszczyk-Dziubinska et al. 2012). The levels of 
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these proteins were not explicitly analysed in the context of this thesis, however a search through 
publically available gene expression data sets pertaining to the HEK293T and UROtsa cell lines 
(HEK293T – hhttps://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-21092/, UROtsa – 
https://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-26828/) allows one to comment 
on As2O3 assimilation. Whilst the expression of most arsenic compatible transporters in the 
HEK293T cell line was absent bar GLUT1, UROtsa cells were found to express AQP3, GLUT1 
and GLUT5, suggesting that more influx and efflux mechanisms are available to UROtsa cells. 
Furthermore, both cells lines readily express AS3MT and glutathione synthetase – GSS, 
suggesting that biotransformation of As2O3 is possible for both cell lines. A comparison between 
the two gene expression arrays also shows that GSS expression in the UROtsa cell line is 1.24 
fold greater than in HEK293T cells, which is particularly significant as the depletion of 
glutathione by buthionine sulphoximine (BSO) leads to an IC50 drop from 100 µM As(III) to 15 
µM As(III) in UROtsa cells (Bredfeldt et al. 2004). The enhanced transport options and 
metabolic capacity of the UROtsa cell line may help to explain why these cells can tolerate As2O3 
more so than the HEK293T cell line in the present study.  
 
5.4 – Tolerated and Toxic As2O3 Exposure Affects Global Histone Acetylation.  
 
Using tolerated and toxic As2O3 exposures this thesis reports temporally sensitive changes in 
global H3K9, H4K12 and H4K16 acetylation in both HEK293T and UROtsa cell lines. 
Significant findings include the global hypoacetylation of H3K9 in both HEK293T and UROtsa 
cells exposed to tolerated and toxic As2O3 concentrations after a 72 hour exposure. Global 
H4K16 hypoacetylation is also observed in the HEK293T cell line after exposure to both 0.5 µM 
and 2.5 µM As2O3 exposures at 72 hours. There is also a temporal component to the findings as 
a shorter 3-hour exposure to 0.5 µM and 2.5 µM As2O3 led to global H3K9 and H4K12 
hyperacetylation and whilst the former residue became hypo-acetylated, the latter became 
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nominal at 72-hours. Prior research has identified histone acetylation changes in vitro and in vivo in 
response to arsenic exposure. Some molecular epidemiology studies have also been successful in 
identifying histone post-translational modifications as a result of arsenic exposure. The observed 
reduction of H4K16 acetylation presented in this thesis is in concert with previous research that 
showed H4K16 hypoacetylation after exposure to 3 mM As2O3 and 1 mM MMA(III) (Jo et al. 
2009). A distinction between the aforementioned study and the present thesis is that the 
exposure period of 7 days was cytotoxic for both concentrations, whereas the 0.5 µM As2O3 
exposure used for 72 hours in HEK293T cells was not toxic. Notably, this exposure still gave rise 
to H4K16 hypoacetylation. A follow up study utilised a tolerated dosage of 1 µM As(III) to 
expose UROtsa cells for 7 days, which revealed a reduction in global H4K16 acetylation via 
quantitative mass spectrometry (Chu et al. 2011). In this example, global H4K16 hypoacetylation 
occurred in the context of tolerance rather than toxicity, demonstrating in light of the previous 
study the challenges involved in characterising the significance of this event. Changes on this 
residue still require further investigation, as prior research from this group has demonstrated that 
H4K16 acetylation can protect cancer cells from cytotoxic drug treatment and may potentially be 
used as a marker of malignancy (Hajji et al. 2010). Under this circumstance loss of H4K16 
acetylation should lead to cytotoxicity, yet this does not occur at the tolerated dosage. A 
combinatorial approach through the examination of multiple global residues may provide a 
clearer indication of cellular outcome.  
 
Hepatocarcinoma cells (HepG2) exposed to 7.5 µM sodium arsenite for 24 hours showed a 
significant increase in global H3K9 acetylation (Ramirez et al. 2007). During this short exposure 
there was no cell death, similar to the data presented at 3 hours for HEK293T cells and for the 5 
µM As2O3 exposure of the UROtsa cell line. This suggests that initial arsenic exposure may 
hyper-acetylate H3K9. However, there is a temporally dependent switch in the profile of H3K9 
acetylation as a 72-hour exposure results in H3K9 hypoacetylation. This has also been 
demonstrated effectively in molecular epidemiology studies that have capitalised on the benefit of 
Sunniyat Rahman | Imperial College London  183 	  
taking samples from long exposures at environmentally relevant dosages. Samples from 40 
participants of a clinical trial in Bangladesh were used for urinary arsenic concentration 
measurements and regressed against global H3K9 acetylation levels of circulating peripheral 
blood mononuclear cells (Chervona et al. 2012). In this study it was found that urinary arsenic 
concentration and the acetylation of H3K9 were inversely correlated, similar to the relationship 
found in this thesis. Another study exposed pregnant mice to arsenic and examined the effect of 
exposure on embryonic development and genome-wide H3K9 acetylation (Cronican et al. 2013). 
Brain tissue examined from these exposed pups also demonstrated global H3K9 hypoacetylation 
and cognitive impairment in a first of its kind study to demonstrate the effects of prenatal arsenic 
exposure. It is unclear in these examples whether or not hypoacetylation of this residue is 
explicitly associated with cellular transformation, as long-term exposures have also led to H3K9 
hyperacetylation. Steel workers exposed to a variety of inhalable metallic compounds including 
arsenic, demonstrate H3K9 hyperacetylation in blood leukocytes in line with the number of years 
of employment (Cantone et al. 2011). These conflicting reports regarding the directionality of 
H3K9 acetylation and H4K16 acetylation demonstrate that global measurements may not be 
useful in delineating the separated outcomes of toxicity and tolerance. This is reflected in the data 
within this thesis, as tolerated and toxic dosages do not provide separated directions of 
acetylation on the residues examined.  
 
The global levels of modification of other residues were also examined for this thesis, although 
the small sample size does impose limitations on the interpretations of the findings. A dose-
dependent increase in H3S10 phosphorylation was observed at both 3 and 72-hour time points. 
Previous studies examining the impact of arsenic exposure on this residue have been conducted 
on short exposure durations. For example human diploid fibroblast WI-38 cells treated with 400 
µM sodium arsenite led to an increase in H3S10 phosphorylation over a number of time intervals 
between 10 minutes and 60 minutes. Similarly the JB6 mouse epidermal cell line Cl41 was 
exposed to 10 µM sodium arsenite for 15 to 240 minutes, which resulted in a time-dependent 
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increase of H3S10 phosphorylation for up to 60 minutes. This was then followed by a reduction 
for the remaining exposure duration (Z. He et al. 2003). These studies are insightful as they utilise 
normal cell lines, however the short exposures limit the possibility of associating elevated H3S10 
phosphorylation to cellular transformation. In the acute promyelocytic leukaemia NB4 cancer cell 
line, which is particularly sensitive to arsenic exposure, a dose-dependent increase in H3S10 
phosphorylation was also observed by interval exposures between 0.2 µM to 1.6 µM As2O3 (J. Li 
et al. 2002). Concentrations of 0.2 µM to 0.4 µM As2O3 did not induce cell death, but did lead to 
an increase in H3S10 phosphorylation, whilst higher dosages did lead to cell death with the same 
outcome. Whilst there is considerable supporting evidence to suggest that As2O3-induced H3S10 
phosphorylation is a genuine toxicant-induced occurrence, the significance of the event is 
unclear.  
 
H3K9 di-methylation was also examined after tolerated and toxic exposure to As2O3. At 3-hours 
there is an apparent dose-dependent increase and at 72 hours there is no significant difference 
between the untreated control and the tolerated exposure. A slight reduction after a toxic 
exposure is also reported. Again, given the small sample size of this experiment it is unclear 
whether or not histone methylation is effectively adjusted from arsenic exposure. There is also 
evidence to suggest arsenic exposure does not affect histone methylation. For example, HepG2 
carcinoma cells treated with 7.5 µM sodium arsenite for 24 hours showed no discernible impact 
on histone methylation across a number of lysines including, H3K4me(1,2,3), H3K9me(1,2,3), 
H4K29me3 and H3K27me3 and remains as one of the few studies that examined such a broad 
range of histone methylations (Ramirez et al. 2007). In contrast, exposure of human lung 
carcinoma A549 cells to 1 µM to 10 µM As(III) led to an increase of H3K9 di-methylation and a 
decrease in H3K27 tri-methylation (X. Zhou et al. 2009). This exposure was not cytotoxic, which 
is notable as a 2.5 µM As2O3 exposure for 72 hours led to a reduction in H3K9 di-methylation 
and cytotoxicity. Although this information alone is not sufficient to conclude that it as a 
protective mark, a similar study also introduced a normal human bronchial epithelial BEAS-2B 
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cell line and used exactly the exact same profile of arsenite trioxide exposure, which led to an 
increase in H3K9 di-methylation without cytotoxicity (X. Zhou et al. 2008). These findings in 
addition to those presented in the thesis provide indications that both phosphorylation and 
methylation events on histone tails may also play a role in arsenic-induced tolerance or toxicity.  
 
To date, there is insufficient data interrogating the reversibility of arsenic-induced histone post-
translational modifications. One study by Zhou et al., did attempt to address this issue, 
demonstrating that 1 µM arsenite exposure leads to H3K4 tri-methylation, which remains for 7 
days after toxicant removal before returning to nominal levels (X. Zhou et al. 2009). In the 
present study, HEK293T cells were exposed for 72 hours and then allowed to rest in fresh 
growth medium in the absence of the toxicant for a further 72 hours. The acetylation status of 
H3K9, H4K12 and H4K16 were all examined. Hypoacetylation of H3K9 and H4K16 both 
appeared to normalise after the rest period, this suggested that the arsenic-induced histone 
acetylation changes are reversible. H4K12 acetylation was nominal at 72 hours and this also 
remained static after the rest period. Understanding the potential for reversibility is considered a 
fundamental cornerstone in the assessement of environmentally derived deleterious epigenetic 
events (Reamon-Buettner et al. 2008; McGowan & Szyf 2010).  
 
Given the disruptions seen the cell cycle in both HEK293T and UROtsa cells, it is worth 
discussing the intrinsic relationship between the cell cycle and histone organisation, as effective 
DNA replication involves the cyclical disruption of chromatin (Bannister & Kouzarides 2011). 
Faithful DNA replication leads to challenges on histone post-translational modification, 
particularly those that are involved in maintaining an established pattern of gene expression. This 
concept of epigenetic maintenance during the vulnerable time of DNA replication has led to the 
proposal of replicative stress, where environmentally derived perturbations during replication 
may contribute to aberrant epigenetic changes and genomic instability leading to carcinogenesis 
(Alabert & Groth 2012). Whilst there is evidence to suggest that global histone H4 
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monoacetylation and trimethylation levels alter during the cell cycle, a direct comparison between 
non-tumourigenic and leukaemia cells with similar doubling times, to account for cell cycle fluxes 
in histone PTMs demonstrated a global reduction in H4K16 acetylation in the tumourigenic cell 
line (Fraga et al. 2005). Moreover, this global hypoacetylation was confirmed in a comparison 
between normal tissues and primary tumours. Whilst a global reduction in H3K9 and H4K16 
acetylation was observed in the present study, further time points in addition to the 3 and 72 
hours used, may help to further corroborate that these arsenic-induced global histone acetylation 
changes are indeed due to the toxicant rather than cyclical effects tethered to the cell cycle.  
 
5.5 – Tolerated and Toxic As2O3 Exposure Alters the Expression of Enzymes 
Regulating Histone Acetylation.   
 
In addition to the aberrant arsenic-induced histone acetylation events reported, there is growing 
evidence that the enzymes involved in regulating these acetylation events are also disrupted by 
arsenic exposure. A prevailing hypothesis about arsenic is that it behaves as an apparent HDAC 
inhibitor (HDACi) and indeed there is evidence to support this. For example in hepatocarcinoma 
HepG2 cells, exposure to 7.5 µM, 10 µM and 15 µM sodium arsenite inhibited overall HDAC 
activity at a comparable intensity to the well documented HDACi trichostatin A (TSA) (Ramirez 
et al. 2007). Additionally in multiple myeloma NCI-H929 cells, exposure to 4 µM As2O3 also 
inhibited overall HDAC activity from cellular lysates (Qu et al. 2012). Whilst these studies helped 
motivate investigations into HDAC expression for this thesis, there is an important distinction to 
be made. The properties of HDAC inhibition demonstrated previously were in the context of 
arsenic as a therapeutic agent to induce cytotoxicity in cancer cell lines. Having said that, the 
latter study also investigated the treatment of NCI-H929 cells with As2O3 at a non-cytotoxic dose 
of 4 µM, after which no HDAC inhibition was observed (Qu et al. 2012).  
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In this thesis, the role of HDACs and HATs were investigated by first identifying the enzymes 
that are effective at adjusting the acetylation status of a particular lysine and secondly through the 
examination of HDAC/HAT expression. HDAC2 and PCAF were identified as regulators of 
H3K9 acetylation in HEK293T cells. Subsequent investigation into HDAC2 and PCAF mRNA 
levels by qRT-PCR, demonstrated that the initial increase in global H3K9 acetylation is 
potentially caused by an adjustment in the HDAC2 to PCAF expression ratio. The direction of 
this imbalance is inverted at the 72-hour time point, where at the tolerated exposure of 0.5 µM 
As2O3, HDAC2 expression is significantly elevated combined with a significant reduction in 
PCAF expression leading to global hypoacetylation of the H3K9 residue at the 72-hour time 
point in HEK293T cells.  
 
Although aberrant PCAF expression in the context of arsenic-induced carcinogenicity has not yet 
been documented, both PCAF and HDAC2 have been implicated in cancer. The role of PCAF is 
not definitive in carcinogenesis, but there is a possibility that PCAF has tumour suppressive 
properties (Zheng et al. 2013). Furthermore, loss of function mutations in the PCAF gene have 
been reported in epithelial cancers (Berdasco & Esteller 2010). Indeed if PCAF were exerting a 
tumour suppressive effect, the reduction in its expression observed after a 72-hour tolerated 
exposure could contribute to cellular transformation. However, due to the lack of studies utilising 
arsenicals in the investigation of PCAF expression and function, it may be suitable to examine 
wider functional data of this HAT in the context of cancer. There are complexities regarding the 
role of PCAF in cancers due to the presence of a functional duality within the enzyme. In its 
traditional role as a HAT, it is often found in transcriptional activation complexes. It has also 
been shown to degrade MDM2 via an intrinsic ubiquitin E3 ligase activity and thus help nuance 
p53 levels (Linares et al. 2007; Infante et al. 2014). PCAF can also directly target P53 at lysine 320 
after DNA damage to assist in repair (L. Liu et al. 1999). This may be significant in the context of 
arsenic-induced carcinogenesis, due to the previously discussed ROS-dependent DNA damage 
mechanisms at tolerated arsenic exposure. Thus the reduced expression of this enzyme reported 
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at 72 hours after a tolerated exposure, speculatively may forgive DNA damage without 
stimulating repair – an outcome assistive to cellular transformation.  
 
The expression levels of other HATs were also investigated in this thesis. Whilst 
HMOF/MYST1 expression was not significantly elevated, there was an indicative increase at 
both tolerated and toxic exposures at 72 hours. Researchers were able to show using UROtsa 
cells exposed to 1 µM – 10 µM As(III) and 0.3 µM – 3 µM MMA(III), that HMOF expression 
was required for cellular viability in the presence of the As(III) and MMA(III) (Jo et al. 2009). 
The increase observed may contribute to cellular survival, but it is unclear as to why the 
indicative increase occurs at both tolerated and toxic exposures and also why at both exposures 
PCAF expression is reduced. This lack of dosage-specific directionality makes PCAF expression 
alone a relatively poor biomarker in arsenic-induced cellular transformation.  
 
Bi-directional mRNA expression of HDAC2 has been reported previously in human prostate 
epithelial RWPE-1 cells exposed for 6 months to 100 pg/mL As (Treas et al. 2013). This 
exposure led to the induction of HDAC2, 1, 3, and 7. But when the dosage was increased to 100 
ng/mL As this led to a significant decrease in HDAC2 and 7 expression. Both exposures were 
tolerated; suggesting that direction of HDAC2 expression does not dictate an outcome between 
tolerance and toxicity. Although a bi-directional expression profile is also reported in this thesis 
due to an initial reduction at 3-hours, this is subsequently increased after a tolerated 72-hour 
exposure only. HDAC2 expression is also believed to be instrumental in the maintenance of 
urothelial cancers as a gene expression profiling study of 18 urothelial cancer cell lines was able 
to identify the upregulation of HDAC2 in 11 of these cell lines compared to normal uroepithelial 
controls (Niegisch et al. 2013). The effectiveness of HDAC2 as a marker for either maintenance 
or as a treatment response was still debated in the concluding segments, as reported mRNA and 
proteins levels did not always match and treatment with the pan-HDACi suberoylanilide 
hydroxamic acid (SAHA) had mixed outcomes. Yet, the apparent specificity of HDAC2 
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overexpression at the tolerated exposure in this thesis cannot be ignored. HDAC2 is believed to 
interact with cell cycle components, where siRNA-mediated silencing of HDAC2, inhibits 
progression through the G1/S checkpoint in hepatocarcinoma cells (Noh et al. 2011). This is 
particularly significant as tolerated As2O3 exposure led to a redistributed cell cycle to favour 
cellular proliferation by passing both G1/S and G2/M checkpoints in both cell lines.  
 
The potential role of other HDACs in arsenic-induced carcinogenesis has been investigated 
further in UROtsa cells exposed for 12 weeks to 50 nM MMA(III) (Ge et al. 2013). The mRNA 
expression levels of HDAC1, 3, 4, 5, 7 and 9 were increased along with a time-dependent 
increase in HDAC activity at 4, 8 and 12 weeks of exposure. In contrast, a 72-hour exposure in 
HEK293T cells results in a significant decrease in HDAC1, 3 and 4 expression at the tolerated 
concentration. Treatment with the HDACi SAHA in the aforementioned study resulted in a 
significant reduction in HDAC2, 4, 5, 6, 7 and 8 mRNA levels, reduction in overall HDAC 
activity and the prevention of colony formation in soft-agar.  
 
By reviewing existing literature along with the evidence presented in this thesis, it is clear that 
HDAC and HAT expression profiles alone are not entirely reliable biomarkers of either cellular 
transformation or toxicity. This is particularly due to the presence of conflicting reports regarding 
the direction of expression and the associated outcomes.  
 
5.6 – Elucidating Epigenetic Aberrations at the Promoter-specific Level Helps to 
Clarify Cellular Outcomes in As2O3 Exposure.  
 
Measurement of global histone acetylation profiles and the expression levels of histone 
modifying enzymes alone did not appear to be effective in separating between arsenic-induced 
tolerance and toxicity. As a result there was a requirement to unify the data onto gene promoters. 
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This was made possible by chromatin immunoprecipitation as it brought the global observations 
of histone hypoacetylation and the aberrant expression profiles of PCAF and HDAC2 into the 
transcriptional control space.  
 
Some studies have characterised histone aberrations at the promoter specific level after low-dose 
arsenic exposure. For example, UROtsa cells transformed by a 52-week exposure to 1 µM As(III) 
and 50 nM MMA(III) led to the differential histone H3 hypo- and hyperacetylation of >50 gene 
promoters (Jensen et al. 2008). A number of these genes including DBC1, FAM83A, ZSCAN12 
and C1QTNF6 found to have hypo-acetylated histone H3 at the promoter regions, exhibited a 
reduction in expression. A follow up study using the same cell lines, identified hyperacetylation 
of histone H3 at the WNT5A gene, which is found overexpressed in three bladder cancer cell 
lines (Jensen et al. 2009). UROtsa cells transformed by sodium arsenite exposure overexpress the 
MT3 gene, which is expressed highly in urothelial cancers (Somji et al. 2011). A similar induction 
of the MT3 gene can be achieved with the HDACi MT-275, which results in an increase in H4 
acetylation at the gene promoter. Similar interactions have also been reported in the context of 
toxicity. Acute promyelocytic leukemia NB4 cells exposed to 1.6 µM As2O3 show increased 
phosphoacetylation of histone H3 at the CASPASE10 gene locus, leading to increased 
expression and apoptosis (J. Li et al. 2002). These studies demonstrate the role of dysfunctional 
arsenic-induced histone acetylation events in the regulation of genes critical in cellular 
transformation. However, histone acetylation events alone are not able to adjust gene expression; 
rather it is the utilisation of additional components such as transcription factors that help 
communicate adjustments in the histone tail to the transactivation of genes.  
 
To assess the significance of global H3K9 hypoacetylation in the transcriptional control of proto-
oncogenes and apoptotic genes, chromatin immunoprecipitation was used to focus on the 
transcription factor E2F1, due to its dual role in proliferation and apoptosis (Korah et al. 2012). 
This present study identified the co-occurrence of promoter-specific H3K9 acetylation and E2F1 
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at the FOS promoter, a well-established proto-oncogene. At the 72-hour time point this 
interaction was significantly strengthened at the tolerated concentration only. E2F1 has been 
previously shown to interact in the promoter region of FOS and the retinoblastoma control 
element (RCE) and regulate the transcription of the pRb protein, an important regulatory protein 
in balancing cellular proliferation and apoptosis (Mimaki et al. 2005).  
 
After 3 hours H3K9 is hyper-acetylated at the FOS promoter similar to the global acetylation 
profile. This localised acetylation is able to stimulate significant E2F1 binding at both tolerated 
and toxic exposures. After 72 hours of exposure, H3K9 acetylation is maintained at the FOS 
promoter specifically at the tolerated treatment in both cell lines, and although global H3K9 
acetylation is reduced at this exposure, E2F1 transcription factor binding is still secure at the FOS 
promoter leading to transcription. It has been previously documented that E2F1 is able to recruit 
other histone acetyltransferases such as GCN5 to acetylate localised H3K9 residues(Guo et al. 
2011). This thesis suggests that a similar mechanism is involved as the elevated binding of PCAF 
at the FOS promoter occurs in concert with E2F1 after a tolerated treatment of 72 hours. This 
allowed for the maintained H3K9 acetylation at the promoter. Although a similar increase in 
PCAF binding is observed at the toxic exposure, this does not occur with E2F1 binding at the 
promoter, leaving FOS expression and H3K9 acetylation nominal. Furthermore, combined 
transfection with PCAF and treatment at the toxic dosage, leads to inhibited acetylation activity 
on the H3K9 substrate compared to transfected untreated controls.  
 
A study by Bi et al., was able to show a significant increase in E2F1 expression after a low 
concentration exposure to 0.5 nM – 32 nM As2O3 for 7 days in human keratinocytes (Bi et al. 
2010). This exposure elevated cellular proliferation and although an explicit mechanism was not 
stated at the time, the data in this thesis helps reconcile the significance of this finding. Another 
point of discussion is the relationship between E2F1 and PCAF. One study has attempted to 
investigate this, going so far as suggesting that E2F1 binding efficiency and transactivation ability 
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can be enhanced by PCAF-dependent acetylation of the transcription factor (Nagy & Tora 2007). 
It is however difficult to assess if this is the case in the present study as no explicit measurements 
of E2F1 acetylation were carried out.  
 
The induction of FOS has also been reported previously in human fibroblast WI-38 cells exposed 
to 50 µM – 400 µM sodium arsenite (J. Li et al. 2003). In this study, the exposure period was 
short at only 120 minutes, but successfully identified an 8.6 fold increase in FOS expression along 
with a change in histone H3K14 acetylation at the FOS promoter. This increased expression of 
FOS is corroborated in this thesis also. The same study also reported an increase in JUN 
expression, which was also reported in this thesis. MDM2 mRNA expression levels were also 
elevated specifically at the tolerated exposure acting as an additional contributor of cellular 
transformation.  
 
The data reported in this thesis demonstrates how arsenic-induced changes in global histone 
acetylation are not always reflected at the promoter specific level. Rather early perturbations in 
global histone acetylation, lead to transcription factor binding and promoter specific effects. The 
proposed mechanism in this thesis is that arsenic exposure leads to an adjustment in HDAC2 
and PCAF expression and hyperacetylation of the H3K9 residue within 3 hours. This allows for 
the early recruitment of E2F1, which after 72-hours leads to PCAF mediated H3K9 
hyperacetylation at the promoter and sustained transcription. This promoter specific effect 
occurs against a background of global H3K9 hypoacetylation.  
 
This understanding of arsenic-induced global acetylation information followed by focused 
profiling at a specific gene promoter locus is a significant step in understanding arsenic-induced 
carcinogenesis from perturbations in histone post-translational status. 
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5.7 – Disruption of Global Chromatin Conformation by Tolerated and Toxic 
As2O3 in a Time-dependent Manner.  	  
Transcriptional regulation and higher order chromatin conformation are intrinsically tethered by 
histone acetylation events which adjust the electrostatic properties of the histones (Shogren-
Knaak 2006). Chromatin relaxation is observed in a dose-dependent manner in addition to 
increases in H3K9 and H4K12 acetylation at the 3-hour time point. Extension of the exposure to 
72 hours led to chromatin condensation in the toxic exposure but normalisation of the 
chromatin architecture at the tolerated exposure in HEK293T cells. This demonstrates the 
reversibility of initial relaxation and this co-occurs with the global hypoacetylation of H3K9 and 
normalisation of H412 acetylation in HEK293T cells. Similar condensation is observed as a 
result of arsenic trioxide initiated apoptosis in the treatment of hepatocarcinoma (Alarifi et al. 
2013). This may explain why initial E2F1 binding at the toxic exposure is not maintained after a 
72-hour exposure, as the chromatin is severely condensed and E2F1 binding becomes 
unfavourable at the FOS promoter.  	  
5.8 – The Potential for As2O3-induced Crosstalk Between MicroRNAs and 
Histone Modifying Enzymes.  
 
In a review by Bailey & Fry, existing literature was examined with the remit to understand 
arsenic-associated epigenetic changes and highlight studies with clear functional consequences 
(Bailey & Fry 2014). To quote the concluding remarks of the paper, the authors suggest that 
more research is needed “…to examine the interplay between multiple epigenetic components 
that likely work in unison to mediate the toxic effects of arsenicals”.  
 
Sunniyat Rahman | Imperial College London  194 	  
Either through the presence of multiple disrupted epigenetic mechanisms running concurrently, 
or through explicit “crosstalk” between the tripartite arms of epigenetics, there is indeed a lack of 
information on the deregulation of multiple epigenetic processes in the context of arsenic-
induced carcinogenesis. This thesis has attempted to address this by seeking novel microRNA 
interactions with histone modifying enzymes under tolerated and toxic As2O3 exposure. Amongst 
the limited existing literature of arsenic-induced transformation, one study stands out because it 
presents evidence of arsenic-induced aberrations in DNA methylation, histone acetylation and 
microRNAs simultaneously. Herbert et al., were able to demonstrate that an increase in H4K16 
acetylation in normal human epidermal keratinocytes (NHEK) exposed to 0.5 µM As(III) was 
due to the miR34a-directed attenuation of SIRT1 (Herbert et al. 2014). Furthermore, long-term 
exposure led to DNA hypermethylation of both SIRT1 and miR-34a promoters and the 
subsequent reduction in H4K16 acetylation. This temporally dependent reduction in H4K16 
acetylation was also reported in this thesis. Furthermore, this study asserts the notion that 
multiple epigenetic mechanisms can lead to arsenic-induced malignant transformation.  
 
For this present study, a PCR array was used to identify differential expression profiles of miRs 
followed by a bioinformatic analysis upon these miRs to predict interactions with the histone 
acetylation machinery. Of the 26 miRs that were up-regulated 6 were predicted to interact with 
the histone modifying enzymes HDAC4, HDAC5 and PCAF. Out of these enzymes, PCAF was 
the highest scoring predicted target of the miRs, including miR-372 and mirR-106b. Independent 
of the PCR array, miR-372 expression was validated by qRT-PCR to report a significant decrease 
at 3 hours exposure, which is then inverted at 72 hours.  
 
PCAF mRNA levels at 3 hours were unchanged, but at 72 hours both a tolerated and toxic 
exposure to As2O3 resulted in a reduced PCAF mRNA. This was inversely correlated to miR-372 
expression at this time-point suggesting that PCAF mRNA could potentially be attenuated by 
miR-372. Further analysis through the utility of a PCAF 3’UTR-luciferase reporter was also able 
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to identify PCAF mRNA degradation mediated via its 3’UTR. This also resulted in a significant 
decrease in H3K9 acetylation at 72 hours. However a planned experiment to diminish miR-372 
through the use of a siRNA and examine the possibility of PCAF mRNA rescue did not come to 
fruition due to time constraints. Hence, miR-372 mediated attenuation of PCAF remains a 
possibility through correlative evidence, but due to the lack of an explicit experiment to 
investigate the interaction; a solid conclusion cannot be made. This is certainly a point of future 
investigations, as it may add further detail to the previously mentioned arsenic-induced global 
H3K9 hypoacetylation effect.  
 
The body of exiting literature regarding arsenic-induced carcinogenesis and the differential 
expression profiles of miRs is relatively small but of growing interest. One study exposed the 
human leukemic (Jurkat) T cell line to 2 µM sodium arsenite at tolerated concentrations (Sturchio 
et al. 2014). In this study, cells formed larger colonies and clumped together more readily along 
with the down-regulated expression of 8 miRs. An in silico analysis of the miRs identified 
predicted targets that were validated by qRT-PCR to be inversely correlated to the miR 
expression profiles, including RNF4, TGFß1, SP1 and CYP1A1. Sturchio et al., go on to state 
that these genes are implicated in cell-cycle progression, proliferation and apoptosis. In addition 
to this study, human lung epithelial cells (BEAS-2B) transformed by arsenic exhibited a 100-fold 
reduction in miR-199-5p expression compared to untreated controls (J. He et al. 2014). When 
miR-199-5p was overexpressed in these arsenic-transformed cells, it impaired malignant growth 
via direct targeting of HIF-1α and COX-2. Another study, used human prostate epithelial 
(RWPE-1) cells malignantly transformed by arsenic exposure to also demonstrate the aberrant 
expression of miRs (Ngalame et al. 2014). Ngalame et al., report that the reduced expression of a 
number of miRs, including miR-134, miR-155, and miR-372, was inversely correlated to the 
expression of target mRNAs including a number of RAS oncogenes. These studies describe 
mechanisms where the down-regulation of miRs contributed to the unregulated expression of 
other genes responsible for malignant transformation. In contrast, all of the miRs differentially 
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expressed in this thesis after a tolerated 1 µM As2O3 exposure for 72 hours were in fact 
overexpressed, suggesting that the respective targets of these miRs may in fact be interacting with 
target mRNAs for attenuation.  
 
Due to the lack of a longer time-point it is unclear if the elevated expression of these miRs 
sustain over prolonged As2O3 exposure. This is particularly important, as there is some evidence 
to suggest that arsenic exposure does induce temporally dependent changes in the expression of 
miRs. In one such study, PBMCs were exposed to 2 µM sodium arsenite for 72 hours, which led 
to a significant increase in miR-2909 for an exposure period up to 48 hours but this then 
dropped dramatically to almost nominal levels at 72 hours (Sharma et al. 2013). The increased 
expression of miR-2909 attenuated KL4, a tumour suppressor protein involved in the 
suppression of cyclin D1 by competing with the SP1 transcription factor at the CCND1 
promoter ultimately having consequences on cell cycle control.  
 
This thesis is the first to describe elevated miR-372 expression after tolerated arsenic exposure, 
therefore there are no existing publications exploring the significance of this induction in the 
context of arsenic-induced carcinogenesis. However there is mounting evidence to suggest miR-
372 has a significant role in carcinogenesis in general. For example, miR-372 has been shown to 
potentiate an increase in cellular proliferation through the inhibited regulation of cyclin-
dependent kinases (Voorhoeve et al. 2005). Hepatocarcinoma tissues compared to normal 
adjacent liver tissues exhibit a significant elevation in miR-372 expression and ectopic expression 
assists in cellular proliferation and invasion of human hepatocarcinoma cell lines (H. Gu et al. 
2013). MiR-372 is also believed to have proto-oncogenic properties, particularly in B-cell 
lymphoma and testicular cancer (L. He et al. 2007; Silahtaroglu & Stenvang 2010). There is an 
indicative increase in miR-372 at the toxic 5 µM As2O3 exposure that this thesis postulates is also 
responsible for PCAF attenuation.   
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To date there is no research that describes the exact mechanism of miR-372 induction following 
environmental stimulation, either through a toxicant or by other means. However, it is well 
established that microRNAs are pre-transcriptionally regulated via control imposed by 
transcription factors, epigenetically controlled through DNA methylation and histone post-
translational modifications, in addition to post-transcriptional restrictions that target the 
processing and maturation of miRs (Ha & V. N. Kim 2014). One can postulate that miR-372 
induction by arsenic occurs through a combinatorial mechanism involving transcription factors 
and epigenetic regulation. Such mechanisms have been reported previously. For example, E2F1 
has been implicated in a miRNA regulatory circuit which includes the proto-oncogene c-MYC 
(O'Donnell et al. 2005). O’Donnell et al., demonstrate that c-MYC can simultaneously activate 
E2F1 transcription and facilitate the miRNA-mediated attenuation of its translation via a cluster 
of miRs situated on chromosome 13. This finding is pertinent as a 500 nM arsenite exposure can 
lead to the overexpression of c-MYC and cellular transformation of the rat liver epithelial cell line 
– TRL 1215 (H. Chen et al. 2001). E2F1 has also been shown to explicitly regulate the 
polycistronic miR-17-92 cluster through the presence of functional E2F1 binding sites within its 
promoter region (Woods et al. 2007). Furthermore, the presence of a c-MYC-miR17-19-E2F1 
regulatory network has been postulated to help cells decide between a proliferative and apoptotic 
cell fate, similar to the core mechanism presented in this thesis (Coller et al. 2007). This thesis has 
also provided evidence of arsenic-induced perturbations of histone PTMs and higher order 
chromatin conformation. Such perturbations may also assist in the induction of miR-372, as 
promoter regions of miRs have differential histone marks including, H3K4me3, H3K9/K14ac 
and H3K27ac (Kuchen et al. 2010). Additionally promoter elements belonging to miRs are 
depleted of nucleosomes, whilst short depleted regions of 70 nucleotides allow for the 
transcriptional initiation and expression of miRs (Schanen & X. Li 2011).  
 
A finding that at first appears contradictory to the postulated miRNA-mediated attenuation 
mechanism of PCAF is the H3K9 hypoacetylation observed at 3 hours after a toxic 80 µM As2O3 
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exposure. At this time point, miR-372 and 106b expression are significantly downregulated 
making a miR-dependent mechanism for this hypoacetylation improbable. Further investigations 
into the expression of histone modifying enzymes, identified a significant increase of HDAC2 
expression at only the toxic 80 µM As2O3, making it more likely to be the cause of H3K9 
hypoacetylation at 3 hours. This is in contrast to the data presented in the HEK293T cell line for 
potentially two reasons. The first is that both 0.5 µM and 2.5 µM As2O3 exposures are tolerated 
at 3 hours in HEK293T cells, whereas the 80 µM As2O3 at 3 hours is actually toxic. Secondly the 
HDAC2 induction observed here could be an attempt at cellular survival, and through 
examination of the toxic 5 µM As2O3 exposure at 72 hours, it is clear that HDAC2 expression is 
significantly diminished. Indeed elevated HDAC2 expression has been well characterised in 
urothelial bladder cancer, with the examination of 348 tissue samples from 174 patients (Poyet et 
al. 2014). So it is notable that overexpression is observed specifically at the tolerated 0.5 µM 
As2O3 exposure in HEK293T cells, which through further assays clearly lead to cellular 
transformation, unlike the 80 µM As2O3 exposure in UROtsa cells that leads to PARP cleavage – 
a solid apoptotic marker.  
 
5.9 – Broader Implications 
 
The incorporation of epigenetic data into existing risk assessment frameworks is of considerable 
benefit, but not without some challenges. Risk assessment frameworks usually include a number 
of steps including the identification of the hazard, a dose-response assessment, a quantification 
of the exposure and a characterisation of the risk. The latter may include toxicokinetic / dynamic 
data with respect to the toxicant (http://www.epa.gov/risk_assessment/health-risk.htm, 
accessed: 01.15). 
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Epigenetic markers may be included in such risk assessments as biomarkers for a particular 
disease state following exposure to an environmental toxicant. The challenge is answering the 
questions regarding the epigenetic alterations themselves, for example are these epigenetic 
alterations dose-responsive, is the observed response specific to the toxicant, is it a genome-wide 
event or a promoter-specific event and do such events actually lead to a clear biological 
endpoint?  (Ray et al. 2014). To some extent this thesis has contributed to answering these 
questions by attempting to draw out specific cellular outcomes at specific doses, and in the 
process, characterise dosage-specific epigenetic events. This has allowed for the identification 
of global H3K9 hypoacetylation and H3K9 hyperacetylation at the FOS promoter at the 
tolerated exposure of 0.5 µM As2O3.  
 
This thesis also contributes to the debate regarding the placement of the risk threshold for 
arsenic exposure. In a news review by Schmidt, published in EHP, a number of scientists voice 
their concerns regarding the extrapolation of data from high-dose Taiwanese studies to allow for 
the placement of risk thresholds by the EPA (Schmidt 2014). Whilst some agree that the 
threshold is low enough to avoid deleterious health outcomes, others suggest that its not low 
enough, and that actually very low-dose arsenic exposure can still lead to negative health 
outcomes. The report continues by citing a number of studies that have identified low-dose 
impacts following arsenic exposure. This thesis helps by contributing to this body of knowledge, 
which may hopefully be integrated into future risk assessments of arsenic exposure.  
 
The evaluation of on-going exposures and the associated risks requires the identification of good 
biomarkers. This thesis demonstrates the challenge in identifying suitable biomarkers for arsenic-
induced carcinogenesis particularly with regards to de-regulated epigenetic mechanisms. Two 
significant insights have emerged, the first being the requirement to characterise exposure 
concentrations by determining the relevance of the exposure prior to the measurement of 
epigenetic aberrations. Secondly, more promoter-specific epigenetic aberrations need to be 
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identified that collectively lead to cellular transformation. The latter point is particularly suitable 
for the development of novel therapies, as the identification and characterisation of novel 
epigenetic pathways that lead to cancer, particularly those that impinge on specific gene targets, 
allow for the development of effective therapies (Dawson & Kouzarides 2012).  
 
5.10 – Future Prospects 
 
This thesis presents additional mechanistic detail to arsenic-induced cellular transformation by 
starting with the analysis of histone post-translation modifications. More research is needed to 
understand As2O3-induced disruptions on histone acetylation machinery. Systematic analysis of 
functional impediments imposed by As2O3 on HATs and HDACs would be of a particular 
insight as well as an investigation into a wider range of enzymatic families. A preliminary 
experiment of this sort was attempted and could be developed further (Appendix. AP1). Some of 
these enzymes also target non-histone proteins to alter the acetylation status of these proteins 
and function. This may provide a cellular network of disruption originating from the aberrations 
on the histone acetylation machinery.   
 
The identification of more promoter targets regulated by histone acetylation as a result of 
tolerated As2O3 exposure may help to further our understanding of arsenic-induced cellular 
transformation – potentially through the utility of ChIP-Seq. This study was able to identify a 
significant increase in H3K9 acetylation at the FOS promoter leading to FOS induction. To 
check if this is really crucial for cellular transformation, this gene could be silenced with siRNAs 
to examine the effect it has on soft-agar growth following long-term 0.5 µM As2O3 exposure. If 
soft agar formation is impeded, it would validate the necessity of FOS induction in arsenic-
induced cellular transformation. Whilst the 0.5 µM As2O3 exposure is tolerated in vitro it is 
difficult to extrapolate this to a concentration of environmental relevance. Hence a molecular 
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epidemiology study would help in examining if this potential biomarker is exhibited in those 
drinking arsenic contaminated water, against those that do not. Although preliminary 
experiments have not yet been conducted, it may be possible to spin-down shed urothelial cells 
from urine samples for this examination, in addition to the more standard collection of PBMCs.  
 
A significant number of miRs were overexpressed as a result of tolerated As2O3 exposure in 
UROtsa cells (Appendix. AP3). The roles of these microRNAs are still not fully understood, 
which could be elucidated with further bioinformatic processing, either through a pathway 
analysis or a larger scale attempt to identify novel targets. Such methods have been attempted 
before with some success (Nie et al. 2013). This thesis proposes that miR-372 attenuates PCAF 
mRNA, which could be examined by transfecting cells with an antisense RNA against miR-372 
to see if the PCAF mRNA levels are rescued. Additionally, miR-372 could be overexpressed in 
cells, followed by an examination of the PCAF mRNA levels to see if it is diminished. It is also 
possible to mutate the proposed seed site within the PCAF mRNA 3’UTR by utilising a genomic 
engineering tool such as CRISPR-Cas9 to destabilise the miRNA:transcript interaction, leading to 
a rescue in PCAF mRNA levels. This will also help define a region of specificity between the 
miR-372 and its potential target.  
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Appendices 
 
Appendix 1 – As2O3 exposure and functional outcomes of histone modifying 
enzymes on target lysines. 
 
A number of histone modifying enzymes were shown to have functional consequences on 
residues of interest. HEK293T cells were therefore exposed to 0.5 µM and 2.5 µM As2O3 for a 
short duration (3-hours) to identify if these functions were disrupted by the presence of As2O3. 
Cells were transfected with the histone deacetylases HDAC1, 2 and 3 in addition to the histone 
acetyltransferases PCAF, HMOF and TIP60. The acetylation status of H3K9, H4K12 and 
H4K16 was evaluated by immunoblotting (Fig. AP1).  
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+ Figure AP1: Transfections with HDACs and HATs in HEK293T cells followed by 
As2O3 treatment for 3 hours.  
 HEK293T cells were transfected with plasmids constitutively overexpressing HDAC 1, 2, 3, 
PCAF, HMOF and TIP60. Cells were also treated with 0.5 µM and 2.5 µM As2O3 followed by 
histone extraction and immunoblotting to evaluate the histone acetylation status on H3K9, 
H4K12 and H4K16. A total of 10 µg of proteins were added in each well. Total histone 3 and 
4 was used as the loading controls. N=1. 
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Appendix 2 – Confocal Image: H3K9ac and HDAC2 after 72 hours As2O3 
exposure in HEK293T cells.  
 
HEK293T cells were exposed to 0.5 µM and 2.5 µM As2O3 for 72 hours. Cells were then 
harvested and prepared for immunocytochemistry with antibodies against H3K9 and HDAC2. 
See materials and methods for additional details.  
 
 	    
DAPI - Control 
DAPI – 0.5 µM As2O3 
DAPI – 2.5 µM As2O3 
H3K9ac - Control 
H3K9ac – 0.5 µM As2O3 
H3K9ac – 2.5 µM As2O3 
HDAC2 - Control 
HDAC2 – 0.5 µM As2O3 
HDAC2 – 2.5 µM As2O3 
Merged - Control 
Merged – 0.5 µM As2O3 
Merged – 2.5 µM As2O3 
+ Figure AP2: Immunoflourecent image of H3K9ac and HDAC2 following 0.5 µM and 2.5 
µM As2O3 exposure in HEK293T cells.  
 HEK293T cells were seeded on coverslip and treated. Cells were then fixed and permeabilised 
prior to incubation with primary antibodies against acetylated H3K9 and HDAC2. See materials 
and methods for additional details.  
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Appendix 3 – Up-regulated microRNAs from the PCR array.  	  
+ Table 10: Full list of up-regulated microRNAs as a result of tolerated 1 µM As2O3 
exposure for 72 hours in human urothelial cells (UROtsa).  
 
Mature ID Fold Regulation 
hsa-miR-218-5p 200.9464 
hsa-miR-122-5p 117.6263 
hsa-miR-206 115.9828 
hsa-miR-373-3p 104.3341 
hsa-miR-196a-5p 55.4558 
hsa-miR-215 41.1 
cel-miR-39-3p 39.5846 
hsa-miR-10b-5p 36.8621 
cel-miR-39-3p 33.6881 
hsa-miR-133b 32.2509 
hsa-miR-10a-5p 30.5578 
hsa-miR-214-3p 26.9697 
hsa-miR-143-3p 23.8889 
hsa-miR-1 22.1167 
hsa-miR-144-3p 19.3273 
hsa-miR-372 15.6021 
hsa-miR-184 11.0906 
hsa-miR-142-5p 9.3727 
hsa-miR-150-5p 9.0115 
hsa-miR-155-5p 9.0003 
hsa-miR-181d 8.3447 
hsa-miR-127-5p 6.0986 
hsa-miR-124-3p 4.4923 
hsa-miR-138-5p 4.0656 
hsa-miR-134 3.7094 
hsa-miR-335-5p 3.419 
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Appendix 4 – Plasmids Maps 
HDAC1 
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HDAC3 
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HDAC4 
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PCAF 
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P300 
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3’UTR Reporter Backbone Vector 
 
Base pairs: 3910 
RPL10 Promoter: 33-307 
RenSP reporter gene (synthetic renilla luciferase; includes mODC PEST): 350-1408 
Multiple cloning region 2 (UTR region): 1409-1446 
SV40 late poly(A) region: 1455-1676  
ColE1-derived plasmid replication origin: 2001 
Synthetic Beta-lactamase (Ampr) coding region: 2792-3652 
Synthetic poly(A) signal/transcriptional pause site: 3757-3910   
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3’UTR Reporter Inserts 
 
The below represents the sequence inserted into the 3’UTR Reporter Backbone Vector to 
generate the 3’UTR PCAF(KAT2B) plasmid used in the present study.  
 
These constructs were acquired commercially from Switchgear Genomics via Active Motif.  
 
 
 
 
Product(ID S810567
Vector(name pLightSwitch_3UTR
Gene(symbol KAT2B
Insert(length 1989
Restriction(pair NHE1XHO1
NOTE
Sequence
AATGTGCCAATATCCTGGAGAAATTCTTCTTCAGTAAAATTAAGGAAGCTGGATTAATTG
ACAAGTGATTTTTTTTCCCCTCTGCTTCTTAGAAACTCACCAAGCAGTGTGCCTAAAGCA
AGGTGGTTTAGTTTTTTACAAAGAATTGGACATGATGTATTGAAGAGACTTGTAAATGTA
ATAATTAGCACTTTTGAAAAAACAAAAAACCTCCTTTTAGCTTTTCAGATATGTATTTAA
ATTGAAGTCATAGGACATTTTTATTTTATGGAATAGATTTTAATCTATTTACTACTATTA
AGGTAAATTTTCTATGGCATGTCCATTAGCTATTTCATGATAGATGATTAGGGGTTTCCT
CAAAACCTGTGTGTGAGGAAATTGCACACAGTAGCAAAATTTGGGGAAATCCATAACATT
TTCAGACCATGAATGAATGTTTCCATTTTTTTCTAATGGAATGTGAGAGTTTACTTTTAT
TTTATTCTGAAGGACTTTAAGGAAGGGATACATGATTTTAAAAAAGCCTGTAAGAGGTGA
AATATGTGATGTTTGAAGTCTCTTTATAGACTTTTTATATATATTTTTTAAAACACTCAT
CTAGATGAGGTGCTTTGAGCAGTTCTGAAAAATGCAGTTCCAGGAAAGCAACTGCTTTGG
TTCCTAAGGAAGAAATTCTAAATAATGCAAACTTTTAAAATAAGCATCTAGGTTTTTGAT
AATTCTGTCTACTTACAACAAACTTGTTAGTACATAACCACTATTTTAATAATTATTTTC
TCTACACAAATGTGTAATATCATATTTGACTTTGCTTATGCAGGCCATAAGTTCCAAAAG
ATAATTTCCCTGCCCACAAAGGCATAAACTTGAAAACACATGAGATTGAATCAACATGCT
TTAATAGGAAAAGATGTATGGTCTATATATGTATCAATCTGGTGAATCCTCGTTCTAATA
AAGGTTCTTTTTCTTTTCTATGATACACACAGCCACGCTGATAATATGCAAATGAACATT
TTCCTTTATGTCTCTCCAGATAATGTTTATTGTCTGAGGTAAATTAAATTCCCACCAGGG
TTTGCTGTCAGTATTTTAACACCCACATTAGTATATGCGTCCAGGGTCATAACCCCCTAA
AATCCATCATGCAACCTTATTAATCTGTCTTGGGATTCCAGTTTAGTGCTTGGATTTATT
TCCTGATTACACTACATAGAAAAGTGAGACATCTGCCATTCCCAACTCTGGGAAAACCAA
CTAATATACAACCATATAAATGAAGGCCATCTTGATGGTCTCAACACTAATTTTTATGAT
GCAAATTTATACACTGATTTTTGTAAAGGACAAAGTTTTAAAAGCGTATTTAACTTGATG
TTTTCTATCAGCATAAATAAAATGGTCATGAATAGTCATTAAAAACAGTTGCCAGTGATA
ATCTGCATGAAGGAAAAAGAACCCTGCAAATGGCTATTGAGTTGGAAGTATTGTTTTTGA
TATGTAAGAGATATTCAGAATGCTCACACTGAAAATGCCTCAACTTTTTAAAGTGTAAGA
AACCACCATGAGTGGTGTCTAGATTTCTAATGAAGAATCATGATACAGTTTGGATTAAGT
ATCTTGGACTGGTTTTAAACAGTGCTTTGTACCGGATCTGCTGAAGCATCTGTCCAGCTG
GTATCCTGTGAAAGTTTGTTATTTTCTGAGTAGACATTCTTATAGAGTATTGTCTTTAAA
ATCAGATTGTCTCTTCTATATTGAAAGCATTTTTATGTTTTCTAATTTAAAAATTAATAT
TTTCTTATAGATATTGTGCAATAAAGCTGAAGTAGAATGTGTGGTTTTTGCAAATGCTTT
AACAGCTGATAAAAATTTTACATTTGTAAAATTAATATATTGTACTGGTACAAAATAGTT
TTAAATTATATTTTAAAAAGCTTCCAATCTTGTGGTGTGTTTTATTCATTCAGTAGGCTG
AGGTTAACA
